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Progression through the cell cycle is central to cell proliferation and fundamental 
in growth and development of all multicellular organisms, including higher plants. 
A central role in the regulation of the cell cycle is played by the cyclin-dependent 
kinases (CDKs) (chapter 1). CDK activity is controlled by a variety of 
mechanisms, including by docking of a family of mainly low molecular weight 
proteins called CDK inhibitors (CKIs), which negatively regulate CDK activity by 
tight association with CDK/cyclin complexes. The Arabidopsis thaliana genome 
contains seven CKI genes called KRPs (Kip related proteins), because of their 
homology with the mammalian CKIs of the Kip/Cip family (chapter 2). The goal of 
this research was to decipher the role of KRPs during the cell cycle and in plant 
growth and development. 
Most part of this work (chapter 3, 4 and 5) focuses on a detailed analysis of 
KRP2.  
Analysis of Arabidopsis plants overexpressing KRP2 illustrated a role for KRP2 as 
activator of the mitosis-to-endocycle transition (chapter 3). Moreover, we showed 
that KRP2 protein abundance is regulated through CDK phosphorylation and 
proteasomal degradation and propose a mechanism in which CDKB1;1 controls the 
level of CDKA;1 activity through regulating KRP2 protein abundance.  
In chapter 4, the effect of CDK phosphorylation on KRP2 function and stability was 
studied in more detail and proven to alter the CDK binding-specificity and to 
enhance the degradation of KRP2. We also show that CKS1 regulates KRP2 
function, indirectly by competing with KRP2 for CDKA;1 interaction, and directly 
through binding and destabilization of KRP2.  
Deletion mapping and mutagenesis of KRP2 identified its functional domains 
involved in protein stability and CDK and cyclin interaction and revealed that CDK 
inhibition requires tight association of KRP2 with both the CDK and cyclin subunit 
(chapter 5). Furthermore, analysis of KRP2 mutants with impaired CDK inhibitory 
activity suggested a possible dual role for KRP2 as CDK regulator.  
Finally, in chapter 6, we present the partial molecular analysis of a KRP interacting 
KBR1 RING finger protein and suggest a possible function of RFP1 in the 
degradation of KRPs and other stress induced negative regulators of cell cycle and 
plant growth.   
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 Introduction 
The plant cell cycle 
       
 
Introduction  
      
 
Cell division is one of the most conspicuous features of life, and thus the main 
events in the control of cell cycle regulation are highly conserved throughout 
evolution (Amon, 1998; Leatherwood, 1998). However, despite this overall 
evolutionary conservation, individual mechanisms of cell cycle control vary 
considerably between different species. Plants have unique features that give the 
control of cell division particular importance, including their post-embryonic organ 
initiation and growth throughout the entire plant lifespan from specialized regions 
called meristems, the absence of cell migration, and the responsiveness of 
growth rate and development to changes in environmental conditions. Plant cell 
division therefore plays a role both in the developmental processes that create 
plant architecture and in the modulation of plant growth rate in response to the 
changing environment (Cockcroft et al., 2000; Menges et al., 2002). 
 
The central convergence point of eukaryotic cell cycle control, where intrinsic and 
extrinsic cues are integrated, is a group of heterodimeric Ser/Thr kinase 
complexes, consisting of a catalytic subunit, the cyclin-dependent kinase (CDK), 
and an activating cyclin subunit (Nigg, 1995). CDKs comprise several subtypes, 
based on the constituents of a catalytic and a regulatory subunit (Pines, 1994). 
CDK activity is highly regulated at specific stages of the cell cycle by a number of 
events including availability of cell cycle components (through transcriptional and 
translational regulation and proteolysis) (Peters, 1998), post-translational 
modifications, subcellular localization, and interaction with other regulatory 
proteins (Lees, 1995). The coordinated progression through the cell cycle occurs 
through the phosphorylation of a plethora of substrates by activated CDKs, 
resulting in the entry into a new round of DNA replication and the entry into 
mitosis, respectively. This chapter focuses on the different classes of plant CDKs 
and cyclins, and summarizes our current knowledge on cell cycle regulation in 
plants, compared to what is known in other eukaryotes.   
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Plant CDKs     
      
 
Since the identification of the yeast cdc2 (S. pombe) and CDC28 (S. cerevisiae) 
(Lörincz and Reed, 1984; Nasmyth and Reed, 1980) a multitude of CDK related 
kinases  have been isolated and characterized in different organisms, including 
plants (Mironov et al.,1999). While in yeast a single CDK is responsible for 
initiating all cell cycle transitions, different CDKs with specialized functions during 
the cell cycle exist in higher eukaryotes. The plant CDKs have been classified into 
six (A to F) subtypes (Joubès et al., 2000a). In the Arabidopsis thaliana genome, 
12 CDKs have been identified, displaying a high degree of homology with yeast 
and animal CDKs (Vandepoele et al., 2002). The functions of the A- and B-type 
CDKs are the best documented.  
 
CDKA 
A-type CDKs are related to yeast cdc2/CDC28 and animal CDK1/CDK2. All 
members of this class contain the conserved PSTAIRE motif in the cyclin-binding 
domain and have been shown to functionally complement yeast cdc2/CDC28 
mutations (Colasanti et al., 1991; Ferreira et al., 1991; Hirt et al., 1991, 1993; 
Fobert et al., 1996). CDKA mRNAs are expressed throughout the cell cycle, and 
their protein kinase activity becomes activated at both the G1/S and G2/M 
transitions (Martinez et al., 1992; Hemerly et al., 1993; Bögre et al., 1997; Magyar 
et al., 1997).  
CDKA;1 transcripts are confined to tissues in which the cells have retained the 
capacity to divide and are induced upon cell division stimulating treatments, 
suggesting the involvement of CDKAs in cell proliferation and maintenance of cell 
division in non-proliferating tissues (Hemerly et al., 1993). However, CDKA 
activity within cells is not regulated at the level of its expression as constitutive 
overexpression of Arath;CDKA;1 in either Arabidopsis or tobacco did not affect 
plant development (Hemerly et al., 1995). Rather its activity is regulated at the 
posttranscriptional level, and constitutive overexpression of a CDKA;1 dominant-
negative (CDKA;1.DN) mutant allele, which does not posses kinase activity, 
causes lethality in transgenic Arabidopsis plants and a severe inhibition of cell 
proliferation in transgenic tobacco plants (Hemerly et al., 1995). Interestingly, this 
reduction in cell number was accompanied by an increase in cellsize, but did not 
affect plant morphogenesis of CDKA;1.DN tobacco plants, illustrating the 
flexibility of plant development in relation to cell number.  
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CDKB 
B-type CDKs constitute the second major group of CDKs involved in plant cell 
division. Unlike the CDKA, the expression of the B-type CDK genes is under strict 
cell cycle control as transcripts and proteins peak mainly from S phase till mitosis 
(Hirayama et al., 1991; Fobert et al.,1996; Segers et al.,1996; Magyar et al.,1997; 
Joubès et al., 2000a). In accordance, kinase activity of B-type CDKs is 
predominantly linked to mitosis (Sorrell et al., 2001; Porceddu et al.,2001). B-type 
CDKs are subdivided in two groups B1- and B2-type CDKs, distinguished by the 
PPTALRE or PPTTLRE amino acid motif in their respective cyclin-binding domain 
and are unable to functionally complement temperature-sensitive cdc2 yeast 
mutants (Imajuku et al., 1992; Fobert et al., 1996).  
In etiolated seedlings, expression of the Arabidopsis CDKB1;1 gene is correlated 
with the elongation rate of the hypocotyls. Inhibition of CDKB1;1 gene expression 
by an antisense construct resulted in short hypocotyls and open cotyledon 
phenotypes when transgenic seedlings were grown in darkness, indicating a role 
for CDKB1;1 in hypocotyl cell elongation and cotyledon cell development 
(Yoshizumi et al., 1999). Moreover, cotyledons of antisense lines fail to green 
when transferred from darkness to light, which is attributed to the conversion of 
etioplasts to amyloplasts. Recently CDKB1;1 has been postulated to have a 
function in stomatal development, as it is highly expressed in guard cells and 
stomatal precursor cells of cotyledons (Boudolf et al., 2004a). In accordance, 
transgenic Arabidopsis plants with reduced B-type CDK activity show a 
decreased stomatal index due to an early block of stomatal precursor cell 
division. Many aberrant stomata cells were observed that were blocked in the G2 
phase of the cell cycle. Although division of stomatal precursors was inhibited, 
cells still acquired stomatal identity, illustrating that stomatal cell differentiation is 
independent of cellular and nuclear division. In addition to their stomatal 
phenotype, Arabidopsis plants overexpressing a dominant negative allele of 
CDKB1;1 were found to undergo premature endoreduplication, demonstrating a 
function of CDKB1;1 in the control of the timing of endocycle onset (Boudolf et al., 
2004b). 
 
CDKC 
Several plant C-type CDKs have been isolated and characterized from different 
species (Feiler and Jacobs, 1991; Magyar et al., 1997; Burssens et al., 1998; 
Joubès et al., 2001; Barroco et al., 2003; Fulop et al., 2005). Members of the C-
type CDK group are characterized by the presence of a PITAIRE motif in the 
cyclin binding domain. This motif is also present in the human cholinesterase-
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related cell-division controller (CHED) kinases that are suspected to be involved 
with megakaryocyte differentiation in hematopoiesis (Lapidot-Lifson et al., 1992).  
Although CDKC function is poorly documented, CDKCs were recently partially 
characterized and suggested to have a function in the control of the 
transcriptional machinery (Barroco et al., 2003; Fulop et al., 2005). T-type cyclins 
were identified as binding partner of the CDKCs. Plant CYCT shares homology 
with animal cyclins from the T and K group that bind CDK9, a CDK containing the 
divergent PITALRE motif that has a function in transcription elongation (De Falco 
and Giordano, 1998; Bregman et al., 2000), suggesting that CDKC proteins are 
functional homologues of CDK9. Arath;CDKC expression was not detected in 
actively dividing Arabidopsis tissues and transcripts were mainly confined to 
epidermal cells of differentiated flower tissues (Barroco et al., 2003). This is in 
accordance to what has been described for animal CDK9, that is present in 
elevated levels in terminally differentiated cells (Price, 2000), suggesting the 
implication of CDKCs in the molecular mechanisms triggering cell differentiation.  
 
CDKE 
E-type CDKs harbour the SPTAIRE motif and were identified in alfalfa and 
Arabidopsis (Joubès et al., 2000a; Vandepoele et al., 2002). CDKE expression in 
synchronized alfalfa cells displays a weak constitutive signal throughout the cell 
cycle (Magyar et al., 1997). 
Recently, the Arabidopsis HUA ENHANCER3 (HEN3) gene was mapped and 
found to encode CDKE (Wang and Chen, 2004). HEN3 exhibits CTD kinase 
activity, like human CDK8, which regulates transcription through the 
phosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II 
(Rickert et al., 1996). This means that CDKE could play a regulatory role in 
transcription. Moreover, E-type CDKs are proposed to have a function in cell 
differentiation since the HEN3 mutation affected the specification of stamen and 
carpel identity and the proper termination of stem cells in the floral meristem. 
 
CDK-activating kinases CDKD and CDKF 
CDK activation requires, beside cyclin interaction, the phosphorylation of a 
conserved Thr residue by CDK-activating kinases (CAKs). In plants CAKs were 
classified in two groups: the D- and the F-type CDKs (Vandepoele et al., 2002; 
reviewed by Umeda et al., 2005). Till now the D-type class of CDKs comprises 
one rice CAK (Orysa;CDKD;1, R2) and three Arabidopsis CAKs (Arath;CDKD;1-
3). 
CDKDs are related to the mammalian CDK7 kinases that regulate both cell cycle 
progression through the phosphorylation of other CDKs (CAK activity), and basal 
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transcription through phosphorylation of the CTD of the largest subunit of RNA 
polymerase II (CTD kinase activity) (Harper and Elledge, 1998). Rice CDKD;1 
was shown to be able to complement a CAK-deficient mutant of budding yeast, to 
display both CAK and CTD kinase activity and to be positively regulated by 
cyclinH, as described for CDK7 kinases (Yamaguchi et al., 1998 and 2000). From 
the Arabidopsis CDKDs only CDKD;2 and CDKD;3 were shown to phosphorylate 
both CDK and CTD, and CDKD;3 was able to complement temperature sensitive 
CAK1 mutants of budding yeast (Shimotohno et al., 2003).  
The Arabidopsis CDKF;1 displays similarity to CDK7 only in restricted domains 
and has CAK activity, but no CTD kinase activity, despite the observation that it 
can complement yeast CAK1-deficient mutants (Shimotohno et al., 2003). 
Recently, it was shown that CDKF;1 acts as a CAK-activating kinase (CAKAK) 
since it possesses cyclinH-independent kinase activity and is able to 
phosphorylate D-type CDKs, resulting in the activation of the CTD kinase activity 
of CDKD;2 in vitro and in root protoplasts (Shimotohno et al., 2004). Inducible co-
suppression of Arabidopsis CDKF;1 using either sense or antisense constructs 
resulted in a gradual reduction of CDK activity and caused premature 
differentiation of initial cells in the root meristem, suggesting a function of CDKF;1 
in differentiation (Umeda et al., 2000).  
 
 
Plant cyclins 
      
 
By definition, all CDKs share the feature that their enzymatic activation requires 
the binding of a regulatory cyclin subunit. Crystallographic studies of human 
CDK2 and its partner cyclinA revealed that CDKs display a bilobal structure (De 
Bondt et al., 1993; Jeffrey et al., 1995; Russo et al., 1996). The cofactor ATP 
binds deep within the cleft between the two CDK lobes, with its phosphates 
oriented outward. In protein kinases other than CDKs, the protein substrate 
interacts with the entrance of the active site cleft, but this region is obscured in 
monomeric CDKs by a large flexible loop called the T-loop. Moreover, key 
residues in the ATP-binding site are misoriented in the CDK monomer, further 
contributing to its inactivity. CDK activation through cyclin interaction therefore is 
accompanied with significant structural changes in the CDK active site.  Major 
changes involve the repositioning of the T-loop that `releases´ the protein 
substrate-binding site, and the reconfiguration of the ATP binding site that 
corrects the positioning of the ATP phosphates for the phophotransfer reaction to 
the substrates (Jeffrey et al., 1995).  
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Multiple cyclins have been isolated in plants according to their sequence 
homology with well characterized cyclins in other eukaryotic systems as well as 
by complementation of yeasts deficient in the expression of specific cyclins 
(Sauter et al., 1995; Umeda et al., 1999b, Yamaguchi et al., 2000). They can 
broadly be classified into G1 and mitotic cyclins, according to their expression 
pattern during the cell cycle.  Genome-wide analysis of the Arabidopsis cyclin 
gene family revealed a much greater complexity than that reported for cyclin 
genes in animals (Vandepoele et al., 2002). Plant cyclins are classified in three 
main groups (A-, B-, and D-type cyclins) according to their expression pattern and 
function during the cell cycle, and three other types (C-, H-, and T-cyclins) that 
are less well characterized (Renaudin et al., 1996; Yamaguchi et al., 2000; 
Barroco et al., 2003; Fulop et al., 2005).  
 
Plants contain a large number of mitotic cyclins, no fewer than 21 in Arabidopsis, 
belonging to three A-type (CYCA1, CYCA2 and CYCA3) and three B-type 
(CYCB1, B2 and B3) subclasses (Renaudin et al., 1996; Vandepoele et al., 2002; 
Wang et al., 2004).  
In synchronized tobacco BY2 cells, different A-type cyclins are expressed 
sequentially at different time-points during the cell cycle. The expression of two 
CYCA3s was upregulated at the G1/S transition, whereas a CYCA1 was induced 
at mid-S phase (Reichheld et al., 1996). The alfalfa A2-type cyclin 
Medsa;CYCA2;2 is expressed in all phases of the cell cycle, but its associated 
kinase activity peaks both in S-phase and during the G2/M transition (Roudier et 
al., 2000). These molecular data, together with different cellular compartmental 
localizations suggest that A-type cyclins may have different functions in plants 
(Roudier et al., 2000; Mews et al., 1997; Criqui et al., 2001; Yu et al., 2003). 
Antisense expression of Medsa;CYCA2;2 in alfalfa halted regeneration of somatic 
embryos, suggesting a role for CYCA2;2 in the formation or activity of apical 
meristems (Roudier et al., 2003).  Arabidopsis plants overexpressing 
Nicta;CYCA3;2 show a dramatically modified morphology and a reduced cell 
differentiation and endoreduplication, implying a positive association with cell 
proliferation (Yu et al., 2003).  
B-type cyclins are expressed within a narrow time window from late G2- to mid 
M-phase, and the ectopic expression of both Arath;CYCB1;1 and Oryza;CYCB2;2 
accelerates root growth without altering root morphology (Doerner et al., 1996; 
Lee et al., 2003). Ectopic expression of Medsa;CYCB2;2 in developing tobacco 
plants interferes with differentiation events and specifically blocks root 
regeneration (Weingartner et al., 2003).  
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In addition to mitotic cyclins, plants also contain a large number of D-type 
cyclins. CYCDs have been described as G1-specific cyclins on the basis of their 
capacity to rescue yeast mutants lacking endogenous G1 cyclins (Soni et al., 
1995).The expression of several  D-type cyclins is regulated by nutrient 
availability and hormones (reviewed by Dewitte et al., 2003). In synchronized 
Arabidopsis cell cultures, most CYCDs increase during cell cycle re-entry, but 
during the subsequent cycles their transcripts remain relatively constant (Menges 
et al., 2003). They are proposed to be sensors of growth conditions and 
presumed to regulate the G1/S transition by activating the Rb/E2F-DP pathway 
(Gutierrez et al., 2002; Shen, 2002; Trimarchi and Lees, 2002). However, 
evidence points to an additional function of plant D-type cyclins at the G2-to-M 
transition (Sorrell et al., 1999; Schnittger et al., 2002a; Kono et al., 2003; Koroleva 
et al., 2004). Transgenic tobacco plants overexpressing Arath;CYCD2;1 show an 
increased cell division rate and a shortened G1 cell cycle phase (Cockcroft et al., 
2000). Ectopic expression of CYCD3;1 in Arabidopsis results in hyperplasia in 
leaves and dramatically affects plant morphogenesis, demonstrating that 
CYCD3;1 promotes the proliferative phase of mitotic cycles and inhibits 
differentiation (Riou-Khamlichi et al., 1999; DeWitte et al., 2003).  
Genes encoding H-type cyclins have been identified in Arabidopsis, rice and 
poplar and are believed to be the regulatory subunit of CAKs (Yamaguchi et al., 
2000; Vandepoele et al., 2002). In rice and poplar high CYCH transcript levels are 
associated with dividing cells. Rice cyclinH interacts specifically with 
Orysa;CDKD;1, increases its kinase activity and enhances the rescue by CDKD;1 
of a CAK mutant in budding yeast (Yamaguchi et al., 2000). 
C-, and T-type cyclins are till now not experimentally characterized in plants. 
They are proposed to be involved in the control of the transcription machinery 
(Barroco et al., 2003; Fulop et al., 2005).  
 
  
The coordinated progression of the cell cycle depends on the timely activation of 
CDKs that is, in part, regulated by the cell-cycle dependent oscillation of cyclins. 
Regulation of cyclin abundance occurs through repetitive rounds of highly 
controlled cyclin gene transcription and cyclin proteolysis.  
Little information about transcriptional regulation of plant cyclins is available. Plant 
B-type cyclin promoters  contain a common cis-acting element, called the M-
specific activator (MSA) element, which is necessary and sufficient to direct 
G2/M-specific gene expression (Ito et al., 1998; Tréhin et al., 1999; Ito et al., 
2001). Three different MYB-like proteins (Nicta;MYBA1, A2 and B) were shown to 
specifically interact with the MSA element (Ito et al., 2001). Nicta;MYBA1 and 
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Nicta;MYBA2 are expressed specifically at the G2/M transition, when B-type 
cyclins are transcribed, while Nicta;MYBB is expressed constitutively. Moreover, 
A-type MYBs are activators of MSA-containing promoters, whereas Nicta;MYBB 
is a repressor. Interestingly, a MYB protein also activates cyclinB transcription in 
Drosophila, indicating some similarity between the mechanisms of cyclin 
transcription regulation in plant and animal cells (Okada et al., 2002). 
Cyclin degradation occurs mainly through ubiquitin-dependent proteolysis. Mitotic 
cyclins are degraded during or at the end of mitosis by the proteasome, after 
ubiquitination by the highly conserved anaphase-promoting complex/cyclosome 
(APC/C) (King et al., 1996; Zachariae et al., 1996). G1 cyclins are highly unstable 
owing to the action of non-APC/C ubiquitinating Skp1-Cdc53/Cullin-F-box protein 
(SCF) complexes (Willems et al., 1996; Patton et al., 1998). APC/C complex 
substrates are characterized by the presence of a short peptide motif, called the 
D-box, which is necessary for their degradation during mitosis. The fact that most 
plant mitotic cyclin sequences contain a D-box and that the APC/C subunits are 
conserved in plants suggest that plant mitotic cyclins may be APC/C targets 
(Vandepoele et al., 2002; Capron et al., 2003b). Indeed, the existence of a D-box 
pathway in plants was proven (Genschik et al., 1998). Moreover, both an A2-type 
cyclin from Medicago and an A3-type cyclin from tobacco seemed to be degraded 
in early M phase (Roudier et al., 2000; Criqui et al., 2001).  Furthermore, it is 
shown that a proteasome inhibitor induces tobacco cyclinB1 accumulation, 
suggesting degradation by the ubiquitin-dependent pathway (Criqui et al., 2000). 
The functional relevance of this cyclin destruction is exemplified by the 
observation that overexpression of a nondegradable B1-cyclin, lacking the D-box, 
causes severe growth retardation and abnormal development, with a higher 
percentage of cells exhibiting duplicated ploidy levels than in the controls 
(Weingartner et al., 2004). The proteolysis of a B2-type cyclin in early mitosis has 
also been reported, but surprisingly seemed proteasome-independent 
(Weingartner et al., 2003). Little is known of the stability or mechanisms of 
turnover of G1 cyclins in plants. Recently, Arath;CYCD3;1, but not CYCD2;1, has 
been shown to be a highly unstable protein whose proteolysis is mediated by the 
ubiquitin-dependent proteasome (Planchais et al., 2004). Interestingly, in plants 
silenced for Arath;Rbx1, a component of the SCF complex, CYCD3;1 protein was 
stabilized (Lechner et al., 2002). However, the identity of the F-box component of 
the SCF complex involved in CYCD3;1 recognition and targeted proteolysis 
remains elusive.  
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CDK/cyclin regulation    
      
 
Although cyclin binding is the primary determinant of CDK functioning, layers of 
additional regulatory subunits and protein kinases restrict CDK/cyclin activity to 
ensure the correct temporal progression of events leading to the faithful 
duplication of cells (Figure 1).  
 
 
 
Figure 1. Regulation of CDK activity. For details, see text. ⊥ represents inhibitory events, 
→ activating events. Both cyclins and some KRPs are regulated by synthesis and 
ubiquitin-mediated proteolysis.  
 
In addition to cyclin binding, full activation of the CDK/cyclin complex requires the 
phosphorylation of a conserved Thr residue in the T-loop of the CDK (Thr160 in 
human CDK2) by a CDK activating kinase (CAK) (Russo et al., 1996; Brown et 
al., 1999). In plants several CAK kinases, that complement S. cerevisiae CAK 
mutations and that phosphorylate CDKs, have been described (Shimotohno et al., 
2003).  
Although inactivation of CDK/cyclin complexes can be achieved by ubiquitin-
mediated degradation of cyclins (Peters, 2002), a distinct mode of reversible 
inactivation can be triggered through phosphorylating crucial residues, equivalent 
to Thr14 and Tyr15 of human CDK2, located within the CDK ATP-binding loop 
(Nurse, 1997). This phosphorylation is catalyzed by the WEE1 kinase and is 
counteracted by the dual-specificity phosphatase CDC25. Plants possess a 
WEE1 kinase which is involved in the inhibitory phosphorylation of CDKs (Sun et 
al., 1999; Sorrell et al., 2002). Recently, the primitive unicellular algae, 
Ostreococcus tauri has been found to contain a bona fide CDC25, that is able to 
activate purified CDK/cyclin complexes and to suppress a cdc25-22 mutant in S. 
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pombe (Khadaroo et al., 2004). However, in both Arabidopsis and rice, no genes 
with high homology to yeast or animal CDC25 genes have been identified (Buell, 
2002; Vandepoele et al., 2002). Nevertheless, evidence suggests that higher 
plants also have a phosphatase that can activate CDK/cyclin complexes. Inactive 
CDK complexes purified from tobacco cell suspensions arrested in G2 phase by 
cytokinin starvation can be activated upon incubation with the yeast CDC25 
protein (Zhang et al., 1996). Recently, a small protein with dual-specificity 
CDC25-like phosphatase activity has been identified in Arabidopsis. This CDC25-
like protein consists of a sole catalytic domain, has tyrosine phosphatase activity 
and is able to stimulate Arabidopsis CDK activity (Landrieu et al., 2004). The in 
vivo role of this CDC25-like protein, however, remains to be determined. 
 
Further mechanisms of modulating CDK activity exist through the action of 
inhibitors and scaffolding proteins.  
CDK inhibitors inhibit CDK activity by tight association with CDK complexes 
(Nakayama and Nakayama, 1998). All known plant CDK inhibitors share a 31-
amino-acid domain with p27Kip1, a member of the mammalian Kip/Cip family of 
protein inhibitors. Based on this similarity, plant CDK inhibitors were designated 
Kip-related proteins (KRPs, De Veylder et al., 2001a). KRPs interact with CDKA 
and D-type cyclins, but not with CDKBs (Wang et al., 1998; Lui et al., 2000; De 
Veylder et al., 2001a; Jasinski et al., 2002; Zhou et al.,2002). They were shown to 
inhibit CDK activity in vitro (Wang et al., 1997; Lui et al., 2000; Jasinski et al., 
2002; Verkest et al., 2005; Coelho et al., 2005), whereas their overexpression in 
plants results in a decrease in kinase activity in vivo (Wang et al., 2000; De 
Veylder et al., 2001a; Zhou et al., 2002). Plant KRPs function in regulating the cell 
cycle during development and in response to environmental signals (chapter 2).  
The CKS (CDK subunit) proteins represent another class of conserved proteins 
that interact with CDKs and regulate their activity. Arabidopsis contains two 
homologues of the yeast p13Suc1 (De Veylder et al., 1997; Vandepoele et al., 
2002). Although CKS proteins are widely used as an affinity matrix for the 
purification of CDKs their function remains mostly elusive. Crystallographic 
studies of the human CKS/CDK2 complex suggest that these proteins function as 
a docking factor for both positive and negative regulators of CDKs (Bourne et al., 
1996). In situ expression analysis of Arath;CKS1 revealed that CKS1 transcripts 
are present in both mitotically dividing and endoreduplicating cells (Jacqmard et 
al., 1999), suggesting that it is required for both modes of the cell cycle.  
Overexpression of Arath;CKS1 in Arabidopsis causes a prolongation of cell-cycle 
duration and strongly reduced meristem size, implying a role in the inhibition of 
the mitotic cell cycle (De Veylder et al., 2001b).   
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Mitotic cell cycle 
   
 
Several variations in the cell cycle occur in nature, but the most common, and 
best studied, form is the mitotic cell cycle comprising four different stages. In this 
cycle DNA replication (S phase) is directly followed by the segregation of the 
duplicated genetic material between two daughter cells, a process called mitosis 
(M phase). Both the S and M phase are proceeded by a preparative phase (G1 
and G2 phase). During the G1 phase, cells monitor their size and environment, 
whereas one of the tasks performed during the G2 phase is to ensure that DNA 
duplication has been completed. Although many core cell cycle genes have been 
cloned, the mechanisms that control the orderly progression through the cell cycle 
in plants have only recently started to be understood (reviewed by De Veylder et 
al., 2003).  
 
G1-S transition and DNA replication 
The mechanism that regulates progression through G1 and transition to S-phase, 
thereby initiating genome duplication, appears to be conserved between 
mammals and plants and is controlled by the retinoblastoma/E2F pathway. 
Mitogenic stimulation induces accumulation of D-type cyclins that bind specific 
CDKs and initiate the phosphorylation of the retinoblastoma (RB) protein, a key 
regulator of the start of DNA replication (Weinberg, 1995). In its non-
phosphorylated form RB binds E2F/DP transcription factors which activate DNA-
synthesis genes, but its phosphorylation counteracts the inhibitory function of RB, 
and releases E2F/DP.  
RB-related genes (RBR) were first discovered in maize and later in other plant 
species (Grafi et al., 1996; Vandepoele et al., 2002). RBR functions as a negative 
regulator of cell proliferation because Arath;RBR1 mutants fail to arrest mitosis of 
haploid nuclei (Ebel et al., 2004). Similarly, inhibition of Nicta;RBR1 using virus-
induced gene silencing induced prolonged cell proliferation coupled with delayed 
cell differentiation in the leaves and stems of tobacco plants (Park et al., 2005). 
The RBR protein is phosphorylated by CDKA/CYCD complexes in a cell-cycle-
dependent manner, reaching its maximum at the G1/S transition and remaining 
high until mid/late S phase (Boniotti et al., 2001; Nakagami et al., 2002). Although 
not experimentally proven, it is believed that in analogy with mammalian systems, 
this phosphorylation inactivates RBR and relieves repression of E2F/DP 
transcription factors. CYCD3 cyclins seem to play an important function in this 
process, because overexpression of Arabidopsis CYCD3;1 or tobacco CYCD3;3 
stimulates cells to exit the G1 phase (Nakagami et al., 2002; Dewitte et al., 2003). 
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Conversely, KRPs are suggested to prevent CYCD3/CDK phosphorylation of 
RBR, as overexpression of KRPs in Arabidopsis completely complements the 
phenotype induced by CYCD3;1 overproduction (Jasinski et al., 2002; Zhou et al., 
2003). In addition, overexpression of Arath;KRP1 in trichomes is able to restore 
the phenotype induced by CYCD3;1 overexpression (Schnittger et al., 2003). In 
parallel, additional mechanisms control CYCD3/CDK activity. Full kinase activity 
and nuclear localization of CYCD3 was shown to require its phosphorylation by 
an unknown upstream working kinase (Nakagami et al., 2002). Moreover, it is 
suggested that CAK activity could be responsible for activation of CYCD/CDK 
complexes, since overexpression of rice CDKD accelerates S-phase entry 
(Fabian-Marwedel et al., 2002). 
E2F/DPs regulate the expression of genes involved in DNA synthesis and 
replication. The Arabidopsis genome comprises three E2Fs, two DPs and three 
monomeric DP-E2F-like (DEL) genes (Vandepoele et al., 2002). Both E2Fa and 
E2Fb are transcriptional activators, whereas E2Fc and DELs are believed to be 
repressors of E2F/DP target genes (Kosuhi and Ohashi, 2002; Mariconti et al., 
2002). Transient overexpression of E2Fa and DPa induces non-dividing 
mesophyll cells to re-enter S phase (Rossignol et al., 2002), whereas their 
constitutive overexpression induces ectopic cell divisions because of a delay in 
cell differentiation (De Veylder et al., 2002; Kosugi and Ohashi, 2003). Co-
overexpression of E2Fb and DPa in tobacco BY-2 cells leads to a shortening of 
cell cycle duration due to the promotion of both the G1-S and G2-M transitions 
(Magyar et al., 2005). The repressive function of E2Fc was proven by the 
negative effect of the overproduction of a stable form of E2Fc on cell division. 
Furthermore, this overexpression was correlated with decreased expression of 
the known E2F/DP target gene CDC6 (del Pozo et al., 2002). Interestingly, E2Fc 
was shown to be a CYCD/CDKA substrate, whose phosphorylation results in 
ubiquitin-mediated proteasomal degradation of E2Fc. In a competition assay, DEL 
expression antagonizes E2F/DP function, suggesting their role as transcriptional 
repressors (Kosugi et al., 2002). In agreement, DEL1 was proven to suppress 
transcription of DNA replication genes (Vlieghe et al., 2005). The function of DEL3 
on the other hand is less clear, since DEL3 doesn’t affect the endocycle or the 
expression of genes involved in S-phase. Instead it affects a subset of genes 
involved in plant cell wall biogenesis, and is believed to regulate hypocotyl cell 
growth and expansion (Ramirez-Para et al., 2004). 
  
E2F/DPs regulate target gene expression through interaction with E2F-sites in 
their promoters. A database search, in which the Arabidopsis genome was 
screened for genes harboring the E2F binding promoter element, identified 
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numerous genes involved in DNA synthesis and replication (Ramirez-Parra et al., 
2003), and micro-array analyses on E2Fa/DPa overexpressing plants has 
identified some of these as bona fide targets (Vlieghe et al., 2003; Vandepoele et 
al.,2005). Several of these are pre-replicative complex (RC) genes (e.g. CDC6, 
Cdt1, ORC1, MCMs) that regulate initiation of DNA replication. Initiation of DNA 
replication requires licensing of sequences called replication origins. Licensing 
consists of the sequential recruitment of pre-RC multiprotein structures to DNA 
replication origins (Takeda and Dutta, 2005). When DNA synthesis begins, pre-
RC components are inactivated, preventing the origins of replication from re-
replicating the genome until M-phase is completed. Despite the high conservation 
of pre-RC components in eukaryotes, the regulatory network controlling their 
function is extremely diverse in different model systems and very little is known of 
its complexity in plants (Bryant et al., 2001). It is generally accepted that the 
proper and timely control of DNA replication is regulated at several levels, 
including transcription, phosphorylation, subcellular localization, or proteolysis. 
CDK activity plays a crucial role both in triggering DNA initiation of pre-RCs at 
G1/S and in inhibiting pre-RC formation during S and G2 phase. In Arabidopsis 
ectopic expression of CDC6 and Cdt1 induces in a cell-type specific manner 
either enhanced cell proliferation or enhanced DNA endoreduplication, illustrating 
their function in S-phase (Castellano et al., 2001 and 2004). Both E2F targets are 
regulated by proteasome-mediated degradation, which at least in the case of 
Cdt1 occurs through CDK phosphorylation.  
 
Although plants clearly share all of the elements needed for G1/S entry with other 
eukaryotes, they lack the typical class of E-type cyclins, which are known to be 
essential regulators of DNA replication (Duronio et al., 1996). Presumably, some 
of the A- or D-type cyclins assume the role of the CYCEs. Indeed, the lack of a 
consensus RBR binding motif in some D-type cyclins suggests that these might 
have gained other novel functions during evolution.  Moreover, the distinct 
transcriptional accumulation of Arath;CYCD5;1 during G1 and CYCD4;1 in late 
G1/S suggests a possible role as functional equivalents of cyclinE (Menges et al., 
2005). Similarly, some A-type cyclins display transcriptional accumulation in S-
phase. Accordingly, Nicta;CYCA3;2  was suggested to perform an analogous role 
to that of animal cyclinE in the control of plant cell division and differentiation, 
based on similarities in function such as the requirement of CYCA3;2 for reentry 
into cell division and its function in enhancing the expression of S-phase-specific 
histone genes (Yu et al., 2003). 
 
 17
Chapter 1 
 
 
Figure 2. Schematic overview of the regulation of the G1-S transition in plants. Pathways 
that are still not fully demonstrated are marked by question marks. 
 
 
G2-M transition and mitosis   
The regulation of entry in mitosis in plants is still poorly understood. In mammals 
and insects, the G2/M transition is specifically regulated by CDKs that associate 
with A- and B-type cyclins. In plants, kinase activity assays suggest that two types 
of CDKs (A and B) control the G2/M transition (Magyar et al., 1997; Porceddu et 
al., 2001). In planta overexpression of a dominant negative kinase mutant 
indicated that A-type CDKs are involved in both the G1/S and G2/M transition 
(Hemerly et al.,1995), and down-regulation of the activity of a B-type CDK in 
transgenic tobacco plants delayed G2/M transition (Porceddu et al., 1999). Based 
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on their transcriptional levels, both plant A- and B-type cyclins are responsible for 
mitotic events. Ectopic expression of alfalfa CYCB2;2 and Arabidopsis CYCB1;2 
cyclins indeed stimulates G2/M transition (Schnittger et al., 2002b; Weingartner et 
al., 2003). However, the activity of the CDK complexes is regulated by additional 
mechanisms. In yeast and mammalia, CDK/cyclin complexes are maintained in 
an inactive state during the S and G2 phases by WEE1 kinases, and become 
activated at the G2/M boundary by the dual-specificity CDC25 phosphatase. 
Overexpression of plant WEE1 genes in S. pombe inhibits cell division (Sorrell et 
al., 2002). Interestingly, purified WEE1 can inhibit mitotic CDK activity in vitro. 
Although no CDC25 homolog has been identified in plants, accumulating data 
suggest the existence of a CDC25-like regulation of CDKs in plants (see above). 
In accordance, overexpression of the S. pombe CDC25 gene in tobacco plants 
resulted into increased lateral root primordium formation and into a new threshold 
size for cell division in the primordia (Bell et al., 1993; McKibbin et al., 1998). 
Whereas, microinduction techniques in tobacco plants clearly demonstrated that 
CDC25 expression in young leaf primordia leads to changes in cell division 
patterns (Wyrzykowska et al., 2002).  
  
Our knowledge of mitosis in higher plants is still in its infancy. Mitosis is viewed as 
the final phase of the cell cycle during which the mother cell splits itself into two 
daughter cells. During this process, not only are the replicated chromosomes split 
by the mitotic spindle (karyokinesis) but the plasma membrane, organelles and 
cytoplasm must also be divided (cytokinesis). Plant cells divide by building a new 
cell wall between daughter nuclei (called a cell plate while under construction). 
Cell plate positioning involves two major steps. First the establishment of the 
division site early in M phase by a structure called the preprophase band (PPB), 
and then the guidance of the cell plate during cytokinesis by the phragmoplast. 
Both the phragmoplast and the PPB are structures composed of microtubules 
(MTs) and unique to plant cells (Smith, 2001). Although the architectural changes 
of the MTs during the course of the cell cycle have been extensively studied in 
plants, it is not known how MT dynamics are regulated. Studies in animal cells 
have implicated CDKs and mitotic cyclins in the control of MT dynamics, and 
several evidences suggest similar functions of plant CDKs and cyclins.  
Microinjection of purified active mitotic CDK complexes in Tradescantia cells 
accelerates PPB depolymerization and induces a premature breakdown of the 
nuclear envelope (Hush et al., 1996). A role for CDKA in MT stability and 
movement is prompted by its specific localization (Colasanti et al., 1993; Bogre et 
al., 1997; Mews et al., 1997; Stals et al., 1997; Weingartner et al., 2001). CDKA is 
located at the nucleus and cytoplasm during interphase but associates with parts 
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of the PPB, spindle, and phragmoplast during mitosis and cytokinesis. Subcellular 
localization experiments have shown that B-type CDKs and certain A- and B-type 
cyclins also associate with MT structures, such as the PPB, the mitotic spindle 
and the phragmoplast, suggesting their possible involvement in MT array 
regulation throughout mitosis (Mews et al., 1997; Ayaydin et al., 2000; Lee et al., 
2003). Additionally, A- and B-type CDKs and B-type cyclins have been reported 
to bind to chromosomes, signifying their possible participation in chromosome 
condensation (Stals et al., 1997; Mews et al., 1997; Criqui et al., 2001; Lee et al., 
2003). How plant CDK/cyclin complexes are involved in chromosome 
condensation is unknown, but it has been shown that the microinjection of mitotic 
CDK complexes significantly accelerated this process in plant cells (Hush et al., 
1996).  
 
 
 
Figure 3. Schematic overview of the mechanistic regulation of the G2-M transition in 
plants. Question marks indicate pathways that are still not fully demonstrated 
experimentally.  
 
In animal cells, the CDK complex is inactivated at the metaphase/anaphase 
transition by the degradation of mitotic cyclins by the APC/C protein degradation 
machinery (Genschik et al., 1998). As such, the localization on the phragmoplast 
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and the prolonged presence through anaphase and telophase of some plant 
mitotic cyclins is intriguing and the necessity to destroy mitotic cyclins during plant 
mitosis is debated (Mironov et al., 1999; Capron et al., 2003b). However, 
inhibition of the proteasome in prophase blocks plant cells in metaphase, 
suggesting that at least some D-box containing proteins need to be degraded for 
progression through mitosis (Genschik et al., 1998). In accordance, mutations in 
several APC/C component, such as APC2 (Capron et al., 2003a), CDC16/APC6 
(Kwee et al., 2003) or APC27 (Blilou et al., 2002) lead to the accumulation of 
CYCB1 and impaired mitosis. Interestingly, the Arabidopsis cullin protein CUL1, a 
component of the SCF protein-ligase, was found to be associated with the mitotic 
spindle (Farras et al., 2001; Shen et al., 2002). Although it is known that SCF 
primarily controls the G1/S transition in fungi and animals (Tyers and Jorgensen, 
2000), this observation suggests that plant SCF-dependent degradation may also 
have a function during mitosis.  
 
 
E  ndoreduplication cell cycle       
 
Many plant and animal cells have a different cell cycle mode in which cells 
undergo iterative DNA replications without any mitosis and cytokinesis. Although 
endoreduplication is a largely widespread phenomenon in higher plants, its 
physiological role and molecular control in plants is poorly understood. Endoploidy is 
often observed in differentiating plant cells and a requirement for correct organ 
development (Kondorosi et al., 2000). The endoreduplication cell cycle is a 
variant of the mitotic cell cycle. It lacks M-phase regulators but shares with the 
classical cell cycle part of the key regulators, especially those controlling the G1/S 
transition (Grafi, 1998). The mechanisms necessary for the transition of the 
mitotic cell cycle to the endocycle are believed to involve nothing more than loss 
of M-phase CDK activity and oscillations in the activity of S-phase CDKs (Edgar 
and Orr-Weaver, 2001; Larkins et al., 2001). This is achieved through 
modulations in CDK activity to prevent mitosis and to allow re-licensing of origins 
of replication. Initiation of DNA replication is licensed to occur only once during each 
cell cycle and is regulated by pre-RC complex genes like CDC6, Cdt1, ORC and 
MCMs, which are E2F targets. Ectopic expression of either CDC6 (Castellano et al., 
2001) or Cdt1 (Castellano et al., 2004) is sufficient to trigger extra endocycles. 
Similarly, E2Fa-DPa overexpression causes extra rounds of DNA replication (De 
Veylder et al., 2002). Consistent with this, suppression of the E2F inhibitory RBR 
function in tobacco resulted in a similar phenotype (Park et al., 2005). Interestingly, 
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the activation of DNA replication in all these transgenic lines results in a cell-type 
specific, mixed phenotype, with cells that are triggered to proliferate besides the cells 
that are stimulated to endoreduplicate.  De Veylder et al. (2002) proposed that this 
phenotype depends on the presence of a mitosis-inducing factor (MIF) in the cell-
types undergoing extra cell divisions. Recently, DEL1 was shown to inhibit the 
endoreduplication phenotype but not the ectopic cell divisions induced by E2Fa-DPa 
(Vlieghe et al., 2005), suggesting a function of DEL1 in preserving the mitotic state of 
proliferating cells.  
 
Endoreduplication requires exit of the mitotic cell cycle. In maize endosperm and 
during tomato fruit and Arabidopsis leaf development endoreduplication is 
correlated with the inhibition of M-phase associated CDK activity (Grafi and 
Larkins, 1995; Joubés et al., 1999; Verkest et al., 2005). However, the identity of 
the CDK complexes and the mechanisms that account for the decrease in CDK 
activity remain poorly understood.  
Two recent reports shed light on the identity of implicated CDKs. Leiva-Neto et al. 
(2004) demonstrated that CDKA activity plays an active role in the endocycle, 
since the specific overexpression of a dominant negative allele of the maize A-
type CDK could inhibit endoreduplication in endosperm cells. The mitotic-to-
endocycle transition is prevented by the activity of CDKB1;1 (Boudolf et al., 
2004b). In an E2Fa-DPa-overproducing background, the overexpression of a 
dominant negative allele of Arath;CDKB1;1 resulted in both the enhancement of 
the endoreduplication phenotype and the repression of the ectopic cell divisions, 
suggesting that CDKB1;1 is part of the MIF. 
 
Several mechanisms for the control of CDK activity are likely to occur during 
endoreduplication. Dealing with the phosphorylation status of the kinase complex, it 
has been suggested that the WEE1 inhibitory kinase may play a role in 
endoreduplicating cells of maize endosperm (Sun et al., 1999) and of tomato fruit 
(Gonzalez et al., 2005). WEE1 transcripts are most abundant in mitotically active 
organs and in endoreduplicating tissues in maize endosperm and during tomato fruit 
development. This suggests that the observed inhibition of mitotic CDK activity by 
WEE1 (Sun et al., 1999) could be one of the mechanisms that inhibits the G2/M 
transition and activates the endocycle. Another molecular mechanism for the mitosis-
to-endocycle transition is the CCS52 protein, an activator of the anaphase-promoting 
complex (APC/C) whose expression coincides with the onset of endoreduplication 
(Cebolla et al., 1999). CCS52 is thought to be involved in mitotic cyclin degradation, 
resulting in inhibition of M-phase CDK activity. Ectopic expression of CYCB in 
trichomes converts the endocycle program that is associated with their normal 
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development into a mitotic program, resulting in multicellular trichomes (Schnittger et 
al., 2002b). Likewise, Arabidopsis siamese mutants misexpress CYCB1 and, 
consistent with this, have multicellular trichomes (Walker et al., 2000). CDK inhibitors 
have been proven to be important regulators of the endoreduplication cycle in several 
organisms (chapter2). In plants, the involvement of CDK inhibitors in 
endoreduplication was suggested through the observation of accumulation of an 
unidentified inhibitor protein coincident with the onset of endoreduplication in maize 
endosperm (Grafi and Larkins, 1995). Recently, it has been demonstrated that 
KRPs participate in inhibiting M-phase associated CDK activity, and as such 
trigger the endocycle onset (Verkest et al., 2005; Weinl et al., 2005). Furthermore, 
an unidentified role for CDK inhibitors is suggested during endoreduplication 
since the Arabidopsis KRP1 and KRP2 and the maize CKIs are expressed in both 
mitotically dividing and endoreduplicating tissues (Ormenese et al., 2004; Coelho 
et al., 2005). 
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During the development of multicellular organisms, many different cell types are 
created. These display characteristic cell cycle programs that can radically change 
during the organism’s lifetime (Jakoby and Schnittger, 2004) (Figure 1). Usually, in 
young and less differentiated tissues, a proliferative cell cycle mode occurs. In this 
mitotic cell cycle program, DNA replication (also known as the synthesis or S phase) 
is followed by the segregation of the duplicated genetic material to two daughter 
cells in mitosis (M phase). Both the S and M phases are usually preceded by a 
preparative gap phase (G1 and G2 phase, respectively) during which cells scan 
whether all conditions are favorable to continue a new round of DNA replication or 
mitosis. As cells differentiate the rate of cell proliferation decreases. However, 
before complete withdrawal from the cell cycle and concomitant with differentiation, 
many plant cells switch from a mitotic cell cycle to an endoreduplication cycle (also 
called endocycle or endoreplication). During this endocycle the DNA is replicated 
without subsequent mitosis leading to polyploid cells. Eventually, cells exit the cell 
cycle completely. 
Cell cycle progression is controlled by an evolutionary conserved molecular 
mechanism. A central role is played by kinase complexes, which in their minimal 
configuration consist of a Ser/Thr kinase (the cyclin-dependent kinase; CDK) and a 
regulating cyclin subunit. CDKs phosphorylate a plethora of substrates, as such 
triggering the transition from one cell cycle phase into the next one. The sequential 
and transient activation of different CDK-cyclin complexes dictates the unidirectional 
progression through the cell cycle. 
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Figure 1. Cell cycle modes during development. During the growth of a multicellular 
organism, different cell cycle programs are executed. Typically, in young and less 
differentiated tissues, a proliferative cell cycle mode occurs by which more cells are 
generated. As cells differentiate, the rate of cell proliferation decreases and eventually, 
cells exit the cell cycle. However, before complete withdrawal from the cell cycle, and 
along with differentiation, many plant and animal cells switch from a mitotic cell cycle to an 
endoreduplication cycle, in which the nuclear DNA becomes replicated without subsequent 
nuclear and cellular division, leading to polyploid cells. 
 
Because of its importance in growth and development, the CDK-cyclin activity must 
be strictly controlled. In addition, mechanisms must be operational that ensure a 
correct exit of the cell cycle in response to anti-mitogenic stimuli. In yeast and 
mammals, one of the major regulators of CDK activity are CDK inhibitory molecules 
(CKIs) that bind and inhibit or sequester CDKs. Recently, putative orthologs of CKI 
proteins have been identified in plants as well. In this update, we review the current 
knowledge on the biochemical properties of plant CKIs and discuss their 
physiological relevance during plant growth and development. 
  
 
The plant cell cycle: a basic introduction  
      
 
Similar to animals, progression through the cell cycle in plants is regulated by the 
conserved class of Ser/Thr kinases, the CDKs (De Veylder et al., 2003; Inzé, 2005). 
In Arabidopsis thaliana, at least two classes of CDKs are involved in cell cycle 
regulation: the A-type CDKs that are represented by only one gene in the model 
species Arabidopsis (designated Arath;CDKA;1) and the B-type CDK family that 
comprises four members, grouped into the B1 and B2 subclasses (Arath;CDKB1;1, 
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Arath;CDKB1;2, Arath;CDKB2;1, and Arath;CDKB2;2; Vandepoele et al., 2002). 
A-type CDKs display kinase activity from late G1 phase until the end of mitosis, 
suggesting a role for this particular CDK at both the G1-to-S and G2-to-M transition 
points (Magyar et al., 1997; Porceddu et al., 2001; Sorrell et al., 2001). A central 
role for CDKA;1 in controlling cell number has been demonstrated using transgenic 
tobacco (Nicotiana tabacum) plants with reduced A-type CDK activity (Hemerly et 
al., 1995). The requirement for Arath;CKDA;1 at least for entry into mitosis has been 
demonstrated as well by cdka;1 null mutants that fail to progress through the 
second mitosis during male gametophytic development (M. Nowack and A. 
Schnittger, unpublished data). The group of B-type CDKs displays a peak of activity 
at G2-to-M phase transition only (Magyar et al., 1997; Porceddu et al., 2001; Sorrell 
et al., 2001), suggesting that they play a role at the onset of or progression through 
mitosis. Correspondingly, cells of plants with reduced B-type CDK activity arrest in 
the G2 phase of the cell cycle (Porceddu et al., 2001; Boudolf et al., 2004a) 
Although titration of CDK activity by the expression of dominant negative versions of 
both A- and B-type CDKs resulted in cell cycle defects, no extra cell divisions were 
stimulated by the overexpression of wild-type Arath;CDKA;1, Arath;CDKB1;1, and 
Arath;CDKB1;2 alleles in plants (Hemerly et al., 1995, 2000; Boudolf et al., 2004a; 
Schnittger et al, 2003). This observation is consistent with the view that a cofactor is 
required for full CDK activity, i.e. a cyclin. Cyclins are regulated both transcriptionally 
and posttranslationally, mainly by the controlled protein degradation. By regulating 
the abundance of specific cyclins, the CDK activity is precisely tuned and targeted 
to substrates in a spatial and temporal manner. 
The plant cyclin gene family is very complex. For instance, the Arabidopsis genome 
encodes at least 49 different cyclins (Vandepoele et al., 2002; Wang et al., 2004) 
that are classified into seven different subclasses (types A, B, C, D, H, P, and T). To 
date, only a few members of the A-type, B-type, and D-type cyclins have been 
analyzed. With a few exceptions, the expression patterns and activity profiles mimic 
those of their mammalian counterparts. A-type cyclins are important from S-to-M 
phase, while B-type cyclins primarily control the G2-to-M transition. D-type cyclins, 
whose expression is mainly correlated with the proliferative status of cells, are 
presumed to drive cells through the G1-to-S checkpoint in a mitogen-dependent 
manner (De Veylder et al., 2003; Inzé, 2005). In contrast to animals, some evidence 
points to an additional function of plant D-type cyclins at the G2-to-M transition 
(Schnittger et al., 2002; Kono et al., 2003; Koroleva et al., 2004). 
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Plant CDK inhibitors: the Kip-related proteins 
      
 
Besides by binding of cyclins, CDK activity is regulated by docking of mainly small 
proteins, generally known as CKIs, which have been found to induce cell cycle 
arrest or to delay cell cycle progression in response to intracellular or extracellular 
signals. CKIs have been identified in many different organisms and, although all of 
them display CKI activity, they control a broad spectrum of often species-specific 
physiological processes. For example, in budding yeast (Saccharomyces 
cerevisiae), three CKIs have been described, Pho81, Far1, and Sic1 (Mendenhall et 
al., 1998). Pho81 inhibits a CDK-cyclin complex that controls gene expression 
under low phosphate conditions; Far1 binds and inactivates G1 CDK complexes to 
mediate pheromone-depedendent cell cycle blockage; and Sic1 plays a role in the 
timing of S-phase onset. In fission yeast (Schizosaccharomyces pombe), the CKI 
Rum1, is structurally and functionally related to Sic1, inhibits mitotic CDKs, and 
plays a central role in the regulation of the G1 phase.  
In mammals, based on shared structural features and biochemical functions, CKIs 
have been divided into two major classes, the INK4 and the Kip/Cip class (Sherr 
and Roberts, 1999). Members of the INK4 family (p15INK4b, p16INK4a, p18INK4c, and 
p19INK4d) are structurally similar to the Pho81 inhibitor of budding yeast and are 
characterized by the presence of multiple ankyrin-type repeats for CDK binding. 
They bind and inhibit a small subset of CDKs (CDK4 and CDK6) that are primarily 
responsible for passage through G1. INK4 protein binding to monomeric CDKs or 
CDK-cyclin complexes causes allosteric changes that impair cyclin binding or lead 
to the dissociation of the CDK-cyclin complex, respectively. In contrast, inhibitors of 
the Kip/Cip family (p21Cip1, p27Kip1, and p57Kip2) bind and inhibit a broader range of 
CDKs and function in dimeric as well as heterotrimeric complexes with CDKs and 
cyclins; all share a conserved inhibitory domain at their N-terminus. Kip/Cip binding 
does not dissociate the CDK-cyclin complex, but distorts the catalytic ATP-binding 
center of the CDK subunit. 
The first plant CKIs have been detected in yeast two-hybrid screens performed to 
identify CDKA;1-associating proteins (Wang et al., 1997; Lui et al., 2000; De 
Veylder et al., 2001; Jasinksi et al., 2002b). Additional plant CKIs have been 
discovered in silico through genome data mining (De Veylder et al., 2001; Coelho et 
al., 2005). Overall, the plant CKIs have only low sequence identity to each other and 
the non-plant CKIs. Interspecies sequence homology is restricted to a short 
amino-acid region shared between the plant CKIs and the mammalian Kip/Cip 
inhibitors. Because of this homology, the name Kip-related proteins (KRPs) was 
suggested for the seven CKIs found in the Arabidopsis genome (De Veylder, et al., 
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2001); but some family members are also known under different names such as 
ICK1 (KRP1) and ICK2 (KRP2) (Wang et al., 1997; Lui et al., 2000). No Arabidopsis 
homologs to the INK4 or yeast inhibitors have been identified so far (Vandepoele et 
al., 2002). 
 
 
Biochemical properties 
 
Despite their low sequence similarity with the mammalian CKIs, plant KRP genes 
encode functional CKIs, as demonstrated by their ability to inhibit CDK activity. In 
vitro, CKI activity was proven by adding recombinant KRP to partially purified CDK 
complexes (Wang et al., 1997; Lui et al., 2000; Jasinski et al, 2002b; Coelho et al., 
2005). In vivo CKI activity was demonstrated by overexpressing diverse KRP genes 
in Arabidopsis (Wang et al., 2000; De Veylder et al., 2001; Jasinski et al., 2002a; 
Zhou et al., 2002). The reduced CDK activity observed upon KRP overexpression 
correlates with a decrease in cell division rate, resulting in leaves whose cell 
number is dramatically low. This decrease in cell number is accompanied by a 
change in leaf morphology (Figure 2).  
Whereas KRPs have clearly been demonstrated to operate as inhibitors of CDK 
activity, the identity of the targeted CDK complexes remains unknown. Not all CDKs 
are KRP-sensitive, as even applying a high dose of recombinant KRP protein to 
purified CDK complexes only results into a partial inhibition of total CDK activity 
(Wang et al., 1997). In accordance with this observation, yeast two-hybrid 
interaction analysis demonstrated that the KRPs bind A-type, but not B-type, CDKs 
(Lui et al., 2000; De Veylder et al., 2001; Jasinski et al., 2002b; Zhou et al., 2002). 
Recently a biochemical proof has been supplied: in Arabidopsis plants 
overexpressing Arath;KRP2, only the A-type CDK complexes are targeted for 
inhibition (Verkest et al., 2005). Consistently, the phenotype of plants misexpressing 
Arath;KRP1 could be rescued by co-misexpression of Arath;CDKA;1, but not 
Arath;CDKB1;2 (Schnittger et al., 2003). 
Besides the CDK subunit, KRP binding is also directed by the cyclin subunit. Yeast 
two-hybrid assays have revealed interactions of Arabidopsis and tobacco KRPs with 
D-type cyclins, suggesting that KRPs are potential regulators of CDK-cyclinD 
complexes (Wang et al., 1998; Lui et al., 2000; De Veylder et al., 2001; Jasinski et 
al., 2002b; Zhou et al., 2002). Furthermore, in vivo binding specificity between plant 
CKIs and different D-type cyclins has been proven by the observation that the 
aberrant cell and leaf phenotypes seen upon KRP overexpression can be 
complemented by co-overexpression of D-type cyclins (Jasinski et al., 2002a; 
Schnittger et al., 2003; Zhou et al., 2003b). Recently, it was demonstrated that not 
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only D-type, but also A-type cyclin-harboring CDK complexes can be inhibited by 
KRPs in vitro (Coelho et al., 2005), so that the plant CKIs resemble the mammalian 
Kip/Cip inhibitors, which bind and inhibit a broad range of CDKs, including both A- 
and D-type cyclin containing CDK complexes. 
 
 
 
Figure 2. Phenotypes of KRP-misexpressing plants.  
A. Wild-type Columbia plants.  
B. Plants misexpressing the Arath;KRP2 gene under the control of the shoot meristem-
specific STM promoter, resulting into smaller and more elongated leaves than observed for 
wild-type plants. Plants are at the same developmental stage and magnification as in (A.)  
C. and D., Rosette leaves from a wild-type (Col-0) and a transgenic plant misexpressing 
the Arath;KRP1 gene under the control of the stomatal lineage-specific TMM promoter, 
respectively. Expression of Arath;KRP1 in TMM cells results into an altered leaf 
morphology because of reduced leaf cell numbers.  
E. and F., Close-up of the leaves shown in (C.) and (D.), respectively. Note the enlarged 
epidermal cells in (F). Bars = 1 mm (C. and E.) and 100 μm (D. and F.). 
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Structural organization 
 
Like the mammalian Kip/Cip inhibitors, the plant CKIs have low sequence similarity 
to each other. Detailed analysis allowed the identification of several sequence 
elements shared by different KRPs, but only three C-terminally located motifs are 
conserved in all plant inhibitors (De Veylder et al., 2001). This region of the KRPs 
shows partial homology with the Kip/Cip protein domain necessary for interaction 
with the CDK subunit, suggesting that the plant CKI function resides at their 
C-terminus. Indeed, Wang et al. (1998) showed in a yeast-two hybrid interaction 
assay that the C-terminal domain of KRPs is sufficient for interaction of Arath;KRP1 
with Arath;CDKA;1 and Arath;CYCD3;1. Moreover, the functionality of this domain 
for CDK binding and inhibition was proven in vitro and in vivo (Schnittger et al., 
2003; Zhou et al., 2003a). 
The role of the highly diverse N-terminal plant CKI sequences remains unclear, but 
could have additional functional implications and determine different regulatory 
mechanisms or a different specificity towards CDK-cyclin complexes. In 
Arath;KRP1, the N-terminal region was suggested to negatively regulate CKI 
function; deletion of this region increased the yeast two-hybrid physical interaction 
of Arath;KRP1 with CDKs and cyclins, and the enhanced the phenotype of 
Arath;KRP1 overexpression in Arabidopsis (Wang et al., 1998; Schnittger et al., 
2003; Zhou et al., 2003a). One possible function of the N-terminus could be the 
regulation of the KRP stability. Arath;KRP2 protein is highly unstable and its 
degradation depends on the proteasome (Verkest et al., 2005). Indeed, removal of 
the N-terminal region enhanced the Arath;KRP1 protein level. However, the 
regulating mechanism behind this protein stability remains unknown (Zhou et al., 
2003a; Weinl et al. 2005). 
 
 
Regulation of KRP activity at the transcript level 
 
Yeast and mammalian CKIs are strictly regulated at the transcriptional, translational, 
and posttranslational level through mechanisms that rather affect their abundance 
than their intrinsic activity. Most plant tissues co-express various KRPs, but with 
different intensities in their mRNA levels, suggesting different transcriptionally 
regulatory mechanisms and possibly distinct roles for the plant CKIs within a single 
tissue (Wang et al., 1998; De Veylder et al., 2001, Jasinski et al., 2002b; Ormenese 
et al., 2004). A detailed spatial expression analysis by mRNA in situ hybridizations 
in the Arabidopsis shoot apex revealed different groups of KRPs with similar 
expression patterns. Whereas Arath;KRP4 and Arath;KRP5 expression was 
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confined to mitotically dividing tissues within the shoot apex, other KRP genes could 
be detected in both dividing and maturing cells (Arath;KRP3, Arath;KRP6, and 
Arath;KRP7) or exclusively in maturing cells (Arath;KRP1 and Arath;KRP2) 
(Ormenese et al., 2004). These data hint at a function of Arath;KRP1, Arath;KRP2, 
Arath;KRP3, Arath;KRP6, and Arath;KRP7 during the process of cell cycle exit and 
onset of differentiation, whereas Arath;KRP4 and Arath;KRP5 might direct specific 
aspects of the mitotic cell cycle, such as functioning of the checkpoints that control 
the correct timing of S- and M-phase onset. 
A role for the KRPs during the regular cell cycle is also hinted by their observed cell 
cycle phase-dependent temporal regulation (Menges et al., 2005). Transcript levels 
peak during S-phase for Arath;KRP3 and Arath;KRP5, in G2-phase for Arath;KRP4, 
during late G2-to-M for Arath;KRP1, and at M-to-G1 for Arath;KRP6. The 
expression of Arath;KRP2 and Arath;KRP7 is constitutive during the cell cycle. 
Furthermore, transcript levels of the tobacco NtKIS1a and the AtKRP1 accumulated 
with flower bud aging and leaf aging, respectively (Wang et al., 1998; Jasinski et al., 
2002b). This temporal increase in transcripts during the course of cell cycle arrest 
and cellular differentiation suggests possible functions for these KRPs in 
development. 
KRP mRNA is not only controlled in a spatial and temporal manner, but also 
through the generation of alternative splicing variants, as illustrated by the NtKIS1 
locus that generates two splice variants, NtKIS1a or NtKIS1b (Jasinski et al., 
2002b). The splice variant NtKIS1b lacks the most C-terminal motif found in 
NtKIS1a and other plant CKIs. Consistently, NtKIS1b does not interact with A-type 
CDKs and D-type cyclins and is unable to inhibit CDK activity in vitro and in vivo. 
 
 
Regulation of KRP activity at the posttranslational level 
 
Currently, little is known about the regulation of plant CKIs at the protein level. In 
mammals, regulation of CKI activity is complex and is accomplished through several 
mechanisms. Kip/Cip inhibitors can be inactivated through out-titration by inert CDK-
cyclinD complexes. Upon mitogenic stimuli, D-type cyclins accumulate and 
sequester the CKIs, resulting in their release from inhibited CDK-cyclinE complexes. 
Other mechanisms control the subcellular localization. Kip/Cip proteins have distinct 
nuclear and cytoplasmic functions and their cytoplasmatic compartmentalization 
releases and activates nuclear CDK-cyclin complexes (Coqueret, 2003). However, 
the best-studied posttranslationally regulatory mechanism of the mammalian CKIs 
affects their concentration through ubiquitin-dependent proteolysis. Two alternative 
proteolytic pathways control p27Kip1 stability (Hengst, 2004). One pathway acts in 
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the nucleus and requires p27Kip1 phosphorylation at Thr187 by CDK2-cyclinE 
complexes and subsequent recognition and degradation at the S-phase by the 
SCFSkp2 ubiquitin-ligase complex. The other one acts at the G1-phase, is 
independent of Skp2 and Thr187 phosphorylation, and involves cytoplasmic 
sequestration of p27Kip1 and its degradation through the recently identified Kip 
ubiquitination-promoting complex (Hengst, 2004). 
As evidenced, at least some plant KRPs are regulated through proteolysis. 
Functional analysis of the Arath;KRP1 domains indicated the presence of a 
regulatory motif for protein instability in its N-terminal domain (Zhou et al., 2003a; 
Weinl et al., 2005). Additionally, both Zeama;KRP2 and Arath;KRP2 are regulated 
at the posttranslational level during maize (Zea mays) endosperm and Arabidopsis 
leaf development, respectively, demonstrated by their alteration in protein levels 
while their transcript levels remain constant (Coelho et al., 2005; Verkest et al., 
2005). In the case of Arath;KRP2, protein stability is regulated by the proteasome. 
Moreover, in vitro analysis illustrated that Arath;KRP2 is a CDK-cyclin substrate and 
that its phosphorylation is at least in part responsible for Arath;KRP2 proteolysis. 
Although both Arath;CDKA;1 and Arath;CDKB1;1 complexes phosphorylate 
Arath;KRP2, it is currently neither known at which cell cycle phase this event occurs 
nor which ubiquitin-ligase is responsible for Arath;KRP2 degradation. 
Another mechanism of posttranslational regulation has been identified through 
comparative analysis of the NtKIS1a and NtKIS1b splice variants (Jasinski et al., 
2002b). Even though the spliced form NtKIS1b does not interact with NtCDKA;1 and 
D-type cyclins, NtKIS1b counteracts the capacity of NtKIS1a to inhibit CDK activity 
in vitro. The two splice variants have a different transcriptional expression pattern: 
whereas NtKIS1a is constitutively present during the cell cycle, NtKIS1b transcript 
levels peak at G2-to-M. These data, together with their cooperative subcellular 
localization, suggest that NtKIS1b antagonizes NtKIS1a inhibition of CDK activity at 
the G2-to-M transition. However, the mechanism by which this occurs remains to be 
elucidated. 
 
 
Intercellular and intracellular localization of KRPs 
 
In animals, the CKI function depends on their intracellular localization. The CKI 
p27Kip1 exerts its inhibitory function in the nucleus and entry into the nucleus 
appears to be used as a control mechanism for p27Kip1. In addition, p27Kip1 
degradation is precisely regulated and is seemingly also connected, at least to 
some degree, with its intracellular localization pattern (see above). 
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Fusions of the green fluorescent protein (GFP) or the yellow fluorescent protein 
(YFP) and the Arath;KRP1 or the NtKIS1 have revealed a strict nuclear localization 
(Jasinski et al., 2002b; Zhou et al., 2003a; Weinl et al., 2005) (Figure 3). In addition, 
a putative nuclear localization signal has been identified in the protein sequences of 
Arath;KRP2, Arath;KRP5, and Arath;KRP7 (De Veylder et al., 2001). 
In animals, regulation of nuclear import and export of p27Kip1 is complex and 
involves phosphorylation at Ser10, Thr157, Thr187, and Thr198. None of these 
phosphorylation sites are conserved in plant KRPs. However, the stabilized 
N-terminally truncated Arath;KRP1 shows in addition to a nuclear, also a cytosolic 
localization (Fig. 3D). Thus, one likely possibility is that Arath;KRP1 becomes 
degraded in the cytoplasm and that a motif in the N-terminus of the protein is 
required for this degradation. It will be interesting to see to what degree the 
intracellular localization of CKIs is an important regulatory mechanism in plants as 
well. 
Surprisingly, plant CKIs function in a non-cell-autonomous manner. Fusion proteins 
between YFP and Arath;KRP1 were found at least two to three cells away form their 
site of translation (Weinl et al., 2005) (Figure 3, B and C). Other plant cell cycle 
regulators have also been observed to travel between cells (Jakoby and Schnittger, 
unpublished data). Currently, it is still unclear whether it is the mRNA or the protein 
that moves or whether this movement is based on a targeted versus a non-targeted 
mechanism. So far, the functional relevance of this movement is unknown. On the 
one hand, the non-cell-autonomous behavior could simply be a consequence of 
overproduction of these proteins. On the other hand, the non-cell-autonomous 
action of Arath;KRP1 offers a possibility to link decisions on a cellular level with the 
supracellular division and growth pattern in tissues and organs. For instance, during 
leaf development, epidermal cells have been observed to exit the cell cycle before 
palisade cells do (Donnelly et al., 1999). A mechanism can be envisaged in which 
the diffusion of synthesized KRPs in the epidermis coordinates the initial cell cycle 
exit of the dermal layer with that of the palisade parenchyma layer later during 
development. In any case, the molecular nature of the non-cell-autonomous action 
of KRPs remains to be analyzed in detail.  
 
Figure 3. Intercellular and subcellular localization of Arath;KRP1.  
A. Trichome-specific expression of the GLABRA 2 promoter as revealed by GFP 
fluorescence.  
B. Protein fusions of Arath;KRP1 with YFP expressed from the GLABRA 2 promoter 
spread from the trichome into the neighboring cells.  
C. and D. Close-up of trichomes; the full-length Arath;KRP1-YFP fusion protein is found 
exclusively in the nuclei (C.); the N-terminally truncated Arath;KRP1D2-108 localizes to the 
nucleus and the cytoplasm (D.). Bars =50 μm. 
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KRPs as integrators of developmental signals 
 
The observation that several plant CKIs are transcriptionally regulated during 
development indicates that they share with the mammalian Kip/Cips the potential to 
integrate developmental signals into the core cell cycle machinery. Indeed, 
Arath;KRP1 transcripts are induced by cold treatment, which correlates with a 
decrease in CDK activity. Furthermore, KRP1 expression was found to be activated 
by the phytohormone abscisic acid (ABA) (Wang et al., 1998), suggesting that this 
particular KRP might be in part responsible for the growth inhibitory effect triggered 
upon ABA treatment. By contrast, the mitogenic hormone auxin repressed 
Arath;KRP2 transcription, both in cell cultures and in planta (Richard et al., 2001; 
Himanen et al., 2002). Downregulation of Arath;KRP2 precedes the auxin-induced 
re-entry of quiescent root pericycle cells into the cell cycle. Interestingly, Arath;KRP2 
transcripts have been detected in young roots at the phloem but not the protoxylem 
poles of the pericycle, i.e. the sites at which lateral roots can initiate. In older root 
tissues, Arath;KRP2 expression has been observed at both the phloem and 
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protoxylem poles, corresponding with the observation that new laterals mainly 
initiate at the young parts of the root. Curiously, upon the initiation of a lateral root 
primordium, Arath;KRP2 expression is induced in cells opposite the developing new 
lateral root, implying a mechanism by which Arath;KRP2 prevents the formation of 
two opposing lateral roots. A role for KRPs in controlling root architecture has been 
confirmed by overexpression analysis, as illustrating by the observation that ectopic 
Arath;KRP2 overexpression in Arabidopsis results in a dramatic decrease in the 
number of lateral roots (Himanen et al., 2002). 
 
 
Control of endocycle onset 
 
Mammalian Kip/Cip inhibitor gene expression has been found to correlate with the 
onset of endoreduplication (Bates et al., 1998; Hattori et al., 2000). The endocycle is 
an alternative cell cycle during which DNA replication is not followed by mitosis and 
cytokinesis, and often marks the onset of cell differentiation. Endoreduplication 
represents the most common mechanisms to increase the cellular DNA ploidy in 
plants and, although the physiological relevance of the endoreduplication process is 
still unresolved, there are several indirect reasons to believe that an increase in the 
DNA ploidy level supports cell growth and high metabolic activity (Schnittger et al., 
2003; Sugimoto-Shirasu and Roberts, 2003).  
In yeast and fruitfly (Drosophila melanogaster), the onset of endoreduplication 
corresponds with a decrease in CDK activity (Edgar and Orr-Weaver, 2001; Larkins 
et al., 2001). A similar mechanism is probably operational in plants, because the 
start of endoreduplication in Arabidopsis leaves, maize endosperm, and the fruit of 
tomato (Lycopersicon esculentum) is accompanied with a decline in extractable 
CDK activity (Grafi and Larkins, 1995; Joubès et al., 1999; Verkest et al., 2005). 
Recently, KRPs have been demonstrated to participate in the control of this 
decrease in CDK activity. In strong Arath;KRP2-overexpressing lines CDK activity is 
inhibited in both mitotically dividing and endoreduplicating leaf tissues. By contrast, 
in weak overexpressing lines only the mitotic CDK-cyclin complexes are affected, 
blocking entry into mitosis but still allowing  the onset and progression through S-
phase, resulting into an increase in DNA ploidy levels. The two apparently 
contradictive effects seen upon strong or weak KRP overexpression can be 
explained by assuming that KRPs show a binding preference toward the CDK-cyclin 
complexes that control the G2-M checkpoint or that higher levels of CDK-cyclin 
activity are required for entry into mitosis than for entry into S-phase. The capacity 
of KRPs to trigger the onset of the endocycle in dividing tissues was confirmed by 
the specific overexpression of Arath;KRP2 in proliferating tissues, causing an 
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inhibition of mitotic CDK activity and a premature onset of endoreduplication 
(Verkest et al., 2005). Likewise, low levels of Arath;KRP1 in trichome socket cells or 
its specific expression in the mitotically dividing stomatal precursor cells triggered 
increased ploidy levels (Weinl et al., 2005). 
Interestingly, Arath;KRP2 protein is negatively regulated at the post-translational 
level by B-type CDK activity as seen by the increase in Arath;KRP2 abundance in 
transgenic plants with reduced Arath;CDKB1;1 activity (Verkest et al., 2005). B-type 
CDKs phosphorylate KRPs, marking them for protein destruction (see above). 
Previously, Arath;CDKB1;1 activity has been demonstrated to play an important role 
in the decision process of the cell to divide or to endoreduplicate: plants with 
reduced B-type CDK activity exit the mitotic cell cycle and enter the endocycle 
prematurely (Boudolf et al., 2004b). Because KRPs specifically inhibit A-type CDK 
activity, the controlled destruction of KRPs by B-type CDK complexes suggests a 
mechanism by which the entry into the endocycle is controlled by a sequential 
decrease of first B-type and then A-type CDK activities. In this model, A-type CDKs 
are protected from KRP2-mediated inhibition as long as cells possess a high level 
of B-type CDK activity, because CDKB1;1 marks the KRP proteins for destruction 
(Figure 4A). However, as cells enter the endocycle program they lose B-type CDK 
activity, with a stabilization of KRPs and a subsequent inhibition of A-type CDK 
activity as a result (Verkest et al., 2005) (Figure 4, B and C). 
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Figure 4. Model of KRPs controlling the switch between the different cell cycle programs. 
A. In proliferating cells, B-type CDKs phosphorylate KRPs, triggering their destruction. In 
addition, phosphorylation might change the conformation of KRPs, interfering with their 
binding to A-type CDKs.  
B. In cells triggered to endoreduplicate B-type CDK activity ceases, resulting into a 
stabilization of the KRPs, which now bind and inhibit A-type CDK/cyclin complexes with a 
role in mitosis. The KRP concentration, however, is probably not high enough to inhibit as 
well the CDK-cyclin complexes driving S-phase entry, allowing cells to re-enter the S-
phase.  
C. During cell cycle exit, KRP expression is upregulated. Now, besides blocking entry into 
mitosis also CDK-cyclin complexes controlling the entry into S-phase become inhibited, 
resulting in a complete cell cycle arrest. 
 
 
Do KRPs function outside the cell cycle? 
 
In animals, CKIs might also have functions outside the cell cycle, such as in 
differentiation, morphogenesis, and programmed cell death. So far, no clear 
evidence has been provided that plant CKIs also function outside the cell cycle. 
Strong and constitutive overexpression of Arath;KRP2 did not alter cellular 
differentiation processes as illustrated by the unaltered timing of stomata 
differentiation patterns with respect to leaf development (De Veylder et al., 2001). 
Also premature onset of endoreduplication caused by Arath;KRP1 expression in 
trichome neighboring cells does apparently not interfere with the adaptation of 
trichome socket cell fate (Weinl et al., 2005). However, misexpression of 
Arath;KRP1 in Arabidopsis trichomes induces cell death (Schnittger et al., 2003). 
This phenotype seems to be linked to the developmental program of trichomes, 
because so far for other cell types no cell-death phenotypes have been observed 
upon KRP overexpression. At the moment, it is not clear whether the observed 
trichome cell death phenotype is linked with a compromised endoreduplication 
program, with cell death being indirectly initiated as a consequence of a discrepancy 
between DNA content and cell size. Clearly, additional experiments are required to 
conclude whether KRPs control cell survival. 
 
 
C   onclusions  
 
The recent years have brought about a tremendous increase in our understanding 
of CKIs in plants. Some regulatory pathways are now emerging with KRPs 
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functioning as dose-dependent cell cycle regulators. KRPs might be important for 
adjusting CDK activity within dividing cells, as well as in facilitating the transition 
between different cell cycle programs, such as entering endoreduplication cycles or 
executing cell cycle exit (Figure 4). KRPs possibly play a central role in connecting 
cell cycle progression with developmental as well as environmental cues. Many 
questions, however, still need to be resolved. For instance, KRPs are very poorly 
conserved among species, thus do these proteins still share a common structure 
outside the CDK and cyclin binding motif? Is there a developmental or physiological 
need for the many different KRP genes within an organism (7 in Arabidopsis)? How 
is the KRP abundance and localization regulated? Many tools have been developed 
now that allow us to address these questions on a cellular, biochemical, and genetic 
level. In addition, KRPs from different plant species have been identified, setting the 
path for a comparative approach and leading to the anticipation of general principles 
in KRP function in plants. 
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Abstract  
   
 
Exit from the mitotic cell cycle and initiation of cell differentiation frequently coincides 
with the onset of endoreduplication, a modified cell cycle during which DNA 
continues to be duplicated in the absence of mitosis. Although the mitotic cell cycle 
and the endoreduplication cycle share much of the same machinery, the regulatory 
mechanisms controlling the transition between both cycles remain poorly 
understood. We show that the cyclin-dependent kinase CDKA;1 and its specific 
inhibitor KRP2 regulate the mitosis-to-endocycle transition during Arabidopsis 
thaliana leaf development. Constitutive overexpression of KRP2 slightly above its 
endogenous level only inhibited the mitotic cell cycle-specific CDKA;1 kinase 
complexes, whereas the endoreduplication cycle-specific CDKA;1 complexes were 
unaffected, resulting in an increase in the DNA ploidy level. An identical effect on the 
endoreduplication cycle could be observed by overexpressing KRP2 exclusively in 
mitotically dividing cells. In agreement with a role for KRP2 as activator of the 
mitosis-to-endocycle transition, KRP2 protein levels were more abundant in 
endoreduplicating than in mitotically dividing tissues. We illustrate that KRP2 protein 
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abundance is regulated posttranscriptionally through CDK phosphorylation and 
proteasomal degradation. KRP2 phosphorylation by the mitotic cell cycle-specific 
CDKB1;1 kinase suggests a mechanism in which CDKB1;1 controls the level of 
CDKA;1 activity through regulating KRP2 protein abundance. In accordance to this 
model, KRP2 protein levels increased in plants with reduced CDKB1;1 activity. 
Moreover, the proposed model allowed a dynamical simulation of the in vivo 
observations, validating the sufficiency of the regulatory interactions between 
CDKA;1, KRP2, and CDKB1;1 in fine-tuning the mitosis-to-endocycle transition. 
 
 
Introduction 
   
 
Cells undergoing endoreduplication duplicate their genome in the absence of 
chromatin segregation and cytokinesis, with a progressive increase of their nuclear 
DNA content as a consequence. Endoreduplication is widespread among 
eukaryotes, although most prevailing in plants (Nagl, 1976). Despite its common 
nature, both the physiological role and the molecular control of endoreduplication are 
poorly understood. The endoreduplication level of a cell is often inversely correlated 
with genome size, which has led to the hypothesis that somatic polyploidy represents 
an evolutionary strategy to compensate for a lack of phylogenetic increase in nuclear 
DNA (Folkers et al., 1997; Traas et al., 1998; Kondorosi et al., 2000; Sugimoto-
Shirasu and Roberts, 2003). Other hypotheses link endoreduplication with metabolic 
activity, maintenance of the optimal ratio between nuclear and organellar DNA, or 
protection against irradiation (Joubès and Chevalier 2000; Kondorosi et al., 2000; 
Larkins et al., 2001). Moreover, endoreduplication probably plays an important role in 
the differentiation process of post-mitotic cells because the onset of the endocycle 
often characterizes the switch between cell proliferation and differentiation, as 
observed during hypocotyl elongation, trichome growth, and fruit development 
(Kondorosi et al., 2000; Larkins et al., 2001; Joubès et al., 1999). As such, 
investigating how the endocycle onset is regulated might help to understand how cell 
differentiation is initiated. 
The coincidence of the zone of meristematically dividing cells with the region of 
subsequent endoreduplication in the Arabidopsis thaliana shoot apex suggests that 
the endoreduplication cycle is initiated through a modification and exit of the mitotic 
cell cycle (Jacqmard et al., 1999). Progression through the mitotic cell cycle is 
mediated through sequential activation of S-phase- and M-phase-specific 
heterodimeric protein complexes, consisting of a catalytic subunit, the cyclin-
68 
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dependent kinase (CDK), and a regulatory cyclin subunit. In Schizosaccharomyces 
pombe and Drosophila melanogaster, transition from the mitotic cell cycle into the 
endoreduplication cycle has been suggested to involve nothing more than loss of M-
phase CDK activity (Edgar and Orr-Weaver, 2001; Larkins et al., 2001). A similar 
mechanism probably operates in plant cells, because the onset of endoreduplication 
during endosperm and tomato fruit development correlates with the inhibition of M-
phase-associated CDK activity (Grafi and Larkins, 1995; Joubès et al., 1999). Also 
during Arabidopsis leaf development, the start of endoreduplication coincides with 
the loss of mitotic activity (Boudolf et al., 2004a; Beemster et al., 2005). However, the 
identity of the CDK complexes and the mechanisms that account for the decrease in 
CDK activity are mostly unknown. Previously, we have shown that the G2-M-specific 
CDKB1;1 plays a determining role in whether Arabidopsis leaf cells divide or 
endoreduplicate, because overexpression of a dominant negative CDKB1;1 allele 
triggered cells to enter the endoreduplication cycle prematurely (Boudolf et al., 
2004a). A role for A-type CDK activity in the endocycle has recently been proven by 
the specific overexpression of a dominant negative allele of the maize (Zea mays) A-
type CDK in endosperm cells, that inhibited endoreduplication (Leiva-Neto et al., 
2004). 
Modulations in CDK activity can be achieved through different mechanisms, 
including phosphorylation, cyclin degradation, or association with CDK inhibitory 
proteins (Nurse, 1994; Elledge, 1996; Nasmyth, 1996; Sherr and Roberts, 1999; 
Mironov et al., 1999). A likely candidate involved in CDK inhibitory phosphorylation 
during endoreduplication is the WEE1 kinase that is up-regulated in maize during 
endosperm development, coinciding with the onset of endoreduplication (Sun et al., 
1999). Another well-documented mechanism for inhibition of M-phase CDK activity 
has been found in Medicago truncatula root nodules. CCS52, an activator of the 
anaphase-promoting complex involved in the degradation of mitotic cyclins, links cell 
proliferation to cell differentiation and is involved in the conversion of mitotic to 
endocycles (Cebolla et al., 1999; Vinardell et al., 2003; Tarayre et al., 2004). 
CDK inhibitory proteins have been proven to be important regulators of the 
endoreduplication cycle in several organisms. Overexpression of Rum1 in fission 
yeast induces polyploidy and nuclei enlargement through inhibition of M-phase CDKs 
(Moreno and Nurse, 1994). In mammalian trophoblasts, ectopic expression of p57Kip2 
promotes giant cell differentiation, whereas expression of a stable mutant form of the 
protein blocks endoreduplication (Hattori et al., 2000). Recently, it has been 
demonstrated that the CDK inhibitor Dacapo has a function in the mitosis-to-
endocycle transition in Drosophila follicle cells and that it plays an important role in 
endocycling nurse cells (Hong et al., 2003; Scherbata et al., 2004). 
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Proteins related to the class of mammalian Kip/Cip CDK inhibitors have been 
identified in plants and designated Kip-related proteins (KRPs) in Arabidopsis (De 
Veylder et al., 2001; Vandepoele et al., 2002). The Arabidopsis genome encodes 
seven KRP genes. Despite the limited sequence homology with their mammalian 
counterparts, KRPs have been shown to be true functional homologs of the Kip/Cip 
proteins in inhibiting CDK activity both in vitro and in vivo (Wang et al., 1997; Lui et 
al., 2000; Wang et al., 2000; De Veylder et al., 2001; Zhou et al., 2002). 
Overproduction of KRPs in Arabidopsis resulted in plants with small and serrated 
leaves, due to a reduction in cell number as a consequence of an inhibition of the 
mitotic cell cycle. Moreover, these transgenic plants point to the involvement of KRPs 
and CDK activity in endoreduplication, because overproduction of the Arabidopsis 
KRPs or the tobacco (Nicotiana tabacum) KRP homolog NtKIS1a resulted in a 
decrease in the ploidy level in older leaves (De Veylder et al., 2001; Jasinski et al., 
2002; Zhou et al., 2002). 
Here, we investigate the physiological relevance of the interaction between KRP2 
and CDKA;1 at the onset of endoreduplication. A specific inhibition of the mitotic 
CDKA;1 complexes through mild KRP2 overproduction was found to result into an 
increase in the DNA ploidy level. We propose a mechanism by which the level of 
CDKA;1 activity determines whether a cell divides or endoreduplicates. Moreover, 
we show that the KRP2 protein abundance is regulated posttranscriptionally through 
CDK phosphorylation and proteasomal degradation. The observation that 
CDKB1;1/cyclin complexes phosphorylate KRP2, whereas KRP2 protein levels are 
stabilized in plants overexpressing a dominant negative CDKB1;1 allele, prompts us 
to postulate that CDKB1;1 regulates the level of CDKA;1 activity in dividing cells 
through the control of KRP2 protein abundance. 
 
 
Results 
   
 
KRP2 specifically binds and inhibits CDKA;1 and not CDKB1;1 
 
Previously, the interaction of KRP proteins with the archetypical A-type CDKA;1 but 
not with the B-type CDKB1;1 has been demonstrated by yeast two-hybrid analysis 
(Lui et al, 2000; De Veylder et al., 2001; Zhou et al., 2002). To analyze the CDK-
binding specificity of KRP2 in vivo, transgenic lines were generated that 
overexpressed a N-terminal hemagglutinin(HA)-tagged KRP2 gene under control of 
the constitutive Cauliflower Mosaic virus (CaMV) 35S promoter. Several independent 
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lines were obtained. For molecular analysis, two lines (S1 and S2) homozygous for 
one T-DNA locus with high and two lines (W1 and W2) with low HA-KRP2 levels 
were selected, referred hereafter as strong and weak KRP2OE lines, respectively 
(Figure 1A). Differences in transgene expression were reflected in the KRP2 mRNA 
and protein levels and the strength of CDK activity inhibition (Figures 1B-1E). 
Although CDK activity was more severely inhibited in the strong than in the weak 
KRP2OE lines, no linear correlation was found between the amount of transgenic 
KRP2 protein and the level of CDK inhibition. This observation points toward the 
presence of a KRP2-resistant fraction of CDK/cyclin complexes that cannot be 
inhibited by KRP2, even at high levels. 
As reported previously, strong KRP2OE lines had a reduced leaf size compared with 
that of wild-type plants and a distinct morphology (De Veylder et al., 2001) 
(Figure 1A). The observed decrease in leaf size was due to a strong reduction in cell 
number resulting from an inhibition of the mitotic cell cycle (Table 1) (De Veylder et 
al., 2001). Also for the weak KRP2OE lines, a negative effect on the mitotic cell cycle 
was seen, as illustrated by the reduction in leaf size and cell number, although the 
phenotype was less pronounced than that of the strong KRP2OE lines (Table 1). 
Weak KRP2OE lines differed from the strong lines in the lack of a serrated leaf 
phenotype (Figure 1A). 
 
Figure 1. Phenotypic and molecular analysis of KRP2OE Arabidopsis plants.  
Three-week-old transgenic plants were compared with untransformed control plants (Col-0) of 
the same age. 
A. Phenotypes of wild-type (Col-0) plants and two independent weak (35S:KRP2 W1 and W2) 
and strong (35S:KRP2 S1 and S2) KRP2OE lines. 
B. RNA gel blot analysis of wild-type and KRP2OE plants. Equal loading of the gel was 
confirmed by methylene blue staining of the membrane (bottom panel). 
C. Immunoblot analysis of the same lines as in (B.) using an anti-KRP2 antibody. Rubisco 
protein levels visualized by Ponceau S staining act as loading control. 
D. p10CKS1At-associated kinase activity in transgenic plants. Autoradiogram representing a 
typical result from CDK activity assays with histone H1 as substrate. The first lane is a 
background control, in which the activity of BSA-Sepharose bound Col-0 extract is shown. 
Coomassie blue staining of the electrophoresis gel area with histone H1 was used as a control 
of equal substrate quantity per phosphorylation reaction.  
E. Relative quantification of three independent kinase activity measurements as depicted in 
(D.). The control was arbitrarily set at 100%. 
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Table 1. Abaxial epidermis cell size and cell number in leaves of wild type and KRP2OE plants  
 
Line Leaf size 
(mm2) 
Abaxial Epidermal 
Cells 
Estimated number 
 
 
Size (μm2) 
Col-0 15.03±1.02 13532±875 1160±33 
CaMV 35S:KRP2 W1 11.08±0.38 11104±861 1033±78 
CaMV 35S:KRP2 W2 10.25±0.30 10712±898 968±74 
CaMV 35S:KRP2 S1 7.68±0.37 1895±205 4330±494 
CaMV 35S:KRP2 S2 8.98±0.23 1770±93 5250±358 
All measurements were performed on 3-week-old mature first leaves. The indicated values 
are means ± SE (n = 6 to 10). 
72 
KRP2 controls endocycle onset 
The CDK binding-specificity of KRP2 was initially tested by an in vitro binding assay. 
Recombinant KRP2 proteins were coupled to Sepharose beads that were used to 
make an affinity column. To this column Arabidopsis protein extracts were applied, 
and the bound and unbound fractions were probed for the presence of CDKA;1 or 
CDKB1;1 by protein blot analysis with specific antibodies (Hemerly et al., 1995; 
Porceddu et al., 2001). As a control, a BSA-Sepharose affinity column was used. 
The CDKA;1 protein was found to bind specifically to the KRP2 column (Figure 2A). 
Interestingly, not all CDKA;1 protein retained on the column, because a portion of 
CDKA;1 was found in the unbound fraction. In contrast to CDKA;1, no CDKB1;1 
associated with the KRP2-Sepharose column (Figure 2A). 
To analyze the in vivo binding-specificity of KRP2, HA-KRP2-containing complexes 
were immunoprecipitated from total protein extracts prepared from strong and weak 
KRP2OE lines. Subsequently, the pulled-down material was probed with CDKA;1- and 
CDKB1;1-specific antibodies. For both cell extracts, a clear CDKA;1 signal was 
detected. The amount of CDKA;1 protein that co-immunoprecipitated with KRP2 
correlated with that of the KRP2 protein, although not all CDKA;1 proteins were 
pulled-down. CDKB1;1, on the other hand, did not co-immunoprecipitate with KRP2 
(Figure 2B). 
 
 
 
Figure 2. Specific in vitro and in vivo CDKA;1 binding by KRP2. 
A. In vitro interaction of KRP2 with CDKA;1. Protein extracts were loaded onto a BSA-
Sepharose or KRP2-Sepharose column, and bound and unbound fractions were tested for the 
presence of CDKA;1 or CDKB1;1 with specific antibodies. Input and unbound fractions 
represent 1/30th of the amount of protein loaded on the beads. 
B. In vivo interaction of KRP2 with CDKA;1. Immunoprecipitated HA-KRP2 complexes from 
total protein extracts of 3-week-old wild-type (Col-0) and strong (35S:KRP2 S1) and weak 
(35S:KRP2 W1) KRP2OE plants were analyzed by immunoblot analysis with anti-HA, anti-
CDKA;1, and anti-CDKB1;1 antibodies. Total protein extract (1/10th of the amount loaded) 
from untransformed plants was used as control. 
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The overexpression of KRP genes has been demonstrated to result in a decrease in 
extractable CDK activity (Wang et al., 2000; De Veylder et al., 2001; Jasinski et al., 
2001). To test whether the observed decrease in kinase activity was due to a specific 
inhibition of the CDKA;1 kinase, the effect of increasing amounts of recombinant 
KRP2 and of extracts of a strong KRP2OE plant on the immunoprecipitated CDKA;1 
and CDKB1;1 kinase activity of wild-type plants was analyzed (Figure 3A and 3B). In 
both cases a similar inhibition profile was obtained showing specific inhibition of the 
kinase activity of CDKA;1, and not of CDKB1;1 complexes. Specific inhibition of 
CDKA;1 activity by KRP2 was also confirmed in vivo through comparison of the 
immunoprecipitated CDKA;1- and CDKB1;1-associated kinase activity from an 
untransformed control line and a strong KRP2OE line. In comparison to the control 
plants, CDKA;1 activity was reduced by almost 40% in the KRP2OE line, whereas no 
significant inhibition of CDKB1;1 activity was observed (Figure 3C). 
Together, the interaction data and kinase activity measurements demonstrated that 
CDKA;1, but not CDKB1;1, was inhibited by KRP2 in vitro and in vivo. A systematic 
two-hybrid interaction screen between all Arabidopsis CDKs and KRPs further 
confirmed that CDKA;1 was the only CDK to associate with KRPs (data not shown). 
Therefore, CDKA;1 is very probably the only CDK to be targeted in the KRP2OE lines. 
 
Figure 3. Specific in vitro and in vivo inhibition of CDKA;1 kinase activity by KRP2. 
A. Effect of recombinant KRP2 protein on A- and B-type CDK activity. KRP2 (full line) or 
BSA (dashed line) were incubated with the indicated amounts to CDKA;1 (filled dots) and 
CDKB1;1 (open diamonds) complexes immunoprecipitated from 12-day-old wild-type (Col-
0) plants. Kinase activity was measured with histone H1 as substrate. 
B. Kinase activity measurements of immunoprecipitated  CDKA;1 and CDKB1;1 complexes 
from untransformed plants (Col-0) in the presence of increasing amounts of extract from a 
strong KRP2OE line (35S:KRP2 S2). 
C. Specific inhibition of CDKA;1/cyclin complexes by KRP2 in vivo. Kinase activity assays of 
immunoprecipitated CDKA;1 and CDKB1;1 complexes of wild-type (Col-0)(black) and strong 
KRP2OE (35S:KRP2 S1)(grey) plants. Relative CDK activity was measured using histone H1 
as substrate. For quantification, the control was arbitrary set at 100%. The indicated values are 
means ± SD (n = 3).         
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KRP overexpression triggers a dose-dependent endoreduplication 
phenotype 
 
To analyze the effects of KRP2 overexpression on the DNA ploidy distribution, the 
DNA content of 3-week-old first leaves of wild-type and transgenic lines was 
measured by flow cytometry (Table 2). At this stage of development, the leaf is 
mature: no mitotic divisions can be detected and DNA ploidies have reached a 
steady-state level (De Veylder et al., 2001; Boudolf et al., 2004a; Beemster et al., 
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2005; Vlieghe et al., 2005). Surprisingly, contrasting results were obtained for strong 
and weak KRP2OE lines. In the strong KRP2OE lines, an increase in the 2C population 
was observed, correlated with a decrease in the number of nuclei with a 4C and 8C 
DNA content, illustrating an inhibition of the endoreduplication cycle (Table 2). This 
inhibition of the endoreduplication cycle is in agreement with previous reports on 
KRP overexpression in Arabidopsis (De Veylder et al., 2001; Jasinski et al., 2001; 
Zhou et al., 2002; Schnittger et al., 2003). In contrast, in independent weak KRP2OE 
lines, a reproducible increase in the DNA ploidy level was observed, as seen by the 
decrease in number of cells with a 2C DNA content and the increase in the 8C and 
16C cell populations (Table 2). This effect on the endoreduplication cycle correlated 
with the KRP2 expression level and was also seen in cotyledons (data not shown). 
 
Table 2. DNA ploidy levels in 3-week-old mature first leaves of wild-type and KRP2OE 
transgenic lines 
 
Line 2C (%) 4C (%) 8C (%) 16C (%) 
 
Col-0 31.2 ± 0.9 52.8 ± 0.5 15.5 ± 0.6  
CaMV 35S:KRP2 W1 24.7 ± 0.9 51.1 ± 1.0 21.9 ± 0.4 0.9± 0.1 
CaMV 35S:KRP2 W2 20.8 ± 1.1 36.6 ± 1.2 36.9 ± 1.1 2.7 ± 0.2 
CaMV 35S:KRP2 S1 47.8 ± 0.9 37.4 ± 0.6 13.2 ± 0.1  
CaMV 35S:KRP2 S2 49.5 ± 0.2 39.1 ± 0.1 10.9 ± 0.1  
Data represent average ± SD (n= 4 to 8). 
 
CDKA;1 transcripts can be detected in both dividing and endoreduplicating cells of 
the shoot apex and leaf (Jacqmard et al., 1999; Beemster et al., 2005), suggesting a 
role for CDKA;1 in both the mitotic cell cycle and endoreduplication cycle. Distinct 
CDKA;1/cyclin complexes have been demonstrated to regulate the mitotic cell cycle 
and endoreduplication cycle and endoreduplication has been suggested to involve 
loss of M-phase CDK activity (Grafi and Larkins, 1995; Larkins et al., 2001). As such, 
the different effect on the endoreduplication cycle observed for strong and weak 
KRP2OE lines is best explained by a specific inhibition of the mitotic CDKA;1/cyclin 
complexes in the weak KRP2OE lines, whereas in the strong KRP2OE lines both the 
CDKA;1/cyclin complexes with a role in the mitotic cell cycle and the 
endoreduplication cycle are targeted. To test this hypothesis, CDKA;1 kinase activity 
was measured in the leaf tissue of the first leaf pair harvested 9 and 15 days after 
sowing (DAS). Leaves of nine-day-old plants are predominantly mitotically dividing, 
whereas those of 15-day-old plants mainly endoreduplicate (Boudolf et al., 2004a; 
Beemster et al., 2005; Vlieghe et al., 2005). For wild-type leaves, CDKA;1-
associated kinase activity was lower at 15 than at 9 DAS, illustrating that dividing 
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cells possess more CDKA;1 activity than endoreduplicating cells (Figure 4A-4B). In 
mitotic cells (9 DAS) a decrease in CDKA;1 activity was observed for both the strong 
and the weak KRP2OE lines by approximately 40% and 20%, respectively (Figure 
4A). In contrast, at 15 DAS, kinase activity was inhibited by approximately 40% in the 
strong KRP2OE lines, whereas in the weak lines CDKA;1 activity was unaffected 
(Figure 4B). These data indicate that in the strongest KRP2OE lines CDKA;1/cyclin 
complexes with both a role in the mitotic cell cycle and endocycle were inhibited, 
whereas in the weak KRP2OE lines mainly the mitotic CDKA;1 complexes were 
targeted. 
 
 
 
Figure 4. KRP2 dose-dependent control of the endoreduplication cycle. 
Quantitative analysis of immunoprecipitated CDKA;1 kinase activity in the first leaf pair of wild-
type (Col-0) and weak (35S:KRP2 W1 and W2) and strong (35S:KRP2 S1 and S2) KRP2OE 
plants, using histone H1 as substrate. 
A. Nine-day-old mitotically dividing leaves. 
B. Fifteen-day-old endoreduplicating leaves. 
Data represent average ± SD (n=2). 
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Inhibition of the cell cycle in mitotically dividing cells triggers the 
mitosis-to-endocycle transition 
 
To confirm that a specific inhibition of the mitotic cyclin/CDKA;1 complexes accounts 
for the premature onset of endoreduplication, transgenic lines were generated that 
expressed the KRP2 gene under the control of the promoter of the meristem-specific 
SHOOTMERISTEMLESS (STM) gene (Barton and Poethig, 1993; Long et al., 1998; 
Byrne et al., 2002). The expression pattern of the STM promoter was analyzed using 
transgenic plants harboring a STM:YFP-histone H4 promoter construct. In 5-day-old 
seedlings, STM promoter activity was restricted to the shoot apical meristem 
(Figure 5A). At an earlier growth stage, additional expression was detected in the 
hypocotyl in the cells just underneath the shoot apical meristem, whereas in older 
leaf primordia STM activity could be detected as well in the young vascular cells of 
the leaf primordia  (data not shown). At any stage during leaf development the STM 
promoter activity was restricted to mitotically dividing cells and not observed in 
endoreduplicating cells. 
STM:KRP2OE lines had malformed, elongated leaves that were smaller than those of 
wild-type plants (Figure 5A). Scanning electron microscopy pictures revealed that the 
decrease in leaf size was accompanied with an increase in cell size (Figure 5B). This 
reduction in the total leaf cell number is due to an inhibition of the mitotic cell cycle 
and is similar to that observed in plants overexpressing the KRP2 gene under the 
control of the CaMV 35S promoter. However, in contrast to the strong KRP2OE lines, 
plants expressing the KRP2 gene under the control of the STM promoter displayed a 
different DNA ploidy distribution, as illustrated by the increase in number of cells with 
an 8C and 16C DNA content (Figure 5C).  
 
Figure 5. Meristem-specific overexpression of KRP2. 
A. Expression pattern of the STM promoter as visualized by confocal microscopy on 5-day-old 
STM:YFP-histone H4 seedlings, and phenotypes of 3-week-old wild-type (Col-0) and two 
independent STM:KRP2OE plants. 
B. Scanning electron microscopy analysis of the adaxial epidermis of the first leaf pair of a 3-
week-old wild-type (Col-0) and STM:KRP2OE (line 5) plant. Scale bar 100 µM. 
C. Ploidy level distribution of the first leaves of 3-week-old untransformed (Col-0) and 
STM:KRP2OE plants as measured by flow cytometry. The indicated values are means ± SE (n 
= 3 to 5). 
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Previously, we have illustrated that the timing of endoreduplication cycle onset is 
developmentally regulated during leaf development (Boudolf et al., 2004a; Beemster 
et al., 2005; Vlieghe et al., 2005). Cells of the first leaf pair were found to divide until 
approximately 10 DAS during which most cells had a 2C DNA content and the 
remaining predominantly a 4C. After 10 DAS, the leaf cells exit the mitotic division 
program and enter the endoreduplication cycle, which was correlated with an 
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increase in the 4C DNA population. In the STM:KRP2OE lines, the DNA ploidy 
distribution of the first leaves at 8 DAS was found to be identical to that of wild-type 
plants (Figure 6A). In contrast, at 10 DAS, the 4C DNA population was significantly 
higher in the transgenic lines (Figure 6B). Similarly, at 12 DAS, STM:KRP2OE lines 
had an advanced endoreduplication cycle, as illustrated by the higher number of 
cells with an 8C DNA content than that observed in wild-type plants (Figure 6C). 
These data indicate that inhibition of CDKA;1 activity in mitotically dividing cells 
results into a more rapid entry into the endoreduplication cycle. 
 
 
 
Figure 6. Ploidy level distribution of the first leaves of wild-type (Col-0) and STM:KRP2OE (line 
5) plants during development as measured by flow cytometry. 
A. 8 DAS. 
B. 10 DAS. 
C. 12 DAS. 
Histograms represent average data of two to four independent measurements. 
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KRP protein abundance is regulated at the posttranscriptional level 
during leaf development 
 
To analyze the KRP2 mRNA and protein levels during leaf development, the first leaf 
pair of untransformed plants was harvested at two developmental stages, 
representing mitotically dividing (9 DAS) or endoreduplicating (15 DAS) cells, for 
semiquantitative reverse trancription (RT)-PCR and protein blot analysis. CDKA;1 
and CDKB1;1 were included as controls in the analysis. Both the CDKA;1 transcript 
level and protein abundance were relatively constant during development, whereas 
the mRNA and protein levels of the mitosis-specific CDKB1;1 were clearly most 
abundant at 9 DAS. In contrast, KRP2 protein levels had an inverse abundance 
pattern with low levels at 9 DAS and accumulation at 15 DAS. The corresponding 
KRP2 transcript level remained relatively constant, illustrating that the KRP2 protein 
abundance is regulated at the posttranscriptional level (Figures 7A-7B). 
 
 
 
Figure 7. Expression analysis of KRP2 during leaf development. 
cDNA and total protein were prepared from the first leaf pair of wild-type (Col-0) plants at two 
developmental stages representing mitotically dividing (9 DAS) and endoreduplicating 
(15 DAS) cells. 
A. Semiquantitative RT-PCR analysis with gene-specific primers. Transcript levels of KRP2, 
CDKA;1, and CDKB1;1 were analyzed. The actin2 gene was used as loading control. 
B. Immunoblot analysis with anti-KRP2, anti-CDKA;1 and anti-CDKB1;1 antisera. Equal 
loading of the gel was confirmed by visualizing the Rubisco protein levels by Ponceau S 
staining of the membrane. 
Results of relative quantification using the respective loading controls are indicated below each 
gel image. 
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KRP2 is subjected to proteolysis in a phosphorylation-dependent 
manner 
 
Mammalian and yeast CDK inhibitors are phosphorylated by CDKs, after which they 
are recognized and degraded by the proteasome (Verma et al., 1997; Vlach et al., 
1997; Nishizawa et al., 1998; Tomoda et al., 1999). To test whether a similar 
mechanism might be operational in plants, recombinant KRP2 protein was incubated 
with p10CKS1At-purified CDK complexes in the presence of radioactively labeled ATP. 
As a control, histone H1 was included, a well-known in vitro substrate of CDKs. 
KRP2 was found to be phosphorylated by CDKs, albeit with less intensity than the 
histone H1 protein, possibly as a consequence of the presence of more potential 
CDK phosphorylation sites in histone H1 than in the KRP2 protein (Figure 8A). 
Incubation with CDKA;1- and CDKB1;1-immunoprecipitates illustrated that KRP2 is a 
substrate of both CDKs (Figure 8B). 
To analyze whether KRP2 is regulated by proteasomal destruction, recombinant 
KRP2 protein was added to a protein extract of dividing cells in the absence or 
presence of the proteasome inhibitor carbobenzoxyl-leucinyl-leucinyl-leucinal 
(MG132; Planchais et al., 2000). Immediately after incubation, half of the fraction was 
collected and frozen. The remaining half was harvested 2 h later. Protein gel blotting 
showed a clear decrease in KRP2 abundance after 2 h of incubation with control 
extract, corresponding to protein degradation (Figure 8C). In contrast, protein 
abundance did not decrease in the MG132-containing extract, illustrating that the 
observed KRP2 destruction is mediated through the proteasome. Proteasome-
dependent degradation was confirmed in vivo, by the increase in KRP2 protein 
abundance in plants treated with MG132 (Figure 8D). 
Proteolysis of the KRP2 protein depended on CDK activity, because no KRP2 
destruction was observed in extracts pre-incubated with olomoucine, a strong and 
specific inhibitor of CDK activity (Planchais et al., 2000; Figure 8E). Because B-type 
CDKs phosphorylated KRP2, the KRP2 protein abundance in the first leaf pair of 12-
day-old seedlings was compared between wild-type plants and plants harboring 
reduced CDKB1;1 activity due to the presence of a dominant negative allele (Boudolf 
et al., 2004a, 2004b). The KRP2 protein level was clearly higher in plants with 
reduced CDKB1;1 activity, strongly indicating that KRP2 stability is controlled through 
CDKB1;1 phosphorylation (Figure 8F). 
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Figure 8. CDK-dependent phosphorylation and proteasome-mediated degradation of KRP2. 
A. KRP2 phosphorylation by CDKs. p10CKS1At bound CDK activity recognizes both histone H1 
and KRP2 as substrates. 
B. Phosphorylation of KRP2 by CDKA;1 and CDKB1;1 complexes. CDKA;1 and CDKB1;1 
immunoprecipitated kinase activity was tested with histone H1 and KRP2 as substrates. 
C. Immunoblot analysis with anti-KRP2 antiserum of recombinant KRP2 protein added to 
protein extracts of dividing cell suspensions. KRP2 protein stability was monitored during a 
period of 2 h in the presence or absence of 100 μM MG132. 
D. Immunoblot analysis with anti-KRP2 antiserum of in vivo levels of KRP2 protein in whole 
cell extracts of 5-day-old Arabidopsis seedlings of wild-type (Col-0) and weak KRP2OE plants 
(35S:KRP2 W2) grown in the absence (control) or presence of MG132. CDKA;1 protein levels 
determined with anti-CDKA;1 antiserum act as control. 
E. Analysis of the stability of recombinant KRP2 protein in the presence or absence of 10 μM 
olomoucine. Samples were handled as described in (C). 
F. Protein gel blot with anti-KRP2 and anti-CDKA;1 antisera to analyze the KRP2 and CDKA;1 
protein abundance in 12-day-old first leaf pairs of wild-type (Col-0) and CDKB1;1.N161OE 
(CDKB1;1.DN) plants. 
 
 
Discussion 
   
 
Although our knowledge on how the different cell cycle transitions are regulated has 
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increased dramatically over the last years (De Veylder et al., 2003), it is still unclear 
how a dividing cell exits its division program and enters the differentiation pathway. A 
major cause for the absence of information on this important aspect of development 
is the lack of good differentiation markers. Recently, we have demonstrated by a 
kinematic growth analysis that the exit of the mitotic cell cycle of Arabidopsis leaf 
cells coincides with the onset of endoreduplication (Boudolf et al., 2004a; Beemster 
et al., 2005; Vlieghe et al., 2005). As such, insight into how the mitosis-to-endocycle 
transition is regulated could help us understand how a proliferating cell exits the cell 
cycle and starts to differentiate. 
Here, we showed that KRP2 gain-of-function plants display a positive or negative 
effect on the DNA ploidy level, depending on the level of KRP2 overexpression. The 
inhibition of the endocycle in strong KRP2OE plants is in agreement with previous 
reported KRPPOE studies (De Veylder et al., 2001; Jasinski et al., 2001; Zhou et al., 
2002; Schnittger et al., 2003), but is apparently in contradiction with the observed 
stimulation of the endoreduplication cycle in weak KRP2OE plants. However, all 
previously published analyses were focused on the strongest expression lines, in 
which the amount of transgenic KRP protein exceeds far above the endogenous 
level. KRP2 protein abundance in wild-type plants is very low (unpublished results). 
Although the different spatial expression patterns of the CaMV 35S and the 
endogenous KRP2 promoters do not allow us to quantify the level of KRP2 
overexpression at the cellular level in the weak KRP2OE plants, we may reasonably 
assume that the level of KRP2 in the weakest KRP2OE lines is closer to its 
physiological level than in strong KRP2OE plants. Even though both the strong and 
weak KRP2OE lines specifically target CDKA;1, the phenotypes observed for the 
weak KRP2OE lines might relate more to the natural situation. We hypothesize that 
under these close-to-natural situations KRP2 preferentially targets mitotic cell cycle-
specific cyclin/CDKA;1 complexes. By contrast, in the strong KRP2OE lines, 
cyclin/CDKA;1 complexes with a role in the endoreduplication cycle might be 
inhibited as well. KRP2 specificity toward mitotic cell cycle complexes was confirmed 
by kinase activity measurements, demonstrating that in the weak KRP2OE plants the 
CDKA;1 complexes purified from dividing leaf cells were much more inhibited than 
those isolated from endoreduplicating tissues. In contrast, in the strong KRP2OE 
lines, both mitotic cell cycle and endoreduplication cycle CDKA;1 complexes were 
inhibited to the same degree. 
In mammals, the Kip/Cip inhibitors only bind and inhibit a subset of the CDK/cyclin 
complexes. A similar situation probably exists in plants because KRP2 does not bind 
and inhibit all CDKA;1 proteins in KRP2OE plants. Although the three-dimensional 
structure of p27Kip1 in complex with CDK2/cyclinA revealed that Kip/Cip binding 
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involved interaction with both the CDK and cyclin subunit, the binding specificity of 
the inhibitors has only recently been proven to rely solely on their interaction with the 
cyclin (Russo et al., 1996; Lacy et al., 2004). In vivo binding specificity between 
KRPs and different D-type cyclins has been demonstrated by Schnittger et al. 
(2003), who showed that the trichome endoreduplication phenotype resulting from 
KRP1 overexpression can be complemented by overexpression of CYCD3;1, but not 
of CYCD4;1. In mammalian trophoblasts, the transition of mitotic cell division to 
endoreduplication is accompanied by a switch of D-type cyclin isoform expression 
(MacAuley et al., 1998). Expression of CYCD3 was high in proliferating cells, but 
decreased significantly with the onset of differentiation, whereas expression of 
CYCD1 was only low in proliferating cells, but was induced at the start of 
endoreduplication correlated with differentiation. Similarly, CDKA;1 might change 
cyclin partner at the mitosis-to-endocycle transition, resulting in the shift from a KRP-
sensitive to a KRP-insensitive CDKA;1/cyclin complex.  
Endoreduplicating leaf tissue was found to have less CDKA;1 activity than mitotically 
dividing leaves, illustrating that the onset of endoreduplication is correlated with a 
decrease in CDK activity. Also in maize endosperm and tomato fruits, the onset of 
endoreduplication is accompanied with a decrease in CDK activity (Grafi and 
Larkins, 1995; Joubès et al., 1999). Start of DNA replication requires the assembly of 
a protein complex at the origins of replication, called the pre-replication complex 
(Bryant et al., 2001; Nishitani and Lygerou, 2002). At the onset of S phase, pre-
replication complexes are activated, resulting in DNA replication. For a number of 
species, high CDK activity has been demonstrated to ensure that chromosomes are 
only replicated once per cell cycle by inhibiting reactivation of the replication origins 
in G2 cells. Only when CDK activity drops at the end of S phase, cells are reset for 
replication, resulting in endopolyploidy (Hayles et al., 1994; Moreno and Nurse, 
1994; Itzhaki et al., 1997). The underlying principle of activation of DNA replication is 
conserved in plants (Castellano et al., 2001, 2004; Masuda et al., 2004). As such, it 
is reasonable to assume that also in plants a reduction in CDK kinase activity is 
required for cells to endoreduplicate. The observation that CDKA;1 activity is not 
totally inhibited in endoreduplicating cells suggests an active role for this CDK in the 
endoreduplication cycle. Such a role has recently been elegantly demonstrated by 
the specific overexpression of a dominant negative allele of the maize A-type CDK in 
endosperm cells, resulting in inhibition of endoreduplication, correlated with reduction 
in CDKA;1 activity (Leiva-Neto et al., 2004). 
Specific inhibition of the mitotic cell cycle CDKA;1 complexes, through 
overexpression of the KRP2 gene in the meristem, causes a premature start of the 
endoreduplication cycle. Therefore, we propose a model in which the level of CDK 
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activity determines whether a cell divides mitotically or endoreduplicates (Figure 9). 
We assume that CDK activity gradually decreases as cells move away from the 
meristem. As long as CDK activity is above a certain threshold, cells divide, but once 
kinase activity drops below the threshold, cells stop proliferating and start to 
endoreduplicate. The overproduction of KRP2 probably results in an overall 
reduction of CDKA;1 activity, by which plants reach the endoreduplication threshold 
earlier during development. This model is a confirmation and refinement of that 
previously proposed by Yamaguchi et al. (2003), who proposed that the CDK activity 
level at early organogenesis controls the differentiation state of leaf callus cells and 
as such that CDK activity is a major determinant of cell differentiation to accomplish 
proper organ development. What causes CDKA;1 activity to decrease as cells move 
away from the meristem? Our data suggest a prominent role for the KRP2 proteins, 
because KRP2 protein levels increase in differentiating cells. Also in mammals, 
Kip/Cip inhibitors are up-regulated as cells exit the mitotic cycle and begin to 
differentiate (Polyak et al., 1994; Parker et al., 1995). In p27Kip1- and p57Kip2-deficient 
mice abnormalities in cell number and organ size were observed and many tissues 
had a delayed cell differentiation and an inappropriate continuation of cell 
proliferation (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996; Yan et 
al., 1997; Durand et al., 1998). However, in all cases, cells eventually differentiated, 
suggesting that CDK inhibitors are not critical, but rather are involved in the correct 
timing of cell cycle exit. This result has also been demonstrated by studies on the 
function of the Drosophila Kip/Cip homolog, Dacapo (de Nooij et al., 1996; Lane et 
al., 1996). 
 
 
 
Figure 9. Model illustrating the role of CDK activity in controlling the onset of 
endoreduplication. For details, see text. 
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KRP2 expression is at least partially regulated at the posttranscriptional level, 
through its phosphorylation by A- and B-type CDKs. In mammals, the 
phosphorylation of Kip/Cip inhibitors results in their destruction through the 
ubiquitination pathway (Vlach et al., 1997; Tomoda et al., 1999). Similarly, the yeast 
Sic1/Rum1 inhibitors are substrates of Sic1/Rum1-resistant CDKs, with consequent 
ubiquitin-dependent degradation (Verma et al., 1997; Nishizawa et al., 1998). We 
have demonstrated that KRP2 is an unstable protein and that its degradation 
depends on CDK phosphorylation and the presence of an active proteasome. 
Interestingly, KRP2 was found to be an efficient CDKB1;1 substrate and to be 
stabilized in plants overexpressing a dominant negative CDKB1;1. Previously, we 
showed that CDKB1;1 activity plays an important role in determining whether cells 
divide or endoreduplicate, because overexpression of a dominant negative CDKB1;1 
caused cells to enter the endoreduplication cycle prematurely (Boudolf et al., 2004a). 
It is tempting to speculate that CDKB1;1 controls the level of CDKA;1 activity through 
the phosphorylation of KRPs. In such a model, CDKB1;1 activity in dividing cells 
would prevent CDKA;1 inhibition through the phosphorylation and destruction of 
KRPs. However, when cells enter the endoreduplication cycle they lose CDKB1;1 
activity, resulting in increased KRP stability and inhibition of CDKA;1 activity. This 
hypothesis implies that the factors that regulate the mitosis-to-endocycle transition 
through inactivation of CDKB1;1 activity, simultaneously control the amount of 
CDKA;1 activity (Figure 9). Such a coordinated decrease in activity of both types of 
CDKs might be essential to warrant a correct timing of mitotic cell cycle exit. 
To validate that the model presented in Figure 9 is sufficient to control the timing of 
the mitosis-to-endocycle transition, we performed a number of dynamical simulations 
using the SIM-plex toolpack (Vercruysse and Kuiper, 2005). This software uses the 
PLDE mathematical framework (De Jong et al., 2004), an approach that 
approximates regulatory interactions between proteins as operating in a switch-like 
manner, with activation events depending on concentrations reaching a critical 
threshold (Glass and Kauffman, 1973). The activity of the CDKB1;1 complex was 
predefined as peaking at 4 h in a complete cell cycle of 20 h, as determined by 
Menges and Murray (2002). The KRP2 protein was assumed to be continuously 
produced during the cell cycle and to be degraded when CDKB1;1 activity 
exceeded a critical threshold. When KRP2 reached a specific threshold value, it 
inhibited CDKA;1 activity. In wild-type cells the KRP2 protein level continuously 
increased during a cell division cycle, but was repressed by the peak of CDKB1;1 
activity. As a result, CDKA;1 activity oscillated during the cell cycle, but remained 
high enough to enable mitotic divisions (Figure 10A). Only when CDKB1;1 activity 
dropped, KRP2 protein accumulated above a level high enough to inhibit mitotic 
 87 
Chapter 3 
CDKA;1 activity. Simulating a faster decrease in CDKB1;1 activity yielded a 
pattern with a more rapid increase in KRP2 protein levels, and, as such, a faster 
entry into the endoreduplication cycle (Figure 10B). This result supports the 
observation that overexpression of a dominant negative CDKB1;1 allele results in 
a premature onset of the endoreduplication cycle (Boudolf et al., 2004a). Similarly, 
simulating a scenario with an increased net synthesis of KRP2 results in an earlier 
mitosis-to-endocycle transition, due to a faster decrease in CDKA;1 activity 
(Figure 10C). All simulation scenarios can be viewed and tested at 
http://www.psb.ugent.be/cbd/krp2sim. The capacity to mimic true in vivo situations 
through dynamical modeling allows us to hypothesize that the interactions as 
presented in Figure 9 are an important part of the core mechanism controlling the 
mitosis-to-endocycle transition during Arabidopsis leaf development. 
 
 
 
Figure 10. Simulation of the onset of endoreduplication.  
Simulation of KRP2 protein abundance and CDKA;1 activity as based on predefined CDKB1;1 
activity. Activities were simulated in arbitrary units. CDKB1;1 initiates KRP2 phosphorylation 
when it reaches the activity threshold of 4 units. KRP2 inhibits CDKA;1 activity above its 
threshold 8. CDKA;1 activity first remains above a level that is assumed to be necessary to 
maintain mitotic division. In the grey-colored zone, CDKA;1 activity drops below this critical 
level, marking the onset of the endoreduplication cycle. Note the remaining CDKA;1 activity at 
this stage to keep the endoreduplication cycle running. 
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Methods 
   
   
Regeneration and molecular analysis of transgenic lines and growth 
conditions 
 
The coding region of KRP2 was amplified by polymerase chain reaction (PCR) and 
cloned in the pREP42-HA vector (Craven et al., 1998). A HA-tagged version of KRP2 
was obtained by NcoI and BamHI digestion of the pREP42-HA_N.KRP2 construct. 
Subsequently, the restriction fragment was cloned between the CaMV 35S promoter 
and the nopaline synthase (NOS) 3' untranslated region of PH35S (Hemerly et al., 
1995). The CaMV35S/HA.KRP2/NOS cassette was released of the pH35S.HA.KRP2 
constructs and cloned into the EcoRI and SalI sites of pBinPLUS (van Engelen et al., 
1995) to obtain the pBIN.HA.KRP2 vector. 
The STM promoter was amplified from the full bacterial artificial chromosome clone, 
BAC F2401, as a 4.5-kb fragment. A single ATG site was generated at its 3' end, 
creating a NcoI restriction site through PCR amplification. The KRP2 insert was 
obtained as described previously (De Veylder et al., 2001). The enhancer trap binary 
vector pTer-9 was a kind gift from Prof. I. Negrutiu (Lyon, France). pSTM was cloned 
into pTer-9 at the KpnI/BamHI sites to verify the tissue specificity of this promoter. 
For the transcriptional fusions, pSTM was first cloned into the pBinPLUS vector. 
Thereafter, the cassette containing KRP2 together with a 3´NOS terminator was 
introduced behind pSTM. 
Both pBIN.HA.KRP2 and pSTM.KRP2 were mobilized by the helper plasmid 
pRK2013 into the Agrobacterium tumefaciens C58C1RifR harboring the plasmid 
pMP90 (Koncz and Schell, 1986). Arabidopsis thaliana (L.) Heynh. ecotype 
Columbia-0 (Col-0) was transformed by the floral dip method (Clough and Bent, 
1998). 
Transgenic plants were selected on kanamycin-containing medium. For all analyses, 
plants were grown under a 16-h light/8-h dark photoperiod at 22°C on germination 
medium (Valvekens et al., 1988). Molecular analysis of the obtained transformants 
was performed by RNA gel blot analysis and semiquantitative RT-PCR as described 
before (De Veylder et al., 1999; Boudolf et al., 2004a). Information about the primer 
set sequences used for RT-PCR can be given upon request. Plants harboring the 
mutant CDKB1;1.N161 gene under the control of the CaMV 35S promoter (Boudolf 
et al., 2004b) were constructed as described previously. 
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Microscopy and flow cytometric analysis 
 
Leaves were harvested 21 DAS, cleared overnight in ethanol, stored in lactic acid for 
microscopy, and observed under a microscope fitted with differential interference 
contrast optics (Leica, Wetzlar, Germany). The total (leaf) area was determined from 
pictures digitized directly with a digital camera (Axiocam; Zeiss, Jena, Germany), 
mounted on a binocular (Stemi SV11; Zeiss). From scanned drawing-tube images of 
outlines of at least 30 cells of the abaxial epidermis located 25% and 75% from the 
distance between the tip and the base of the leaf, halfway between the midrib and 
the leaf margin, the following parameters were determined: total area of all cells in 
the drawing and total numbers of pavement and guard cells, from which the average 
cell area was calculated and the total number of cells per leaf estimated by dividing 
the leaf area by the average cell area. Confocal microscopy was performed on 2-
day-old seedlings as described by Autran et al. (2002), and scanning electron 
microscopy samples were prepared as described by Traas et al. (1995). 
For flow cytometric analysis, leaves were chopped with a razor blade in 300 μl of 
45 mM MgCl2, 30 mM sodium citrate, 20 mM 3-(N-morpholino)propanesulfonic acid 
(pH 7), and 1% Triton X-100 (Galbraith et al., 1991). From a stock of 1 mg/ml 4,6-
diamidino-2-phenylindole, 1 μl was added to the filtered supernatants. The nuclei 
were analyzed with the BRYTE HS or CyFlow flow cytometer with Win-Bryte (Bio-
Rad, Hercules, CA) or FloMax (Partec, Münster, Germany) software, respectively. 
     
 
Semi-quantitative RT-mediated PCR analysis 
 
RNA was extracted from leaves of Arabidopsis (Col-0) with TriZol reagent 
(Amersham Biosciences, Little Chalfont, UK). First-strand cDNA synthesis was 
performed on 3 μg of total RNA with the Superscript RT II kit (Invitrogen, Carlsbad, 
CA) and oligo(dT)18 according to the manufacturer's instructions. A 1-μl aliquot of 
the total RT reaction volume (20 μl) was used as a template in semiquantitative RT-
mediated PCR analysis, ensuring that the amount of amplified product remained in 
linear proportion to the initial template present in the reaction. Ten microliters from 
the PCR reaction was separated on a 0.8% agarose gel and transferred onto 
Hybond N+ membranes (Amersham Biosciences). The membranes were hybridized 
at 65°C with fluorescein-labeled probes (Gene Images random prime module; 
Amersham Biosciences). The hybridized bands were detected with the CDP Star 
detection module (Amersham Biosciences). Primers used were 
GGCTCCTCTTAACCCAAAGGC and CACACCATCACCAGAATCCAGC for actin2 
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(At3g18780); CGGAATAAGTTGTTGGAATGTTCTATGAAGTGT and 
GGCGGATCCTCATGGATTCAATTTAACCC for KRP2 (At3g50630); 
CCTAGGATCTCATCATTACTCTACACC and CCATGTATCCTCGTACGGAGTTCC 
for CDKA;1 (At3g48750); and GGTGGTGACATGTGGTCTGTTGG and 
CGCAGTGTGGAAACACCCGG for CDKB1;1 (At3g54180). 
 
 
Preparation of recombinant KRP2 protein and KRP2 antibody, in vitro 
KRP2 binding assay, immunoprecipitations, and immunoblotting 
 
For KRP2 expression and purification, a His-tagged fusion protein was generated. 
The KRP2 coding region was PCR amplified and cloned into the GATEWAY 
pDONR207 vector (Invitrogen). After recombination with pDEST17, the obtained 
expression vector pDEST17.KRP2 was transformed in the Escherichia coli BL21-
CodonPlusTM(DE3)-RIL strain (Novagen, Madison, WI). E. coli cells were grown to an 
A600 nm of 0.5-0.7 at 37°C in LB+ medium and the expression of KRP2 was induced 
by addition of 0.2 mM isopropyl β-D-thiogalactoside for 3 h at 37 °C. The cells were 
lyzed with lysozyme in buffer 50 mM NaH2PO4, pH 8.0, 300 mM NaCl, 2 mM 
imidazole, 0.5% Triton X-100, 0.5 mM DTT, and complete protease inhibitor without 
EDTA (Roche, Diagnostics, Brussels, Belgium). The protein was purified on Ni-NTA 
resin (Qiagen, Hilden, Germany) according to the manufacturers instructions and 
dialyzed against buffer 50 mM Tris–Cl, pH 7.5, 15 mM MgCl2, 5 mM EGTA, and 1 
mM DTT.  
To raise a KRP2-specific antibody, a peptide of 20 amino acids located in the C-
terminal domain of the KRP2 protein [(C)-FEKDEPLGGG RYEWVKLNP, with C 
indicating an extra cysteine] was synthesized, linked to keyhole limpet hemocyanin 
carrier protein, and used to immunize rabbits. The antiserum was immuno-affinity 
purified against the same peptide bound to a Sepharose matrix (Amersham 
Biosciences). CDKA;1 and CDKB1;1 specific antisera were described before 
(Hemerly et al., 1995; Porceddu et al., 2001). 
Purified recombinant KRP2 protein or BSA (Sigma-Aldrich, St. Louis, MO) was 
coupled to cyanogen bromide-activated Sepharose 4B (Amersham Biosciences) at 
a concentration of 5 mg/ml according to the manufacturer’s instructions. Two-day-
old MM1 cell suspension culture extracts (900 μg) (Menges and Murray, 2002) in a 
total volume of 200 μl homogenization buffer was loaded onto 50 μl of 50% (v/v) 
KRP2- or BSA-Sepharose and incubated on a rotating wheel for 2 h at 4°C. The 
unbound proteins were collected and the bead-bound fractions were washed three 
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times with bead buffer. The beads were resuspended in 20 μl of SDS loading buffer 
and boiled. 
For immunoprecipitations, 300 μg of total protein in homogenization buffer (25 mM 
Tris-Cl, pH 7.6, 75 mM NaCl, 15 mM MgCl2, 15 mM EGTA, 15 mM p-
nitrophenylphosphate, 60 mM β-glycerophosphate, 1 mM DTT, 0.1% Nonidet P-40, 
0.1 mM Na3VO4, 1 mM NaF, and protease inhibitor cocktail P9599 (Sigma-Aldrich) 
were precleared with 30 μl of 50% (v/v) protein A-sepharose beads (Amersham 
Biosciences) for 1 h at 4°C or immediately incubated with 30 μl of 50% (v/v) anti-HA 
Affinity Matrix (Roche Diagnostics). After a short centrifugation, the precleared 
supernatants were transferred to new Eppendorf tubes containing CDKA;1 (1/250) or 
CDKB1;1 (1/100) antibodies and incubated at 4°C for 2 h. In the following step, 30 μl 
of 50% (v/v) protein A-Sepharose was added, and the tubes were incubated for 1 h 
at 4°C on a rotating wheel. Thereafter, beads were washed three times with RIPA 
buffer (20 mM Tris-Cl, pH 7.4, 5 mM EDTA, 2 mM EGTA, 100 mM NaCl, 2 mM NaF, 
0.2% Nonidet P-40, 300 μM phenylmethylsulfonyl fluoride, and 10 μg/ml aprotinin 
and pepstatin), and used for CDK activity reactions or protein gel blot analysis. 
Proteins were separated by 12% SDS-PAGE and blotted onto Immobilon-P 
membranes (Millipore, Bedford, MA). Filters were blocked in 3% (v/v) milk powder in 
25 mM Tris-Cl (pH 8), 150 mM NaCl, 0.05% Tween 20 for at least 1 h at room 
temperature and incubated overnight at 4°C with CDKA;1 (1/5000), CDKB1;1 
(1/1000), KRP2 (1/1000), or HA (1/1000) (Roche Diagnostics) antibody in blocking 
buffer. Antigen-antibody complexes were detected with horseradish peroxidase-
conjugated IgG diluted 1/10000 (Amersham Biosciences) with a chemiluminescence 
system (Perkin Elmer, Norwalk, CT). 
 
 
Protein extraction, CDK activity and phosphorylation assays, and 
degradation assays 
 
Arabidopsis plants or tissues and 2-day-old MM1 cell suspension cultures (Menges 
and Murray, 2002) were harvested, used immediately or snap-frozen in liquid 
nitrogen, and stored at –70°C. Proteins were extracted by grinding cells with quartz 
sand in homogenization buffer. The protein content was determined by using the Bio-
Rad protein assay kit. 
Equal amounts of total protein were incubated with p10CKS1At- or BSA-Sepharose 
beads (De Veylder et al., 1997) or used for immunoprecipitations. Kinase assays 
were performed as described by De Veylder et al. (1997) with histone H1 and/or 
recombinant KRP2 as CDK substrates. 
92 
KRP2 controls endocycle onset 
For the in vitro degradation assay, mixtures contained 100 μg of Arabidopsis cell 
suspension culture MM1 protein extract (20 mM HEPES, pH 7.5, 1 mM DTT, 5 mM 
MgCl2) supplemented with an ATP-regenerating system (35 mM phosphocreatine, 
50 μg/ml creatine kinase), 1 mM ATP, 1/15 (v/v) wheat germ lysate (Promega, 
Madison, WI), and 50 ng substrate. The reaction mixtures were incubated at 30°C 
for 2 h and the reactions were stopped by the addition of SDS sample buffer. Either 
10 μM olomoucine (Alexis, San Diego, CA) or 100 μM carbobenzoxyl-leucinyl-
leucinyl-leucinal (MG132) (Affiniti Research, Exeter, UK) were preincubated with the 
extract for 15 min at room temperature before the addition of the substrate. In vivo 
degradation was assayed by MG132 treatment (100 μM) of 5-day-old seedlings for 
12 h. All control samples were treated with dimethyl sulfoxide. 
 
 
Network simulations 
 
For the dynamical simulations we used the SIM-plex software (Vercruysse and 
Kuiper, 2005) that allows the specification of a regulatory network in a series of ‘if-
then’ statements. Network definitions can be found at 
http://www.psb.ugent.be/cbd/krp2sim. For wild-type conditions, the first program 
line predefines a fixed CDKB1;1 activity profile. Peak duration is approximately 
one-fifth of the duration of a full cell cycle according to Menges and Murray (2002). 
The next statements define the different components of the model. Initial KRP2 
protein level and CDKA;1 activity were set so that, from the onset, the simulation 
immediately displayed a robust oscillating profile that assumed the occurrence of 
cyclical state transitions prior to the start of the simulation, as expected during 
normal mitotic division. KRP2 degradation (0.02) was set below that of the 
standard degradation in SIM-plex (0.05) to emphasize the active effect of CDK 
phosphorylation. The “time points” statement primed SIM-plex to simulate the time 
required for four normal mitotic divisions (4 x 20 h). The two “if-true-then” 
statements ensured constant creation of KRP2 and CDKA;1 proteins, by a cause 
not further specified. Natural degradation eventually puts a saturation effect on 
protein creation. The final two statements modeled the phosphorylation of KRP2 
under the influence of CDKB1;1, and the deactivation of CDKA;1 complexes by 
KRP2. Thresholds and creation rates were chosen so that simulated profiles 
matched reality most closely, but taking into account all known data on transcript 
and protein concentrations during the cell cycle. The network definition of the 
dominant negative CDKB1;1 allele was changed from the wild-type settings in the 
CDKB1;1 definition and also in the specification of the initial level of CDKA;1 (12 
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instead of 14, because of the higher KRP2 activity prior to time = 0). The network 
definition of the KRP2-overexpressing line differed from the wild-type settings in 
the initial level of KRP2 protein (7 instead of 6), the constant creation rate of KRP2 
(0.55 instead of 0.5), and the initial level of CDKA;1 activity (12 instead of 14). The 
simulation results were exported into Adobe Illustrator for optimal presentation. 
Simulation conditions can be altered at http://www.psb.ugent.be/cbd/krp2sim.    
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Cyclin-dependent kinase inhibitor regulation through 
CDK kinase phosphorylation and CDK subunit CKS1 
  
 
Aurine Verkest, Dirk Inzé, Lieven De Veylder 
 
Abstract 
   
  
Selective ubiquitin-mediated protein degradation controls the availability, and 
therefore the activity, of several cell cycle proteins. Previously, we showed that 
the Arabidopsis CDK inhibitor KRP2 is regulated through proteasomal 
degradation and CDK phosphorylation. In yeast and mammalia, Suc1/Cks1 
proteins play distinct roles in cell cycle regulated proteolysis. Here, we show 
that Arabidopsis CKS1 regulates KRP2 inhibitory activity. Overexpression of 
CKS1 resulted in plants with reduced KRP protein levels due to 
posttranslational regulation. We illustrate that KRP2 phosphorylation by CDKs 
enhances its degradation and results in loss of its binding and inhibitory 
specificity towards CDKA;1 kinases. Interestingly, mitotic CDKB1;1/cyclin 
complexes do not merely phosphorylate KRP2, marking it for destruction, but 
also only bind phosphorylated KRP2. In agreement with a role for CKS1 in 
KRP2 proteolysis, CKS1 enhanced the CDKB1;1-dependent phosphorylation 
of KRP2. In addition, by competing for CDKA;1 binding, CKS1 counteracts 
KRP2-mediated CDKA;1 inhibition. We postulate that the combination of these 
functions of CKS1 triggers KRP2 degradation by a yet to be identified ubiquitin-
ligase. 
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Introduction 
   
 
Cyclin-dependent kinases (CDKs) regulate progression through the cell cycle 
in all eukaryotes. These Ser/Thr kinases are composed of a catalytic CDK 
subunit and a regulatory cyclin subunit. A third partner often found in complex 
with CDK/cyclins is a small protein known as the Cdc kinase subunit (Cks). 
Suc1/Cks1 proteins were originally identified through their ability to genetically 
suppress defective alleles of the CDKs of both fission and budding yeast 
(Hayles et al. 1986; Hadwiger et al. 1989; Reed et al. 1989). Subsequent 
investigations demonstrated that these small proteins are ubiquitously present 
in eukaryotes and bind directly to CDK/cyclin complexes. Although the precise 
functions of the Cks proteins have been elusive, they were shown to be 
essential for viability in both fission and budding yeast (Pines, 1996).  
Most studies point to a mitotic role for Cks proteins, although other cell cycle 
functions have been suggested (Tang and Reed 1993; Reynard et al., 2000). 
Loss of Suc1/Cks1 function in both fission yeast (S. pombe) and S. cerevisiae 
results in a M phase arrest, correlated with elevated levels of CDK/cyclinB 
kinase activity (Moreno et al., 1989; Tang and Reed, 1993). In Xenopus, 
immunodepletion of the Cks homolog Xe-p9 from interphase egg extracts 
prevents entry into mitosis, whereas its immunodepletion from mitotic extracts 
leads to a M phase arrest with elevated levels of cyclinB and CDK1/cyclinB 
kinase activity (Patra and Dunphy, 1996). Taken together, these results 
suggest that the Cks proteins may be required both for entry into and 
progression through mitosis. It has been demonstrated that Xe-p9 enhances in 
vitro phosphorylation of various mitotic CDK substrates, including Cdc25 and 
Wee1, consistent with its observed role in mitotic entry (Patra et al., 1999). 
Precisely how Cks1 facilitates phosphorylation of CDK substrates is not known, 
but the presence of a phosphate-binding surface on Cks1 suggests that the 
targets of Cks1 are prephosphorylated (Avrai et al., 1995; Bourne et al., 1996). 
Consistently, Suc1 was shown to bind a phosphorylated Cdc25 peptide and 
suggested to stimulate Cdc25 phosphorylation by CDK/cyclin complexes 
(Landrieu et al., 2001).  
Cks was shown to have also a G1 function in budding yeast, as certain Suc1 
mutations lead to a cell cycle arrest in G1 due to a defect in G1 CDK activity 
towards important substrates such as the CDK inhibitors Sic1 and Far1 (Tang 
and Reed, 1993; Reynard et al., 2000).  Phosphorylation of Sic1 and Far1 by 
G1 CDKs is required for their degradation and entry into S phase (Henchoz et 
al., 1997; Verma et al., 1997; Nishizawa et al., 1998). Similarly, CDK 
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phosphorylation of mammalian Kip/Cip CDK inhibitors results in their destruction 
through the ubiquitination pathway (Sheaff et al., 1997; Vlach et al., 1997). One 
of the two mammalian Cks proteins, Cks1, was shown to facilitate the ubiquitin-
mediated proteolysis of the Kip/Cip CDK inhibitors, revealing its role in 
controlling the G0–G1 transition (Ganoth et al., 2001; Spruck et al., 2001; 
Bornstein et al., 2003; Kamura et al., 2003). Interestingly, the mechanism of 
mammalian Cks1-assisted Kip/Cip degradation is different than in yeast. 
Whereas in yeast Suc1 accelerates the phosphorylation of CDK inhibitors, 
marking them for destruction, mammalian Cks1 triggers Kip/Cip degradation by 
enhancing the interaction between phosphorylated p27Kip1 and the SCFSkp2 
ubiquitin ligase (Ganoth et al., 2001; Spruck et al., 2001). Moreover, Cks1 was 
recently shown to negatively regulate Skp2 auto-ubiquitination and proteolysis 
(Wang et al., 2004). 
Whereas lower eukaryotes express only one Cks gene, Arabidopsis thaliana, 
like mammals, expresses two orthologs, Arath;CKS1 and Arath;CKS2 
(Richardson et al., 1990; Vandepoele et al., 2002). In plants, biochemical and 
genetic data concerning CKS function is scarce. Arabidopsis CKS1 was shown 
to bind CDKs and is sufficiently conserved at the structural and functional level 
that it can functionally substitute for Cks1 in yeast (De Veylder et al., 1997; 
Boudolf et al., 2001). Overexpression of Arath;CKS1 in Arabidopsis caused a 
prolongation of cell cycle duration and strongly reduced meristem size (De 
Veylder et al., 2001a). To further characterize the function of Arath;CKS1 we 
investigated its role in KRP2 CDK inhibitor regulation. The Arabidopsis genome 
encodes seven CDK inhibitor genes, designated KRPs (Kip related protein) 
because of their homology with the mammalian Kip/Cip CDK inhibitors (De 
Veylder et al., 2001b; Vandepoele et al., 2002). KRPs have been shown to be 
true functional orthologs of the Kip/Cip proteins in binding and inhibiting CDK 
activity (reviewed in Verkest et al., 2005b). Recently, Arath;KRP1 and 
Arath;KRP2 have been demonstrated to participate in the exit of mitosis and the 
onset of endoreduplication (Verkest et al., 2005a; Weinl et al., 2005). 
Interestingly, Arath;KRP2 was shown to be posttranslationally regulated through 
CDK phosphorylation and proteasomal degradation (Verkest et al., 2005a). Here, 
we demonstrate that CDK phosphorylation of KRP2 interferes with its association 
and inhibition of CDKA;1 complexes and accelerates its degradation. Moreover, 
we reveal that CKS1 negatively regulates KRP2 activity by competing for binding 
of CDKA;1, and by enhancing CDKB1;1-mediated KRP2 phosphorylation, 
marking KRP2 for its degradation.  
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Results 
   
 
KRP2 phosphorylation by CDKs alters its CDK affinity and 
decreases its stability 
 
It was shown recently that the Arabidopsis CDK inhibitor KRP2 is subjected to 
CDK-dependent phosphorylation (Verkest et al., 2005a). Intriguingly, both A- and 
B-type CDKs phosphorylate KRP2, even though KRP2 was shown to bind 
exclusively CDKA;1 in yeast two-hybrid, and in in vitro and in vivo interaction 
assays (Lui et al., 2000; De Veylder et al., 2001b; Verkest et al., 2005a). To 
analyze the effect of CDK-mediated KRP2 phosphorylation upon CDK binding-
specificity, CDKA;1 and CDKB1;1 protein complexes were immunoprecipitated 
using specific antibodies from protein extracts of dividing cells preincubated with 
recombinant KRP2 or CDK phosphorylated KRP2 (Hemerly et al., 1995; 
Porceddu et al., 2001). Subsequently, the bound fractions were analyzed for the 
presence of KRP2 by autoradiography or protein blot analysis. As expected, non-
phosphorylated KRP2 specifically bound CDKA;1 but not CDKB1;1 complexes 
(Figure 1A). In contrast, phosphorylated KRP2 changed its binding specificity and 
interacted exclusively with CDKB1;1 complexes (Figure 1A).  
KRP2 has been verified to inactivate CDK activity in vitro and in vivo due to a 
specific inhibition of the CDKA;1 kinase (Lui et al., 2000, De Veylder et al., 
2001b; Verkest et al., 2005a). To test the consequence of its phosphorylation on 
CDK activity, the effect of recombinant KRP2 and phospho-KRP2 on 
immunoprecipitated CDKA;1 and CDKB1;1 kinase activity was analyzed. 
Whereas non-phosphorylated KRP2 inhibited CDKA;1 activity, its phosphorylated 
isoform had no inhibitory effect, most probably as a result of its inability to bind 
CDKA;1/cyclin complexes (Figure 1B). Curiously, phosphorylated KRP2, as its 
nonphosphorylated form, did not inhibit but instead activated CDKB1;1 kinase 
activity (Figure 1B).  
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Figure 1. Analysis of the effect of KRP2 phosphorylation by CDKs.  
A. In vitro CDK binding-specificity of KRP2 and phosphorylated KRP2 (P.KRP2) towards 
CDKA;1 and CDKB1;1 kinases.  
B. Effect of KRP2 phosphorylation on A- and B-type CDK activity. Recombinant KRP2 or 
phospho-KRP2 were added to CDKA;1 and CDKB1;1 kinase complexes 
immunoprecipitated from actively dividing Arabidopsis MM1 cell suspension extracts. 
Kinase activity was tested towards histone H1 as substrate. Coomassie blue staining of 
the electrophoresis gel area with histone H1 was used as a control of equal substrate 
quantity per phosphorylation reaction. The diagram represent the relative quantification of 
two independent kinase activity measurements with the controls arbitrarily set at 100%.  
C. Immunoblot analysis with anti-His antiserum of recombinant KRP2 and phospho-KRP2 
protein added to protein extracts of dividing cell suspensions. KRP2 protein stability was 
monitored after 30 and 60 minutes of incubation.  
 
Previously, we showed that KRP2 is an unstable proteasome-dependent 
regulated protein, whose protein abundance is stabilized both in vitro and in 
planta in the presence of the proteasome inhibitor carbobenzoxyl-leucinyl-
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leucinyl-leucinal (MG132). Interestingly, in vitro KRP2 degradation was found to 
be diminished by olomoucine, a strong and specific inhibitor of CDK activity.  
Moreover, KRP2 protein levels were shown to be higher in plants harboring 
reduced CDKB1;1 activity (Verkest et al., 2005a). These data suggest that KRP2 
phosphorylation by CDKs is at least in part responsible for its proteolysis. To 
confirm this hypothesis, we compared the in vitro stability of recombinant KRP2 
and its phosphorylated form. The recombinant proteins were added to protein 
extracts of dividing cells and fractions were collected and frozen at the indicated 
time points. Protein gel blotting showed a decrease in KRP2 abundance after 
incubation with control extract (Figure 1C). Analysis of the phospho-KRP2 protein 
level by autoradiography showed an even faster decrease in protein abundance, 
compared to KRP2 (Figure 1C), illustrating that CDK phosphorylation lowers 
KRP2 protein stability.  
 
 
CKS1 regulates KRP2 protein abundance at the posttranslational 
level 
 
In mammalia, ubiquitin-dependent degradation of the Kip/Cip CDK inhibitors is 
regulated through two alternative proteolytic pathways (Hengst, 2004). The 
best studied pathway requires phosphorylation of p27Kip1 by CDK2/cyclinE 
complexes prior to recognition and subsequent degradation by the SCFSkp2 
ubiquitin-ligase complex (Carrano et al., 1999; Montagnoli et al., 1999; 
Sutterluty et al., 1999; Tsvetkov et al., 1999). CKS1 plays an important and 
necessary function in Kip/Cip degradation, as an adaptor that binds 
phosphorylated p27Kip1 and Skp2 (Ganoth et al., 2001; Spruck et al., 2001; Hao 
et al., 2005). To investigate whether CKS1 plays a similar function in plants, we 
analyzed KRP2 mRNA and protein levels in wild-type versus CKS1OE plants by 
Northern and protein blot analysis, respectively. CDKA;1 was included as a 
control in the analysis. Whereas CDKA;1 transcipts were slightly reduced, 
CDKA;1 protein levels were unaffected in CKS1OE plants. By contrast, KRP2 
protein levels were found to be lower in the CKS1OE plants, whereas the 
corresponding KRP2 transcript level slightly increased (Figure 2A and B). 
These data illustrate that CKS1 regulates KRP2 protein abundance at the 
posttranslational level. 
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Figure 2. Analysis of KRP2 levels in CKS1 overexpressing plants.  
RNA and total protein were prepared from three week old wild-type (C24) and CKS1OE 
plants.  
A. RNA gel blot analysis of KRP2, CDKA;1 and CKS1 transcript levels. Equal loading of 
the gel was confirmed by methylene blue staining of the membrane (bottom panel).  
B. Immunoblot analysis with anti-KRP2, anti-CDKA;1 and anti-CKS1 antisera. Equal 
loading of the gel was confirmed by visualizing the Rubisco protein levels by Ponceau S 
staining of the membrane (bottom panel). 
 
 
CKS1 relieves CDKA;1 inhibition by KRP2 and enhances KRP2 
phosphorylation by CDKB1;1 kinase complexes 
 
In order to unravel the mechanism of KRP2 regulation by CKS1 kinase assays 
were performed. First, we examined the in vitro effect of CKS1 on CDK kinase 
activity. Addition of recombinant CKS1 to immunoprecipitated CDK complexes 
showed that CKS1 does not affect CDKA;1, nor CDKB1;1 kinase activity 
towards histone H1 (Figure 3A). In contrast, KRP2 exhibits an inhibitory activity 
specifically towards CDKA;1 complexes, confirming previously published data 
(Figure 3A; Verkest et al., 2005a). To investigate the possible role of CKS1 as 
regulator of KRP2 activity, we subsequently analyzed the combinatorial effect 
of recombinant CKS1 and KRP2 on CDKA;1- and CDKB1;1-
immunoprecipitated kinase activity, using both histone H1 and KRP2 as 
substrates. Interestingly, addition of both CKS1 and KRP2 partially relieved 
KRP2-mediated inhibition of CDKA;1 activity (Figure 3A). Moreover, CKS1 
assisted the phosphorylation of KRP2 by CDKB1;1 complexes (Figure 3B). No 
such enhanced phosphorylation of KRP2 was observed when CKS1 was 
added to CDKA;1 complexes (Figure 3B).  
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Figure 3. CKS1 regulation of KRP2 inhibition of CDKA;1 activity and of KRP2 
phosphorylation by CDKB1;1 kinases.  
A. Effect of recombinant CKS1 and/or KRP2 on A- and B-type CDK activity. Kinase 
activity was measured using histone H1 as substrate.  
B. Analysis of immunoprecipitated CDKA;1 and CDKB1;1 activity towards KRP2 in the 
absence or presence of CKS1. For quantification, the control was arbitrary taken at 
100%. The indicated values are means ± SD (n = 2).  
 
 
CKS1 is a competitor of KRP2 for CDKA;1 interaction and binds 
KRP2 
 
To comprehend the observed effect of CKS1 on lowering the KRP2 inhibitory 
activity on CDKA;1 we performed several binding assays. We initially analyzed 
the effect of adding increasing amounts of recombinant CKS1 protein on the 
ability of KRP2-coupled Sepharose beads to pull down CDKA;1 complexes 
from Arabidopsis extracts (Figure 4A). Also the reciprocal experiment was 
conducted, by adding increasing amounts of recombinant KRP2 protein to 
protein extracts incubated with p10CKS1-beads (Figure 4B).  In both cases, 
weaker CDKA;1 interaction  to KRP2- or CKS1-beads was observed when 
increasing amounts of recombinant CKS1 or KRP2 protein were added, 
respectively. Moreover, analysis of the bound fraction revealed interaction 
between CKS1 and KRP2.  
We next checked whether the observed weakening of CDKA;1 binding to 
CKS1 upon the addition of KRP2, and vice versa, is the result of competition 
between KRP2 and CKS1 for CDKA;1 binding, or merely is caused by mutual 
binding of these proteins in the absence of CDKA;1. Different concentration 
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ratios of recombinant KRP2/CKS1 were pre-incubated with total protein 
extracts of dividing Arabidopsis cells, and CDKA;1 complexes were 
immunoprecipitated. Analysis of the CDKA;1-immunoprecipitated fraction by 
protein blotting using CKS1 and KRP2 antibodies illustrated the lack of 
association between CDKA;1 and KRP2 in the presence of relative high CKS1 
concentrations. Vice versa, in the presence of high KRP2 protein levels, no 
association between CDKA;1 and CKS1 was observed. These data suggest 
that the KRP2 and CKS1 proteins compete for CDKA;1 interaction (Figure 4C).  
 
 
 
Figure 4. CKS1 and KRP2 compete for CDKA;1 interaction.  
A. Protein extracts were pre-incubated with increasing amounts of recombinant CKS1 
and loaded onto a KRP2-Sepharose column. Bound fractions were analyzed with 
CKS1- and CDKA;1-specific antibodies.  
B. Reciprocal experiment of (A.) analyzing CDKA;1 and KRP2 binding to CKS1-
Sepharose in the presence of increasing amounts of recombinant KRP2 protein.  
C. Analysis of the amount of CDKA;1 co-immunoprecipitated CKS1 and KRP2 protein in 
extracts of dividing cell suspensions preincubated with different concentration ratios of 
recombinant CKS1/KRP2. 
  
To confirm in vivo interaction between CKS1 and KRP2, KRP2-bound proteins 
were immunoprecipitated from total protein extracts of CKS1OE plants treated 
with MG132 using a specific anti-KRP2 antibody (Verkest et al., 2005a). 
Subsequently, the pulled-down material was probed with CKS1 and CDKA;1 
specific antibodies (Hemerly et al., 1995; De Veylder et al., 1999). As a control, 
binding to protein A-Sepharose beads was checked. CDKA;1 as well as CKS1 
specifically co-immunoprecipitated with KRP2 (Figure 5A).  
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To characterize whether KRP2 directly interacts with CKS1, we pulled-down 
KRP2 or CKS1 out of a mixture of recombinant KRP2 and CKS1 in the 
absence or presence of Arabidopsis protein extract (Figure 5B). CKS1 bound 
KRP2 preferentially in the presence of cell extract. Interestingly, KRP2 was 
found to bind CKS1 in the presence of CDKA;1-depleted Arabidopsis extract, 
illustrating that CKS1 binds KRP2 in the absence of CDKA;1 (Figure 5B). 
 
 
 
Figure 5. In vivo and in vitro KRP2 binding by CKS1.  
A. In vivo interaction of KRP2 with CKS1. KRP2 immunoprecipitated complexes from 
total protein extracts of 3-week-old CKS1OE plants were analyzed for the presence of 
CKS1 and CDKA;1 with specific antibodies. As a control binding to protein A-Sepharose 
was checked.  
B. In vitro interaction of KRP2 with CKS1. Recombinant CKS1 and KRP2 were 
incubated in the absence or presence of total and CDKA;1-depleted protein extracts 
and subjected to  KRP2- or CKS1-immunoprecipitation. Immunoblot analysis of the 
immunoprecipitated fractions tested the presence of CKS1 or KRP2, respectively.  
 
 
Discussion 
   
 
Because of the significance of linking cell division with growth and 
development, negative control of cell cycle progression has always received 
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extensive attention, especially in animal systems where the inability to correctly 
exit the cell cycle can eventually result in the formation of tumors. CDK 
inhibitors are important negative regulators that delay or arrest cell cycle 
progression through binding and inhibiting CDK complexes (reviewed in Peter, 
1997; Mendenhall, 1998; Verkest et al., 2005b). Accordingly, yeast and 
mammalian CDK inhibitor activities are strictly regulated at the transcriptional, 
translational and posttranslational level. In plants currently little is known about 
the regulation of CDK inhibitors. Recently, we have demonstrated that the CDK 
inhibitor KRP2 is posttranslationally regulated during Arabidopsis leaf 
development (Verkest et al., 2005a). KRP2 was shown to be an unstable 
protein and to be regulated by proteolysis and CDK phosphorylation. Our data 
indicated that KRP2 phosphorylation by CDKs is at least in part responsible for its 
proteolysis. 
Here, we provide further evidence that CDK phosphorylation of KRP2 triggers 
its degradation. In vitro degradation analysis of KRP2 demonstrated that it has 
a lower stability when phosphorylated by CDKs. This confirms our previous 
observation that inhibition of KRP2 phosphorylation through inhibition of CDK 
activity by olomoucine enhances KRP stability (Verkest et al., 2005a). 
Moreover, kinase assays showed that phosphorylated KRP2, in contrast to its 
unphosphorylated form, does not inhibit CDKA;1/cyclin complexes. This loss of 
binding-specificity towards CDKA;1 complexes implies the possibility that CDK 
phosphorylation changes the conformation of KRP2, thereby interfering with its 
binding to A-type CDKs. Indeed, co-immunoprecipitation assays demonstrated 
the loss of CDKA;1 binding of phosphorylated KRP2. Curiously, 
phosphorylated KRP2 interacted with CDKB1;1 protein complexes, a feature 
not shared by its unphosphorylated isoform. Moreover, phosphorylated KRP2 
stimulated CDKB1;1 kinase activity towards histone H1. The exact mechanism 
of this activation remains to be studied in more detail but could be artificial due 
to contaminating residual CDK kinases present in the prepared CDK 
phosphorylated KRP2. Consistent with this, addition of very high amounts of 
phosphorylated KRP2 resulted in the enhancement of CDKA;1 activity (data 
not shown). However, the extent of CDKA;1 activation is much lower than 
observed for CDKB1;1 which indicates that phosphorylated KRP2 possibly 
stabilizes, and as such activates, CDKB1;1/cyclin complexes. Similarly, the 
mammalian Kip/Cip inhibitors were shown to function as assembly factors of 
certain CDK/cyclins (LaBaer et al., 1997; Cheng et al., 1999). Previously, we 
demonstrated that both A- and B-type CDKs phosphorylate KRP2 in vitro 
(Verkest et al., 2005a). Moreover, KRP2 protein abundance was shown to be 
negatively regulated at the posttranslational level by B-type CDK activity, as seen 
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by the increase in KRP2 abundance in transgenic plants with reduced 
Arath;CDKB1;1 activity. This suggests that phosphorylation by B-type CDKs 
marks KRP2 for protein destruction. The observed switch in CDK specificity upon 
KRP2 phosphorylation indicates that CDK activity possibly controls KRP2 binding 
to CDKB1;1. In such a model, CDKA;1/cyclin phosphorylation of KRP2 would 
target it to CDKB1;1/cyclin complexes for secondary phosphorylation, triggering 
its degradation (Figure 6). The observed CDKB1;1 kinase activation by 
phosphorylated KRP2 possibly exemplifies a negative feedback mechanism, 
enhancing KRP proteolysis.  Multisite phosphorylation has been recognized as a 
general mechanism to set thresholds in regulated protein-protein interactions. 
The yeast CDK inhibitor Sic1, for example, requires phosphorylation of at least 
six of its nine CDK sites prior to recognition and degradation by its proteasomal 
pathway (Nash et al., 2001).  
Further investigation suggested that CKS1 has a role in posttranslational 
regulation of KRP proteins as indicated by the decreased KRP2 protein levels in 
CKS1 overexpressing plants and by the observed in vivo interaction between 
CKS1 and KRP2. In yeast and animals, Cks proteins are known to function in 
cell cycle specific proteolysis (Patra and Dunphy, 1998; Kaiser et al., 1999; 
Shteinberg and Hershko, 1999; Ganoth et al., 2001; Spruck et al., 2001; Morris 
et al., 2003). Interestingly, CKS1 enhanced the phosphorylation of KRP2 by 
CDKB1;1/cyclin complexes, further emphasizing that it contributes to KRP2 
proteolysis (Figure 6). In budding yeast, Suc1 was similarly shown to activate 
the ability of CDK complexes to phosphorylate the CDK inhibitors Sic1 and 
Far1 (Reynard et al., 2000). In contrast to the situation seen with CDKB1;1, 
CKS1 did not enhance CDKA;1-dependent KRP2 phosphorylation. 
Surprisingly, CKS1 diminished the extent of the in vitro KRP2 inhibition of 
CDKA;1 kinase activity towards histone H1. This effect is the result of an in 
vitro competition between CKS1 and KRP2 for CDKA;1 interaction. The 
structural basis for this competition is unclear. The crystal structures of the 
mammalian Kip/Cip CDK inhibitor p27Kip1 bound to CDK2/CyclinA and  that of 
the CksHs1/CDK2 complex do not exclude mutual binding of p27Kip1 and Cks 
proteins to CDKs, because both proteins interact with different sites of CDK2 
(Bourne et al., 1996; Russo et al., 1996). Previously, we suggested that KRPs, 
like the mammalian Kip/Cip inhibitors, might only bind and inhibit a subset of 
the plant CDK/cyclin complexes (Verkest et al., 2005a). Indeed, in vitro assays 
illustrated that B-type CDK kinases are KRP2-insensitive and that 
CDKA;1/cyclin complexes could only be inhibited partially upon the addition of 
high doses of recombinant KRP2. Moreover, only mitotic cell cycle CDKA;1 
complexes, and not endocycle CDKA;1 kinases, were inhibited in weak KRP2 
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overexpressing Arabidopsis plants. Similarly, Suc1/Cks1 proteins, although 
widely used as affinity matrix for the purification of CDKs, do not bind all CDK 
complexes. In synchronized fission yeast cells Cdc2 binding to Suc1 was only 
observed during mitosis, correlating with the peak in cdc13 cyclin levels and 
the associated peak in Cdc2/cdc13 kinase activity (Booher et al., 1989). In 
agreement, Nigg et al. (1991) detected no Suc1 precipitation of Cdc2 from G1 
lysates of synchronized chicken cells. Similarly, Suc1 could not bind all plant 
CDK kinases of maize endosperm extracts (Grafi and Larkins, 1995). 
Interestingly, CksHs1 and Suc1 were shown not to bind CDK4 and CDK6 (Azzi 
et al., 1994; Vogel et al., 2002), two well known Kip/Cip CDK targets (Harper et 
al., 1995). Together this could imply that CDK inhibitor-bound CDKs do not bind 
Cks and vice versa, which fits with our observation that CKS1 and KRP2 work 
antagonistic (Figure 6). Although binding assays indicated that CKS1 only 
binds recombinant KRP2 efficiently in the presence of Arabidopsis extract, this 
could be due to the requirement of posttranslational modifications of either one 
of these components. The observation that KRP2 also binds CKS1 in CDKA;1-
immunodepleted extracts and that phosphorylated KRP2 is unable to interact 
with CDKA;1 kinases, strengthens our hypothesis that KRP2 bound and 
inhibited CDKA;1/cyclin complexes do not contain CKS1 (Figure 6).  
The identified role of CKS1 in enhancing KRP2 phosphorylation by CDKB1;1 
complexes, however, implies the existence of CDKB1;1/cyclin/CKS1 
complexes bound to phosphorylated KRP2. Similar complexes were suggested 
to exist in mammals, where Cks1 functions as a cofactor for SCFSkp2-
dependent Kip/Cip inhibitor ubiquitination and degradation (Ganoth et al., 2001; 
Spruck et al., 2001; Bornstein et al., 2003; Kamura et al., 2003). Assembly of 
p27Kip1 with the Cdk2/cyclinA/E complex has been reported to stimulate its 
ubiquitination (Montagnoli et al., 1999; Nguyen et al., 1999) and binding of 
Cks1 to this trimeric complex via its Cdk-binding site was shown to increase the 
affinity of SCFSkp2 to the p27Kip1 substrate (Sitry et al., 2002). This has been 
suggested to reflect a recruitment effect, because compared to free p27Kip1, 
Cdk2/cyclinA bound p27Kip1 could in principle benefit from two additional 
interactions with the SCFSkp2/Cks1 complex, one between Cks1 and Cdk2 
(Bourne et al., 1996) and the other between Skp2 and cyclinA (Zhang et al., 
1995). Consistent with this, the ability of Cdk2/cyclinA to stimulate p27Kip1 
ubiquitination is abolished by the deletion of the cyclinA binding site of Skp2 
(Zhu et al., 2004) and is reduced by mutations in the Cdk2 binding site of Cks1 
(Sitry et al., 2002). Moreover, Hao et al. (2005) recently demonstrated the co-
existence of Cks1, p27Kip1, Cdk2/cyclinA, and SCFSkp2 in one complex. 
Interestingly, in vitro kinase assays and the three-dimensional structure of the 
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p27/Cdk2/cyclinA complex showed that p27Kip1 binding inhibits Cdk2/cyclinA/E 
catalytic activity (Polyak et al., 1994; Toyoshima et al., 1994; Harper et al., 
1995; Russo et al., 1996). How p27Kip1 can be regulated by the Cdk/cyclin 
complex that it targets for inhibition was explained by kinetic analysis 
experiments suggesting that p27Kip1 binds to Cdk2/cyclinE in at least two ways: 
first as a substrate (loose binding), and then as an inhibitor (tight binding) 
(Sheaff et al., 1997). Recently, p27Kip1 binding to Cdk/cyclin complexes was 
shown to occur through a sequential mechanism initiated by cyclinA binding 
and followed by a slower binding to Cdk2 (Lacy et al., 2004 and 2005). 
Possibly p27Kip1 phosphorylation makes it an inefficient inhibitor that interacts 
loosely with the Cdk2/cyclinA/E complex, allowing binding of Cks. Consistent 
with this, p27Kip1 needs to be phosphorylated prior to Cks1 and Skp2 binding 
and degradation (Ganoth et al., 2001). This suggests that the Kip/Cip proteins 
have two interaction sites: one on the CDK/cyclin complex; and one, when 
phosphorylated, for CKS binding even when bound on the CDK since the Cks 
phospho-binding site is free in the CDK/cyclin/Cks complex. In plants similar 
theories could explain phosphorylation of KRP2 by ‘inhibited’ CDKA;1 
complexes and, although phosphorylated KRP2 does not bind CDKA;1, the 
occurrence of CKS1 bound CDKB1;1/cyclin/phospho-KRP2 complexes. 
 
 
K R P
K R P
C y cC D K A ; 1
A c t i v e I n a c t i v e
C K S
C y cC D K A ; 1
C y cC D K A ; 1
K R P P
C K S
C y cC D K A / B
K R P P
P
P
C K S
C y cC D K B 1 ;1
p r o t e o l y s i s
C K S
?
 
Figure 6. Schematic overview of the role of CKS1 in regulating KRP2 function and 
stability. By competing with KRP2 for CDKA;1/cyclin interaction CKS1 counteracts 
KRP2-mediated inhibition of CDKA;1 kinases. In addition, this might enhance in vivo 
KRP phosphorylation by A-type CDKs. Once phosphorylated, KRP2 changes its 
binding-specificity from A- to B-type CDKs. Multisite CKS1 enhanced CDKB1;1-
dependent phosphorylation of KRP2 finally triggers its degradation. Whether CKS1 also 
plays a direct role in the proteolytic process of KRP2 remains to be determined.    
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Although the function of CKS1 in enhancing the phosphorylation of KRP2 is not 
conserved in mammalia (Ganoth et al., 2001), the indication that it binds 
phosphorylated KRP2 suggests the possibility that Arabidopsis CKS1, like 
CksHs1, directly activates KRP degradation (Figure 6). Several SCF ubiquitin-
ligase complexes were shown to play important functions in plants (Nemhauser 
and Chory, 2005). Moreover, two F-box proteins, similar to the metazoan Skp2, 
have been identified in Arabidopsis thaliana. Previously, the role of the plant 
SCFSkp2 in regulating the cell cycle was shown by controlling the stability of the 
E2Fc transcription factor (del Pozo et al., 2002). However, experimental proof 
that the plant SCFSkp2 is regulating KRP protein levels is still missing and the 
ubiquitin-ligase involved in KRP degradation remains to be identified. Whether 
CKS1 directly regulates this complex awaits future investigation, but it is at least 
indirectly enhancing KRP proteolysis (Figure 6). 
 
 
Methods     
 
Regeneration and molecular analysis of transgenic lines 
 
Plants overexpressing the CKS1 gene (De Veylder et al., 2001a) under the 
control of the 35S promoter of the cauliflower mosaic virus (CaMV35S) were 
constructed as described previously. Molecular analysis of the transgenic 
plants by RNA and protein gel blotting was performed as described by De 
Veylder et al. (1999) and Verkest et al. (2005a). 
 
 
Antibodies, protein extraction, recombinant proteins, kinase assays, 
and degradation assays 
 
CDKA;1, CDKB1;1, CKS1, and KRP2 specific antisera were described before 
(Hemerly et al., 1995; Porceddu et al., 2001; De Veylder et al., 1999; Verkest 
et al., 2005a). 
Arabidopsis plants and 2-day-old MM1 cell suspension cultures (Menges and 
Murray, 2002) were harvested, used immediately or snap-frozen in liquid 
nitrogen, and stored at –70°C. Proteins were extracted by grinding cells with 
quartz sand in homogenization buffer (25 mM Tris-Cl, pH 7.6, 75 mM NaCl, 
15 mM MgCl2, 15 mM EGTA, 15 mM p-nitrophenylphosphate, 60 mM β-
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glycerophosphate, 1 mM DTT, 0.1% Nonidet P-40, 0.1 mM Na3VO4, 1 mM NaF, 
and protease inhibitor cocktail P9599 (Sigma-Aldrich)). The protein content was 
determined by using the Bio-Rad protein assay kit. 
His-tagged KRP2 was expressed in Escherichia coli and purified by nickel-
agarose chromatography, as described previously (Verkest et al., 2005a). For 
GST-tagged KRP2 expression and purification the KRP2 coding region was PCR 
amplified and cloned into the GATEWAY pDONR207 vector (Invitrogen). After 
recombination with pDEST15, the obtained expression vector pDEST15.KRP2 
was transformed in the Escherichia coli BL21-CodonPlusTM(DE3)-RIL strain 
(Novagen, Madison, WI). E. coli cells were grown to an A600 nm of 0.5-0.7 at 
37°C in LB+ medium and the expression of KRP2 was induced by addition of 0.2 
mM isopropyl β-D-thiogalactoside for 3 h at 37 °C. The cells were lyzed with 
lysozyme in PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM 
KH2PO4) and the protein was purified on Glutathione Sepharose-4B (Amersham 
Biosciences) according to the manufacturers instructions. Recombinant CKS1 
was obtained as described by Landrieu et al. (1999).  
For preparation of phosphorylated KRP2, purified recombinant His.KRP2 was 
incubated for 60 min at 30°C in a kinase reaction mixture. All other in vitro kinase 
assays were performed as described by De Veylder et al. (1997) with histone H1 
as CDK substrate and recombinant KRP2 and/or CKS1. 
For the in vitro degradation assay, mixtures contained 100 μg of Arabidopsis cell 
suspension culture MM1 protein extract (20 mM HEPES, pH 7.5, 1 mM DTT, 
5 mM MgCl2) supplemented with an ATP-regenerating system (35 mM 
phosphocreatine, 50 μg/ml creatine kinase), 1 mM ATP, 1/15 (v/v) wheat germ 
lysate (Promega, Madison, WI), and 50 ng substrate. The reaction mixtures were 
incubated at 30°C for the indicated times and the reactions were stopped by the 
addition of SDS sample buffer. 
 
 
Binding assays, immunoprecipitations, and immunoblotting 
 
When used for ligand affinity purification recombinant KRP2 or CKS1 was 
coupled to cyanogen bromide-activated Sepharose 4B (Amersham 
Biosciences) at a concentration of 5 mg/ml according to the manufacturer’s 
instructions. Non-reacted groups of the resin were blocked adding 1M 
ethanolamine pH 8.0. Different concentrations of purified recombinant CKS1 or 
KRP2 were added to MM1 cell suspension culture extracts (300 μg) (Menges 
and Murray, 2002) in a total volume of 200 μl homogenization buffer, loaded onto 
40 μl of 50% (v/v) KRP2- or CKS-Sepharose, respectively and incubated on a 
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rotating wheel for 2 h at 4°C. The bead-bound fractions were washed three times 
with RIPA buffer (20 mM Tris-Cl, pH 7.4, 5 mM EDTA, 2 mM EGTA, 100 mM 
NaCl, 2 mM NaF, 0.2% Nonidet P-40, 300 μM phenylmethylsulfonyl fluoride, and 
10 μg/ml aprotinin and pepstatin) and resuspended in 20 μl of SDS loading 
buffer. 
For immunoprecipitations, MM1 extracts containing the indicated amounts of 
recombinant CKS1 and KRP2 or phospho-KRP2 protein in homogenization 
buffer were precleared before incubation at 4°C for 2 h with CDKA;1 (1/250), 
CDKB1;1 (1/100), CKS1 (1/100), KRP2 (1/100), GST (1/1000) (Amersham 
Biosciences) or penta-His (1/200)(Qiagen) antibodies. After incubation for 1 h at 
4°C with 30 μl of 50% (v/v) protein A-Sepharose and extensive washes in RIPA 
buffer the beads were used for CDK activity reactions or protein gel blot analysis. 
Proteins were separated by SDS-PAGE and blotted onto Immobilon-P 
membranes (Millipore, Bedford, MA). Filters were blocked in 3% (v/v) milk 
powder in 25 mM Tris-Cl (pH 8), 150 mM NaCl, 0.05% Tween 20 for at least 1 h 
at room temperature and incubated overnight at 4°C with CDKA;1 (1/5000), 
CDKB1;1 (1/1000), KRP2 (1/1000), CKS1 (1/1000), GST (1/1000) (Amersham 
Biosciences) or penta-His (1/2000) (Qiagen) antibody in blocking buffer. Antigen-
antibody complexes were detected with horseradish peroxidase-conjugated IgG 
diluted 1/10000 (Amersham Biosciences) with a chemiluminescence system 
(Perkin Elmer, Norwalk, CT). 
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the plant cyclin-dependent kinase inhibitor KRP2 
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Abstract  
   
 
The ability of the plant Kip-related proteins (KRPs) to act as cyclin-dependent 
kinase (CDK) inhibitors and repressors of the cell cycle is becoming well 
established, yet little information is available regarding their mechanism of CDK 
binding and inhibition. The Arabidopsis thaliana CDK inhibitor KRP2 is known to 
inhibit mitotic cell cycle progression and to function in the mitosis-to-endocycle 
transition. To identify the protein domains within the KRP2 protein that account for 
KRP2 activity, a mutational analysis was performed. Deletion of its N-terminal 
domain enhanced the cell cycle inhibitory effects of KRP2 in transgenic plants. 
Moreover, a role was demonstrated for this N-terminal sequence in regulating 
KRP protein stability and CDKA;1 affinity. In contrast, deletion of the C-terminal 
domain completely abolished the CDK binding activity of KRP2. Directed point 
mutagenesis within the CDK binding domain of KRP2 confirmed its importance in 
CDK inhibition. The centrally located cyclin-binding domain, which is partially 
overlapping with the CDK-binding site, efficiently complexes CDKA;1/cyclin 
complexes, but is on its own insufficient for inhibiting CDKs. The observation that 
the KRP2 CDK binding domain solely does not affect kinase activity, further 
strengthens our hypothesis that CDK inhibition requires binding of KRP2 to both 
the cyclin and CDK subunit.  
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Introduction 
   
 
In all eukaryotes progression through the cell cycle requires the activity of a family 
of protein kinase complexes known as cyclin-dependent kinases (CDKs). CDK 
catalytic subunits are inactive as monomers and require heterodimerization with 
activating regulatory subunits known as cyclins (Pines, 1994). The assembly of 
these CDK/cyclin complexes is regulated by the temporal cell cycle-dependent 
expression and proteolytical destruction of different cyclins (Morgan, 1995; 
Peters, 1998). In addition, the activity of these CDK/cyclin complexes is regulated 
by positive and negative phosphorylation events executed by the CDK activating 
kinase (CAK), by the WEE1 kinase and the CDC25 phosphatase, respectively 
(Dunphy, 1994). Furthermore, kinase activity is indirectly regulated by binding 
with small proteins, known as CDK inhibitors (CKIs), which either physically block 
CDK activation or block CDK/cyclin substrate/ATP access.  
In mammals, CKIs have been divided into two families, the INK4 and the Kip/Cip 
class (Sherr and Roberts, 1995). The CKIs from different families differ in their 
protein structure, mode of action and substrate specificity.  Members of the INK4 
family (p15INK4b, p16INK4a, p18INK4c, and p19INK4d) are characterized by the presence 
of ankyrin-type repeats for CDK binding and bind and inhibit only a small subset of 
CDKs that are primarily responsible for passage through G1. Binding of INK4 
proteins to monomeric CDKs or CDK/cyclin complexes causes either allosteric 
changes that impair cyclin binding or lead to the dissociation of the CDK/cyclin 
complex, respectively. In contrast, inhibitors of the Kip/Cip family (p21Cip1, p27Kip1, 
and p57Kip2) bind and inhibit a broader range of CDKs and function in dimeric as 
well as heterotrimeric complexes with CDKs and cyclins. Kip/Cip binding occurs 
through a conserved inhibitory domain at their N-terminus that does not dissociate 
the CDK-cyclin complex, but distorts the catalytic ATP-binding center of the CDK 
subunit. 
Proteins related to the class of mammalian Kip/Cip CDK inhibitors have been 
identified in plants, designated Kip-related proteins (KRPs) in Arabidopsis (De 
Veylder et al., 2001; Vandepoele et al., 2002). Overall, the plant KRPs display only 
low sequence identity to each other and the non-plant CKIs. Despite this limited 
sequence homology, KRPs have been shown to be true functional homologs of the 
Kip/Cip proteins in binding and inhibiting CDK/cyclin complexes both in vitro and in 
vivo (Wang et al., 1997; Lui et al., 2000; Wang et al., 2000; De Veylder et al., 2001; 
Zhou et al., 2002; Jasinski et al, 2002a and b; Coelho et al., 2005; Verkest et al., 
2005a). Overproduction of KRPs in Arabidopsis results in plants with small and 
serrated leaves, due to a reduction in cell number as a consequence of an inhibition 
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of the cell cycle. Interaction analysis demonstrated that the plant KRPs bind A-
type CDKs and D-type cyclins (reviewed by Verkest et al., 2005b), suggesting 
that they inhibit CDKA;1/cyclinD complexes. Consistently, Arath;KRP2 and 
Zeama;KRP1 and KRP2 were shown to inhibit CDKA;1- and cyclinD5;1-
immunoprecipitated kinase complexes, respectively (Coelho et al., 2005; Verkest 
et al., 2005a). In vivo binding specificity between the plant KRPs, CDKA;1, and D-
type cyclins has been demonstrated by the observation that in planta the aberrant 
cell and leaf phenotypes seen upon KRP overexpression can be complemented 
by the co-overexpression of CDKA;1 and D-type cyclins (Jasinski et al., 2002a, 
Schnittger et al., 2003; Zhou et al., 2003b; Cho et al., 2004). However, still little is 
known about the molecular mechanism of KRP interaction and inhibition of 
CDK/cyclin complexes. Here, a deletion and mutational analysis of the 
Arabidopsis KRP2 allowed the identification of important domains and amino acid 
residues required within KRP2 for specific functions and regulation in plants. We 
demonstrate that CDK inhibition requires the presence of both the CDK- and 
cyclin-binding domains of KRP2, suggesting that CDK/cyclin binding by KRPs 
mainly occurs through a sequential mechanism initiated by cyclin interaction. 
Curiously, analysis of KRP2 mutants with impaired CDK inhibitory activity 
suggests a possible dual role for KRP2 as negative and positive CDK regulator. 
 
 
Results 
   
 
KRP2 binds both monomeric CDKA;1  and CDKA;1/cyclinD 
complexes in vitro 
 
In mammals, Kip/Cip CDK inhibitors were shown to bind both monomeric cyclins 
and CDKs and CDK/cyclin complexes (Hall et al., 1995; Harper et al., 1995; Lin et 
al., 1996). By yeast two-hybrid analysis it was previously shown that all 
Arabidopsis KRPs interact with D-type cyclins and CDKA;1, but not with B-type 
CDKs (De Veylder et al., 2001; Zhou et al., 2002). Independently, binding assays 
confirmed some of these interactions for KRP1, KRP2 and KRP3 (Wang et al., 
1997; De Veylder et al., 2001; Verkest et al., 2005a).  However, it is not known 
whether the plant KRPs bind monomeric CDKs and cyclins or only interact with 
CDK/cyclin complexes.  
Using a coupled transcription-translation system we generated both S35-labelled 
and cold c-myc-tagged CYCD4;1, HA-tagged CDKA;1 and His-tagged KRP2, 
respectively (Figure 1A). Different combinations of translation products were 
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mixed, subjected to immunoprecipitation with a specific antibody against the 
tagged cold protein in the mixture, and subsequently analyzed by 
autoradiography (Figure 1A). In the absence of cold translation product, no S35-
labelled proteins were precipitated by the anti-c-myc, anti-HA or anti-His 
antibodies (data not shown). However, both S35-HA-CDKA;1 and S35-c-myc-
CYCD4;1 co-precipitated with His-KRP2 (Figure 1A). Identical results were 
obtained in a reciprocal experiment, confirming that KRP2 interacts with CDKA;1 
and CYCD4;1. We also observed the previously reported interaction of CDKA;1 
with CYCD4;1 (Kono et al., 2003). Moreover, our data also shows 
CDKA;1/CYCD4;1/KRP2 complex formation, since equal amounts of CDKA;1 and 
CYCD4;1 can be co-precipitated with KRP2 (Figure 1A).  
To analyze the KRP2 binding to monomeric CDKA;1, we pulled-down a mixture of 
purified recombinant His-KRP2 and MBP or MBP-CDKA;1 with amylose beads. 
The fraction bound to the amylase-agarose was, after extensive washes, 
subsequently analyzed for the presence of His-KRP2 by protein blot analysis 
using an anti-His antibody (Figure 1B). A small fraction of KRP2 was detected on 
the MBP-CDKA;1 bound beads, but not on the MBP beads, suggesting only a 
weak binding of KRP2 with monomeric CDKA;1. 
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Figure 1. In vitro binding assays.  
A. Analysis of the interaction between KRP2, CDKA;1, and CycD4;1 using in vitro 
translated His-, HA- , and myc-tagged cold and S35-labelled proteins. The first panels show 
autoradiograph and protein blot analyses of the produced proteins (WGE = wheat germ 
extract). The right panel shows the α-His, α-HA, and α-myc immunoprecipitated proteins 
as visualized by autoradiography.  
B. In vitro binding of KRP2 to monomeric CDKA;1. Purified recombinant MBP or 
MBP.CDKA;1 was incubated with 50 times the amount of His.KRP2 input.  
 
 
Identification of KRP2 CDK/cyclin binding and inhibiting domains  
 
In order to identify the KRP domains involved in the binding and inhibition of 
CDK/cyclin complexes we generated KRP2 deletion mutants. Figure 2 shows the 
different KRP2 domains that were generated and their initial evaluation to interact 
with CDKA;1 and CYCD4;1 by yeast two-hybrid analysis. The deletion mutants 
were generated based on sequence homology of KRP2 with the other KRPs and 
the Kip/Cip proteins. Previously, it was shown that the C-terminal domains of 
KRP1/ICK1 and KRP2/ICK2 interact with CDKA;1 and D-type cyclins (Wang et 
al., 1998; Lui et al., 2000). We confirmed these results showing that the N-
terminal domain of KRP2 (KRP2.N) is dispensable for CDK and cyclin binding. By 
contrast, the C-terminal domain of KRP2 (KRP2.C/K) is needed for CDKA;1 
interaction. Similarly, the KRP2.C/K domain is sufficient for D-type cyclin 
interaction with CYCD3;1. To uncouple the CDK and cyclin binding motives, extra 
deletion mutants were generated and tested for their interaction with CDKA;1 and 
CYCD3;1 (Figure 2).  
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Figure 2. Schematic presentation of the KRP2 domains and their yeast two-hybrid 
interaction with CDKA;1 and CYCD3;1 (FL = full length protein, N = N-terminal sequence, 
C/K = CDK and cyclin binding domain, C = cyclin binding domain, K = CDK binding 
domain).  
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To investigate the functionality of the different KRP2 domains in vivo, transgenic 
plants were generated overexpressing N-terminal fusion proteins with hemagglutinin 
(HA) of the full-length and deleted forms of the KRP2 gene under control of the 
constitutive Cauliflower Mosaic virus (CaMV) 35S promoter (used KRP2 domains 
are depicted in black in Figure 2). Several independent transgenic lines were 
analyzed for gene and protein expression levels. RNA and protein gel blot analysis 
revealed variation in expression among different lines harboring the same construct 
(data not shown). Comparison of the RNA with the protein levels within each class 
of transgenics ectopically expressing a specific gene construct, indicated 
differences in protein stability for the different KRP2 constructs (Figure 3). In 
comparison with wild-type plants, clear accumulation of both transcript and protein 
levels for the KRP2.FLOE and KRP2.NOE plants was detected. By contrast, although 
the KRP2.C/KOE, KRP2.COE and KRP2.KOE plants clearly expressed the transgenes 
(Figure 3B), little or no protein was detected, suggesting that the N-terminal domain 
plays a regulatory role in protein stability (Figure 3C).  
As reported previously, strong KRP2.FLOE plants are characterized by a striking 
serrated leaf phenotype and a reduced plant size (De Veylder et al., 2001; 
Verkest et al., 2005a) (Figure 3A). By contrast, all KRP2.NOE, KRP2.COE and 
KRP2.KOE plants displayed a wild-type like phenotype. Compared to KRP2.FLOE 
lines, a higher percentage of KRP2.C/KOE transgenics showed a strong phenotype 
with serrated leaves.  
Previously, the overexpression of KRP genes has been demonstrated to result in a 
decrease in extractable CDK activity (Wang et al., 2000; De Veylder et al., 2001; 
Jasinski et al., 2002a). In this study we could confirm via analysis of the p10CKS1At-
purified CDK kinase activity in the transgenic plants that KRP2.FL and KRP2.C/K 
are potent inhibitors; yet KRP2.N, and KRP2.K have no effect on CDK activity 
(Figure 3D and E). Curiously, KRP2.COE plants displayed a somewhat reduced level 
of CDK activity. Together, these results indicate that full KRP2 inhibition of CDK 
activity requires the presence of both the cyclin and CDK binding domain.  
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Figure 3. Phenotypic and molecular analysis of transgenic Arabidopsis thaliana plants.  
Three-week-old transgenic plants were compared with untransformed control plants (Col-0) of 
the same age.  
A. Phenotypes of wild-type (Col-0) and transgenic plants  
B. RNA gel blot analysis 
C. Immunoblot analysis with an anti-HA antibody 
D. p10CKS1At-associated kinase activity in transgenic plants. Autoradiogram representing a 
typical result from CDK activity assays with histone H1 as substrate 
E. Relative quantification of three independent kinase activity measurements as depicted in 
D. The control was arbitrarily set at 100%. 
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KRP2 overexpression in Arabidopsis thaliana was recently shown to trigger a dosis-
dependent endoreduplication phenotype (Verkest et al., 2005a). As such, we 
compared the DNA ploidy level distribution among different transgenic lines with 
high, similar levels of transgene expression of the different KRP2 deletion 
variants in 3-week-old cotyledons (Table 1). Similar effects on the endocycle were 
seen in leaves (data not shown). As reported previously, high levels of  KRP2.FL 
resulted into a partial inhibition of the endocycle, as seen by the strong increase in 
the 2C DNA population, accompanied with a decrease in the number of cells with a 
8C or 16C DNA content. Similarly, KRP2.C/K overexpression resulted into an 
inhibition the endocycle, whereas the N-terminal and the separate cyclin and CDK 
binding domains have no effect (Table 1). 
 
Table 1. DNA ploidy levels in 3-week-old cotyledons of wild-type (Col-0) and transgenic 
lines. 
 
 
Line 2C (%) 4C (%)  8C (%) 16C (%) 32C (%) 
 
Col-0 23.1 ± 1.8 26.7 ± 0.4 30.2 ± 2.3 19.1 ± 0.9 0.8 ± 0.1 
KRP2 FL 33.5 ± 4.4 25.2 ± 0.7 25.0 ± 2.2 15.9 ± 0.6 0.4 ± 0.2 
KRP2 N 23.1 ± 2.4 26.0 ± 0.4 31.4 ± 2.6 19.3 ± 0.1 - 
KRP2 C/K 31.3 ± 2.5 22.2 ± 1.4 26.6 ± 2.4 16.7 ± 0.9 0.8 ± 0.4 
KRP2 C 24.6 ± 1.5 25.8 ± 0.9 28.3 ± 1.9 19.9 ± 0.5 1.4 ± 0.1 
KRP2 K 26.0 ± 0.9 24.6 ± 0.1 29.6 ± 1.7 19.0 ± 0.9 0.7 ± 0.1 
Data represent average ± SD (n = 2). 
The in vivo binding-specificity of the different KRP2 domains towards CDKA;1 was 
analyzed by immunoprecipitation of HA-KRP2-containing complexes from total 
protein extracts prepared from the same transgenic lines as depicted in Figure 3B 
and C. Subsequently, the pulled-down material was probed with CDKA;1-specific 
antibodies (Hemerly et al., 1995). In both KRP2.FL and KRP2.C/K cell extracts, 
CDKA;1 was co-precipitated with KRP2 (Figure 4A). Remarkable, relatively more 
CDKA;1 was pulled-down with KRP2.C/K, suggesting that this deletion mutant of 
KRP2 has a higher affinity for CDKA;1 than the full-length protein. Interestingly, 
although in the yeast two-hybrid system only an interaction with cyclins was 
observed, immunoprecipitation of HA-KRP2.C could pull-down CDKA;1 as well, 
suggesting that KRP2 binds both monomeric cyclins and cyclin/CDK complexes in 
vivo. On the other hand, no CDKA;1 signal was obtained in the KRP2.K pulled-
down material, illustrating no or very weak in vivo interaction of KRP2 with 
monomeric CDKA;1. No CDKA;1 interaction was observed with KRP2.N. This is in 
agreement with the observed yeast two-hybrid results of KRP2.N and confirms that, 
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as was previously shown for KRP1/ICK1 (Wang et al., 1998; Zhou et al., 2003a), 
the N-terminal domain of the Arabidopsis KRPs is not involved in CDK binding.  
To analyze the functionality of the different KRP2 domains towards CYCD3;1, we 
crossed the different transgenic Arabidopsis plants overexpressing KRP2 
domains with CYCD3;1 overexpressing plants. As a control all the transgenic 
lines were crossed with wild-type plants. The fidelity of the crosses was confirmed 
by PCR analysis (data not shown). Crossing CYCD3;1OE with KRP2.FLOE plants 
resulted in the expected restoration of a wild-type phenotype (Jasinski et al., 
2002a; Zhou et al., 2003b; Cho et al., 2004; Figure 4B). Similarly, co-expression 
of KRP2.C/K with CYCD3;1 complemented the KRP2 and CYCD3;1 phenotype. 
Crosses between CYCD3;1 OE  plants and KRP2.N OE  or KRP2.K OE  plants 
showed the typical CYCD3;1 overexpression phenotype with undulated and 
curled leaves (Rhiou-Khamlichi et al., 1999; DeWitte et al.,2003), indicating the 
lack of complementation. Interestingly, ectopic expression of KRP2.C and 
CYCD3;1 resulted in a different phenotype with larger leaves, suggesting that 
KRP2 has an additional cyclin regulatory role besides its inhibitory function.  
 
 
 
Figure 4. CDK and cyclin specificity of full-length and truncated KRP2.  
A. In vivo interaction of KRP2 domains with CDKA;1. HA-immunoprecipitated complexes 
from total protein extracts of 3-week-old wild-type (Col-0) and transgenic plants were 
analyzed by immunoblot analysis with anti-CDKA;1 antibody. B. In vivo specificity of KRP2 
for CYCD3;1. Phenotypes of 6-week-old Arabidopsis thaliana plants co-overexpressing 
CYCD3;1 and KRP2 domains. 
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KRP2 CDK-binding domain is critical for CDK inhibition 
 
Considering the importance for KRP2 functioning of the CDK- and cyclin-binding 
domains we performed a combined random mutagenesis of its C-terminal domain 
(KRP2.C/K) and reverse two-hybrid screen to identify mutants for CDKA;1 or 
CYCD3;1 binding. No KRP2.C/K mutants for CYCD3;1 binding were isolated. In 
contrast, we identified several KRP2 mutants with altered CDKA;1 binding affinity. 
Most of these mutants showed point mutations of residues that are conserved in 
all Arabidopsis KRPs (Figure 5). Interestingly, Kip/Cip homologues of some of the 
isolated mutants were described previously and analyzed in mammalia, where 
they analogously were demonstrated to lack CDK-binding affinity (Goubin et al., 
1995; Welcker et al., 1998). To further analyze these mutants we performed a 
site-directed mutagenesis on KRP2. Figure 5 depicts the different KRP2 mutants 
tested for the interaction with CDKA;1 and CYCD3;1 by yeast two-hybrid analysis. 
Mutation of strictly conserved residues in the CDK binding domain of all plant 
KRPs and animal Kip/Cips abolished CDKA;1 interaction, corroborating our 
reverse two-hybrid data.  
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Figure 5. KRP2 mutants with altered CDKA;1 binding affinity. Sequence of the wild-type 
KRP2 CDK binding domain with motifs 1 and 2 boxed and the reverse two-hybrid isolated 
point mutations indicated in grey. Yeast two-hybrid interaction analysis of full length and 
motif 2 mutated KRP2 with CDKA;1 and CYCD3;1. (M1 = N188 → A, M2 = D190 → A, 
M3 = N188, D190 → A). 
 
To analyze the functionality of the KRP2.M1, KRP2.M2 and KRP2.M3 mutants in 
vivo, transgenic plants were generated overexpressing N-terminal 
hemagglutinin(HA)-tagged mutant forms of the KRP2 gene under control of the 
constitutive Cauliflower Mosaic virus (CaMV) 35S promoter. Several independent 
lines were obtained. For phenotypic analysis, wild-type and mutant KRP2 
overexpressing lines with similar levels of transgene expression were selected. No 
clear differences in protein stability were detected by analyzing the RNA and protein 
levels of the different KRP2 constructs (Figure 6B and C). 
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In comparison with KRP2.FL overexpressing plants, only a minority of the 
transgenic Arabidopsis plants overexpressing KRP2.M1 showed limited serration of 
the leaves and reduced growth, whereas KRP2.M2 and KRP2.M3 overexpression 
were indistinguishable from untransformed control lines in respect to their growth 
rate and leaf morphology (Figure 6A).  
The CDK binding-specificity of these three mutants was analyzed through 
immunoprecipitation of HA-KRP2-containing complexes. The results show that, in 
contrast to the yeast two-hybrid data, all mutant forms bind CDKA;1. Probably this 
interaction is indirect and occurs through the cyclin partner of CDK complexes, as 
the amount of CDKA;1 protein that co-immunoprecipitated with the KRP2 mutants 
was lower than seen for wild-type KRP2 (Figure 6D).  
Purification of active CDK/cyclin complexes with p10CKS1At-beads allowed analysis of 
the effect of full-length and mutant KRP2 overexpression on the CDK activity 
towards histone H1. KRP2.M1 overexpression resulted in a decrease of extractable 
CDK activity (Figure 6E). However, the extent of CDK inhibition was less severe 
than seen for the KRP2.FLOE plants with the same level of transgene expression, 
suggesting that the mutated KRP2 is a less efficient inhibitor than the wild-type 
protein. In contrast, overexpression of KRP2.M2 or KRP2.M3 did not result in CDK 
inhibition, but curiously seemed to activate CDK/cyclin complexes.  
 
Figure 6. Phenotypic and molecular analysis of transgenic Arabidopsis plants 
overexpressing KRP2.FL, KRP2.M1, KRP2.M2, and KRP2.M3.  
A. Phenotypes 
B. RNA gel blot analysis 
C. Immunoblot analysis with an anti-HA antibody 
D. Analysis of the CDK binding specificity. HA-immunoprecipitated complexes from total 
protein extracts of 3-week-old wild-type (Col-0) and transgenic plants were analyzed by 
immunoblot analysis with anti-CDKA;1 
E. Relative quantification of three independent p10CKS1At-associated kinase activity 
measurements towards histoneH1. The control was arbitrarily set at 100%. 
 
 
145 
Chapter 5 
 
 
 
KRP2.M3 enhances endocycle onset through activation of endocycle-
specific CDKA;1 complexes 
 
To comprehend the observed stimulation of CDK activity observed for the 
KRP2.M3OE plants in more detail, the DNA content of 3-week-old first leaves of 
independent wild-type, KRP2.FLOE and KRP2.M3OE lines was measured by flow 
cytometry. At this stage of development the leaf is mature: no mitotic divisions can 
be detected and DNA ploidies have reached a steady-state level (De Veylder et al., 
2001; Verkest et al., 2005a; Vlieghe et al., 2005). Contrasting results were obtained 
for KRP2.FLOE and KRP2.M3OE plants. Whereas full-length KRP2 overexpression 
triggered a dosis-dependent endoreplication phenotype (Verkest et al., 2005a), 
KRP2.M3 overexpression was always correlated with enhanced DNA ploidy levels 
(Figure 7B). These effects on the endocycle correlated with the KRP2.FL and 
KRP2.M3 expression levels (Figure 7A) and were also seen in cotyledons (data not 
shown). 
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Figure 7. Analysis of the effect of wild-type and mutant KRP2 overexpression on 
the DNA ploidy distribution.  
A. RNA gel blot analysis of 3-week-old wild-type and transgenic lines. Equal loading of the gel 
was confirmed by methylene blue staining of the membrane (bottom panel).  
B. Ploidy level distribution of the first leaves of 3-week-old wild-type (Col-0) and independent 
KRP2.FL and KRP2.M3 overexpressing plants as measured by flow cytometry. The indicated 
values are means ± SE (n = 2 to 4).   
 
The timing of endoreplication onset is developmentally regulated during leaf 
development (Boudolf et al., 2004; Beemster et al., 2005; Vlieghe et al., 2005). Cells 
of the first leaf pair primarily divide at 9 DAS (days after sowing) during which most 
cells have a 2C DNA content and the remaining predominantly 4C. At 15 DAS, leaf 
cells have exited the mitotic division program and are mainly endoreduplicating, 
correlated with an increase in the 4C DNA population and the presence of cells with 
an 8C DNA content. When comparing the DNA ploidy distribution at these 
developmental stages in wild-type, strong KRP2.FLOE, and KRP2.M3OE plants, 
young KRP2.FLOE leaf cells (9 DAS) showed no altered ploidy distribution when 
compared to wild-type plants, and clear inhibition of the endocycle was only seen in 
older tissue (21 DAS; Figure 7B and 8A; De Veylder et al., 2001). In contrast, 
KRP2.M3OE tissues showed elevated ploidy levels at the mitotically dividing 
developmental stage (9 DAS), illustrating a premature onset of the endocycle. 
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Distinct CDKA;1/cyclin complexes have been demonstrated to regulate the mitotic 
cell cycle and the endocycle (Grafi and Larkins, 1995; Verkest et al., 2005a). 
Consistently, in strong KRP2 overexpressing lines CDK activity was inhibited in 
both mitotic dividing and endoreplicating leaf tissues; whereas in the weak lines 
only the mitotic CDK/cyclin complexes were affected. To test the effect of 
KRP2.M3 overexpression, CDKA;1 kinase activity was measured in the leaf tissue 
of the first leaf pair harvested at 9 and 15 DAS. Preliminary data show that in mitotic 
cells (9 DAS) CDKA;1 activity was unaffected or weakly inhibited compared to wild-
type plants (Figure 8B). Absent or weak inhibition of the mitotic cell cycle was also 
demonstrated by analyzing leaf epidermal cell numbers and sizes in three-week old 
leaves (Table 2). Surprisingly, at 15 DAS, kinase activity was activated in 
KRP2.M3OE plants (Figure 8B). These data suggest that the increased CDK activity 
observed in KRP2.M3OE plants and the enhanced endocycle onset results from the 
activation of endocycle CDKA;1 complexes. 
 
 
 
 
Figure 8. KRP2.M3 enhances endocycle onset.  
A. Ploidy level distribution of the first leaves of wild-type (Col-0) and strong KRP2.FL and 
KRP2.M3 overexpressing plants during development as measured by flow cytometry,  
B. Autoradiograph analysis of immunoprecipitated CDKA;1 kinase activity in the first leaf pair 
of wild-type (Col-0) and strong KRP2.FL and KRP2.M3 overexpressing plants, using histone 
H1 as substrate. 
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Table 2. Abaxial epidermis cell size and cell number in leaves of wild-type, KRP2.FL and 
KRP2.M3 plants 
 
 
Line Leaf size 
(mm2) 
Abaxial Epidermal Cells 
Estimated number                Size ( μm2) 
Col-0 15.03±1.02 13532±875  1160±33 
KRP2.FL/1 9.84±0.93 2789±204 3897±417 
KRP2.M3/3 15.42±0.94 11682±691 1345±89 
All measurements were performed on 3-week-old mature first leaves. The indicated values are 
means ± SE (n = 6 to 10). 
 
 
Discussion 
   
 
Since the isolation of the first plant CDK inhibitory gene ICK1/KRP1 (Wang et al., 
1997), a family of related genes has been identified (reviewed by Verkest et al., 
2005b). Whereas the ability of the plant KRPs to act as CDK inhibitors and 
repressors of cell proliferation is becoming well established, little information is 
available regarding their molecular mechanism of CDK inhibition. Here, a deletion 
and mutational analysis of the Arabidopsis thaliana CDK inhibitor KRP2 allowed 
the identification of important domains and amino acid residues defining KRP2 
function. 
The high diversity of the N-terminal domain among KRP sequences suggests that 
this particular region is not involved in CDK binding or inhibition. Previously, it 
was shown that deletion of the N-terminal region of KRP1/ICK1 indeed does not 
impede its interactions with either CDKA;1 and CYCD3;1 (Wang et al., 1998). The 
N-terminal domain of KRP2 similarly does not bind CDKA;1 nor CYCD3;1. The 
observation that Arabidopsis plants overexpressing the N-terminal domain of 
KRP1 or KRP2 do not exhibit lowered CDK kinase activities (Zhou et al., 2003a; 
this study) and that KRP2.N, in contrast to KRP2.FL, did not complement the 
CYCD3;1 overexpression phenotype, indeed illustrates that the N-terminal KRP 
domain does not function in CDK/cyclin targeting. Interestingly, the N-terminal 
sequences of KRP1 and KRP2 appear to have opposing functions in regulating 
KRP protein stability: the N-terminus of KRP1 was found to destabilize this plant 
CDK inhibitor (Zhou et al., 2003a), whereas the N-terminal domain of KRP2 
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stabilizes the KRP2 protein. The specific amino-acid sequence conferring KRP2 
stability still remains to be identified.  
A variety of techniques, including: sequence analysis, deletions, mutations and 
peptides allowed the mapping of the CDK and cyclin binding sites of the 
mammalian Kip/Cip proteins. A conserved N-terminal-located region of 65 amino-
acids was shown to be necessary and sufficient for Kip/Cip binding and inhibition 
of CDK/cyclin complexes (Luo et al., 1995; Chen et al., 1995, Goubin et al., 1995, 
Nakanishi et al., 1995). The crystal structure of the p27Kip1 N-terminal CDK 
inhibitory domain bound to the cyclinA/CDK2 complex showed that this peptide 
spans and interacts with a large surface area of the CDK/cyclin complex causing 
conformational changes in and around the catalytic cleft of CDK2 (Russo et al., 
1996). In this complex the p27Kip1 domain has a nonglobular, extended structure 
that consists sequentially of a rigid coil, an amphiphatic α-helix, a β-hairpin, a β-
strand and a 310-helix (Figure 9). The p27Kip1-cyclinA interaction predominantly 
involves the p27Kip1 coil-located ZRXLFG motif that binds a shallow groove of 
cyclinA lined with highly conserved cyclin-box amino acids. Interaction with the 
CDK subunit occurs through the β-hairpin, the β-strand, and the 310-helix. The 
first two structures associate with the N-terminal lobe of the CDK, resulting in the 
destabilization of the ATP binding site, whereas the 310-helix binds to the catalytic 
cleft and occupies the ATP binding site (Russo et al., 1996). Despite their low 
sequence identity, the conserved C-terminal domains of the plant KRPs show 
partial homology with the Kip/Cip protein sequence necessary for interaction with 
the CDK subunit, suggesting that the plant CKI inhibitory function resides at their 
C-terminus. Indeed, yeast-two hybrid interaction assays demonstrated that the 
C-terminal domains of KRP1 and KRP2 are sufficient for interaction with CDKA;1 
and CYCD3;1 (Wang et al., 1998; Lui et al., 2000; this study). Moreover, the 
functionality of these domains for CDK binding and inhibition (Schnittger et al., 
2003; Zhou et al., 2003a; this study) and the specificity of KRP2.C/K for CYCD3;1 
was proven in vivo.  
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Figure 9. Comparison of the KRP2 protein sequence with its mammalian p27Kip1 
homologue. Plant KRP conserved motifs 1, 2, and 3 are indicated in boxes, the cyclin and 
CDK binding domains of KRP2 are underlined. For more details, see text.  
 
The sequence homology of the conserved KRP motifs 1 and 2 with part of the 
CDK binding domain of the Kip/Cips suggests that this domain is involved in plant 
CDKA;1 interaction (Figure 9). In agreement, yeast two-hybrid interaction analysis 
demonstrated that the KRP2 deletion mutant harboring this domain (KRP2.K) 
could bind CDKA;1, but does not complex CYCD3;1. Although the plant KRPs 
display no region of similarity to the cyclin binding domain of the mammalian 
Kip/Cip CKIs, further deletion mapping allowed us to identifiy a KRP2 motifs 2 
and 3 containing cyclin binding domain (Figure 9). Curiously, motif 2 of the CDK 
binding domain is necessary for interaction of KRP2.C with CYCD3;1. This partial 
overlap between the CDK and cyclin binding domains was also suggested to 
occur in KRP1 (Wang et al., 1998), but is not reported in Kip/Cip inhibitors. 
Analysis of the in vivo functionality of the separate KRP2 CDK and cyclin binding 
domains suggested that the inhibiting function of KRP2 depends on both domains 
since KRP2.C nor KRP2.K overexpression resulted in an alteration of the wild-
type phenotype. Moreover KRP2.KOE plants displayed wild-type CDK activity 
levels. The weak inhibition of CDK activity which was measured in the KRP2.COE 
plants is in agreement with the observation that peptides from the cyclin-binding 
domain of p21Cip1 partially inhibit CDK activity through blocking CDK/cyclin 
accessibility of other CDK substrates containing cyclin-binding domains (Chen et 
al., 1996). In vivo binding assays demonstrated that KRP2.K could not 
complement the CYCD3;1 Arabidopsis phenotype and did not bind CDKA;1, 
when compared to KRP2.FL. This suggests that KRP2 preferentially associates 
CDK/cyclin complexes and does not or very weakly binds monomeric CDKA;1. In 
vitro binding assays demonstrated weak interaction of full-length KRP2 with 
CDKA;1. Similarly, Kip/Cip interaction with isolated CDK-subunits is weak and 
appreciable CKI binding is only found when the kinase is associated to a cyclin 
partner (Harper et al., 1995; Lin et al., 1996). In contrast, Kip/Cip CKIs show a 
high affinity for monomeric cyclins as was illustrated by Hall et al. (1995) with a 
mutant cyclinD1 construct, which whilst retaining the ability to interact with 
Kip/Cips, was inactive for CDK binding. Analysis of the CDK binding-specificity of 
KRP2.C showed that, in contrast to the yeast two-hybrid data, it binds CDKA;1. 
Probably this interaction is indirect and occurs through the cyclin partner of CDK 
complexes.  Moreover, even though we did not analyze KRP binding to 
monomeric cyclins, the observation that co-expression of KRP2.C and CYCD3;1 
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results in an additional plant phenotype suggests that KRPs, like the Kip/Cip 
proteins, bind monomeric cyclins.  
In mammalia, the ZRXL motif was identified as involved in cyclin binding in 
several cell cycle proteins, including E2F1, Cdc25a, p107 and the Kip/Cip 
inhibitors (Vlach et al., 1997; Lin et al., 1996; Chen et al., 1996; Welcker et al., 
1998). Although this motif does not appear in other Arabidopsis KRPs it is present 
in the analyzed cyclin binding domain of KRP2 (Figure 9). Yeast two-hybrid 
interaction analysis of ZRXL mutants of KRP2 however showed that it does not 
function in CYCD3;1 binding (data not shown). This observation further suggests 
that plant KRPs use a distinct cyclin-binding mechanism. However, we can not 
exclude that this sequence motif has no other cell cycle function since even in 
mammalia the nature of the ZRXL motif is not completely understood. Whereas it 
functions in the interaction with A-, E- and D-type cyclins in p21Cip1, it binds 
cyclinA and cyclinE, but not D-type cyclins in p107 (Ewen et al., 1992; Li et al., 
1993). Moreover, the ZRXL motif of p21Cip1 was shown to be necessary for its 
interaction with monomeric A- and E-type cyclins and for the interaction and 
inhibition of cyclinE/CDK2, but not of cyclinA/CDK2 complexes (Wohlschlegel et 
al., 2001). 
Random mutagenesis and reverse two-hybrid analysis allowed the fine-mapping 
of the KRP2 CDK binding site. All KRP2.C/K mutants with altered CDKA;1 
binding affinities showed amino-acid mutations in or near motifs 1 and 2, further 
emphasizing their sufficiency and necessity for CDKA;1 binding. Furthermore, this 
illustrated that the KRPs utilize the homologous K/RWNFDFX4PLEG sequence 
for CDK interaction, like observed for their mammalian counterparts (Figure 9). 
Based on these results and reports from the Kip/Cip inhibitors we rationally 
designed three KRP2 point mutants in the conserved motif 2 for in vivo analysis 
(Goubin et al., 1995; Nakanishi et al., 1995). Yeast two-hybrid analysis 
demonstrated that the KRP2.M1, KRP2.M2 and KRP2.M3 mutants kept the KRP2 
ability to bind CYCD3;1, but they could not interact with CDKA;1. By contrast, 
immunoprecipitation of HA-KRP2 from plant extracts overexpressing KRP2.M1, 
KRP2.M2 and KRP2.M3 illustrated that all of them pulled down CDKA;1, although 
less efficiently than KRP2.FL. In agreement with this observed altered CDKA;1 
affinity, KRP2.M1 overexpression in plants resulted in a less dramatic phenotype 
and less efficient CDK inhibition, when compared to KRP2.FL plants. 
Overexpression of KRP2.M2 and KRP2.M3 even stimulated CDK activity. 
Similarly, some Kip/Cip mutants in CDK binding were reported to be less efficient 
inhibitors, whereas others activated CDK complexes (Welcker et al., 1998). 
These results confirm that tight binding of the KRPs with both the cyclin and CDK 
subunit is a prerequisite for CDK inhibition. Combined, our data indicate that, 
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similar to the Kip/Cip inhibitors, the cyclin-binding motif is involved in the docking 
of the CDK/cyclin complex, but that the CDK binding domain accounts for the 
inhibitory activity of KRPs (Russo et al., 1996; Lacy et al., 2004 and 2005).  
The observed stimulation of CDK activity upon KRP2.M2 or KRP2.M3 
overexpression indicated that both alleles might encode dominant negative forms 
of the wild-type KRP2 protein. To test this hypothesis, we crossed KRP2.FLOE 
and KRP2.M3OE plants (data not shown). As a control both lines were separately 
crossed with wild-type plants. The fidelity of the crosses was confirmed by PCR 
analysis with dCAPS primers. Phenotypical analysis of the crossed lines, 
however, showed that the observed effects of KRP2.M3 overexpression did not 
result from an obstruction of CDKA;1 binding with wild-type KRP2 through 
KRP2.M3, as crossed plants still exhibited the KRP2.FL overexpression 
phenotype, suggesting that the activation of CDK activity in KRP2.M3OE plants 
occurs through another unidentified mechanism. Previously, we demonstrated 
that wild-type KRP2 overexpression triggers a dose-dependent endoreplication 
phenotype (Verkest et al., 2005a). Whereas the overexpression of KRPs at high 
levels induces an inhibition of the endocycle (De Veylder et al., 2001; Jasinski et 
al., 2002a; Zhou et al., 2002), mild overexpression leads to increased DNA ploidy 
levels (Verkest et al., 2005a; Weinl et al., 2005). In contrast, both weak and strong 
KRP2.M3 overexpressing plants exhibited increased ploidy levels. The apparently 
contradicting results in KRP2.FLOE plants were shown to result from an inhibition 
of both CDKA;1/cyclin complexes with a role in the mitotic cell cycle and endocycle 
in strong KRP2.FLOE lines, whereas in weak KRP2.FLOE lines mainly the mitotic 
CDKA;1 complexes were targeted (Verkest et al., 2005a). Curiously, the enhanced 
endocycle onset in KRP2.M3OE plants was shown to result from an activation of 
endocycle CDKA;1 complexes. This suggests that KRP2, besides having a role in 
the mitotic cell cycle and mitosis-to-endocycle transition, also functions in the 
endocycle. Consistent with this KRP2 was shown to be expressed in both 
mitotically dividing and endoreplicating tissues (Ormenese et al., 2004; Verkest et 
al., 2005a). In mammals, Kip/Cips display besides their inhibitory function also a 
role as assembly and targeting factors of CDK/cyclin complexes (Sherr and 
Roberts, 1999). These contradicting functions are the consequence of binding of 
Kip/Cip CKIs to both sensitive and insensitive CDK complexes (Blain et al., 1997). 
Whereas interaction of Kip/Cip inhibitors to susceptible CDK complexes results in 
their inhibition, binding to inert CDK/cyclins stabilizes these complexes (LaBaer et 
al., 1997; Cheng et al., 1999). Moreover, Kip/Cips have been implicated as 
nuclear import factors for CDK/CycD complexes and were shown to increase the 
stability of D-type cyclins (LaBaer et al., 1997; Cheng et al., 1999; Alt et al., 
2002). In vivo inhibitory specificity between KRPs and different D-type cyclins has 
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been demonstrated by Schnittger et al. (2003), who showed that the trichome 
endoreduplication phenotype resulting from KRP1 overexpression can be 
complemented by overexpression of CYCD3;1, but not of CYCD4;1. Previously, the 
ability of modest levels of KRP2 to inhibit mitotic cell cycle CDKA;1 complexes, but 
not endocycle complexes was suggested to possibly result from a shift in CDKA;1 
cyclin partners at the mitosis-to-endocycle transition since this transition in 
mammalian trophoblasts is accompanied by a switch of D-type cyclin isoform 
expression (MacAuley et al., 1998; Verkest et al., 2005a). Another possibility is that 
this switch to KRP-inert CDKA;1 complexes is accompanied by their activation by 
KRP2 and masks the inhibition of KRP-sensitive CDKA;1 complexes. Although 
further investigations are required to identify a possible function of KRP2 as 
assembly or targeting factor, this could explain how KRP2 mutants with weakened 
or impaired CDK inhibitory function activate endocycle CDKA;1 complexes. 
  
  
M   ethods  
 
Construction of KRP2 domains and mutants – Plasmids 
 
The pGAD.KRP2.FL, pGBT.CDKA;1, pGBT.CYCD3;1 and pDEST17.KRP2 
constructs were obtained as described before (De Veylder et al., 2001; Verkest et 
al., 2005a). The different KRP2 domains were amplified by polymerase chain 
reaction (PCR) with specific primers and cloned in the EcoR1 and BamH1 sites of 
pGAD424 (Clontech) or in the Nde1 and BamH1 sites of pREP42-HA_N (Craven 
et al., 1998). Information about the primer set sequences can be given upon 
request. Site-directed KRP2 mutants were generated by PCR of the KRP2.FL 
sequence in pGEM-T using the following pre-phosphorylated primers: 5’-
CTTCGATTTCGAGAAAGATGAGCCACTTGGTGGAGG –3’ and 5’- 
GCATACTTCATAGAACATTCCAACAACTTATTCCG –3’ for substitution of N186 
→ A186, 5’- TTTCGAGAAAGATGAGCCACTTGGTGGAGGAAGATACG -3’ and 
5’- GCGAAGTTATACTTCATAGAACATTCCAACAACTTATTCCG –3’ for 
substitution of D188 → A188 in pGEM-T.KRP2.FL or pGEM-T.KRP2.N186 → 
A186. Information about the primer set sequences for ZRXL motif mutations can 
be given upon request. The linear PCR products were circularized by ligation and 
the resulting plasmids were sequenced to confirm if the correct residue 
substitution took place. The mutants were amplified with the KRP2.FL primers 
and subcloned in the pGAD424 and pREP42-HA_N vectors. 
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 HA-tagged versions of the KRP2 domains and mutants were obtained by Nco1 
and BamH1 digestion of the pREP42-HA_N.KRP2 constructs. Subsequently, the 
restriction fragments were cloned between the CaMV35S promoter and the 
nopaline synthase (NOS) 3' untranslated region in the NcoI and BamHI sites of 
PH35S (Hemerly et al., 1995). The CaMV35S/HA.KRP2/NOS cassettes were 
released of the pH35S.HA.KRP2 constructs by EcoRI and SalI and cloned in 
pBinPLUS (van Engelen et al., 1995) to obtain the pBIN.HA.KRP2 vectors.  
Random mutagenesis of pGAD.KRP2.C/K was performed by error-prone PCR 
with modified dNTP concentrations and Mn2+ with primers 5’- 
AGGGATGTTTAATACCACTAC –3’ and 5’- GCACAGTTGAAGTGAACTTGC –3’ 
(Miyazaki and Arnold, 1999). A reaction contained 1 × PCR buffer (Roche, with 
MgCl2), 0.2 mM dATP, 0.2 mM dGTP, 1 mM dCTP, 1 mM dTTP, 0.5 mM MnCl2, 1 
μM of both primers, 30 ng template and 5 U Taq DNA polymerase (Boehringer 
Mannheim). PCR was carried out at 94°C for 5 min (denaturation), 40 cycles: 
94°C for 1 min, 40°C for 1 min, 72°C for 2 min, and 72°C for 5 min.  
HA- and MBP-tagged versions of CDKA;1 were constructed by cloning, CDKA;1 
digested out of the EcoR1 and BamH1 sites of pGAD.CDKA;1 (De Veylder et al., 
2001), into pBluescript plasmid (Stratagene) containing a HA-tag (HA-pSK) or 
pMal2c (New England Biolabs), respectively.  CYCD4;1 was obtained by PCR 
and cloned into the EcoR1 and Pst1 sites of the pBluescript plasmid (Stratagene) 
containing a double c-myc tag. All cloning steps were carried out according to 
standard procedures, and the reading frames were verified by direct sequencing. 
 
 
Yeast two-hybrid and reverse two-hybrid experiments 
 
The vectors pGAD424 and pGBT9 harboring the GAL4 activation domain and the 
GAL4 binding domain respectively, and the yeast strain AH109 (Clontech) were 
used for yeast two-hybrid interactions. Yeast cells were transformed according to 
the Matchmaker two-hybrid system protocol (Clontech) and assayed for their 
ability to grow on Leu-/Trp-/His- minimal medium supplemented with 10 mM 3- 
aminotriazole (3-AT) after 3 days of incubation at 30°C. Bait plasmids co-
transformed with empty pGAD424 and prey plasmids co-transformed with empty 
pGBT9 were assessed along as controls for the specificity of the interaction. 
For reverse two-hybrid screening the yeast strain MaV203 (Life Technologies) was 
sequentially transformed with pGBT.CDKA;1 and a library of mutated KRP2.C/K 
constructed in pGAD424 by gap repair cloning (Fusco et al., 1999). For gap repair 
cloning 250 ng linearized pGAD424 and 750 ng PCR fragment were used to 
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transform MaV203.pGBT.CDKA;1 with the lithium acetate method. Transformed 
yeasts were plated on Leu-/Trp- minimal medium to evaluate the overall efficiency of 
the transformation and on Leu-/Trp- minimal medium supplemented with 0.2% 5-
fluoro-orotic acid to screen for KRP2.C/K mutants with impaired ability to bind 
CDKA;1. 3×104 transformants were screened to yield approximately 40 RTH 
positive clones. PCR on spheroplasted yeast colonies was performed to check 
insert size and nucleotide sequence.  
 
 
In vitro transcription/translation of proteins, production of 
recombinant proteins, and in vitro binding assays  
 
In vitro transcription and translation experiments were performed using the TnT 
T7-coupled wheat germ extract kit (Promega) primed with the appropriate 
plasmids for 90 min at 30 °C in the presence or absence of 35S-methionin.  
For MBP.CDKA;1 expression and purification the pMal2c.CDKA;1 vector was 
transformed in the Escherichia coli BL21-CodonPlusTM(DE3)-RIL strain (Novagen, 
Madison, WI) and after induction purified  by amylose affinity chromatography 
according to the manufacturer’s instructions (New England BioLabs). His-tagged 
KRP2 was expressed in Escherichia coli and purified by nickel-agarose 
chromatography as described previously (Verkest et al., 2005a).  
For immunoprecipitations 10 μl of each in vitro translated protein was mixed and 
diluted at 1:5 in Nonidet NP40 buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1% 
Nonidet P40, 1 mM PMSF, 10 μg/ml leupeptin/aprotinin/pepstatin) and incubated 
for 2 h at 4°C with anti-HA (16B12; BabCo), anti-c-myc (9E10; BabCo) or penta-His 
(Qiagen) antibodies, respectively. Protein-A-Sepharose (40 μl 25% [v/v]) was 
added and incubated for 1 h at 4°C, beads were washed four times with Nonidet 
NP40 buffer and immune complexes were eluted with 10 μl 2× SDS sample buffer 
and analyzed by 13% SDS-PAGE and by autoradiography. 
Binding of KRP2 to monomeric CDKA;1 was analyzed by incubation of 500ng 
recombinant His.KRP2 and MBP or MBP.CDKA;1 in RIPA buffer (20 mM Tris-Cl, 
pH 7.4, 5 mM EDTA, 2 mM EGTA, 100 mM NaCl, 2 mM NaF, 0.2% Nonidet P-40, 
300 μM phenylmethylsulfonyl fluoride, and 10 μg/ml aprotinin and pepstatin). After 
addition and incubation with amylose resin, the bead bound fractions were washed 
three times with RIPA buffer and eluted by boiling the samples in SDS loading 
buffer for subsequent gel blot protein analysis with a penta-His antibody (Qiagen). 
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Regeneration and analysis of transgenic lines  
 
The pBIN.KRP2 plasmids were mobilized by the helper plasmid pRK2013 into the 
Agrobacterium tumefaciens C58C1RifR harboring the plasmid pMP90 (Koncz and 
Schell, 1986). Arabidopsis thaliana (L.) Heynh. ecotype Columbia was 
transformed by the floral dip method (Clough and Bent, 1998). Transgenic 
CaMV35S-KRP2 plants were obtained on kanamycin-containing medium. To 
minimize the effects of copy numbers on gene expression, transgenic plants with 
one insert were selected by the segregation ratio of kanamycin resistance on 
selective medium. Double KRP2.FL-KRP2.M3OE plants were obtained by crossing 
homozygous KRP2.FLOE plants with homozygous HA.KRP2.M3 overexpressing 
plants with similar levels of transgene expression. Similarly crossing of 
homozygous CycD3;1OE plants with plants overexpressing the KRP2 domains 
resulted in the regeneration of double transformants. The fidelity of the crosses 
was confirmed by PCR analysis. For all analyses, plants were grown under a 16 h 
light/8 h dark photoperiod at 22°C on germination medium (Valvekens et al., 
1988).  
Analysis of the transgenic plants by RNA and protein gel blotting was performed 
as described by Verkest et al. (2005a). For flow cytometric analysis, leaves or 
cotyledons were chopped with a razor blade in 300 μl of 45 mM MgCl2, 30 mM 
sodium citrate, 20 mM 3-(N-morpholino)propanesulfonic acid (pH 7), and 1% Triton 
X-100 (Galbraith et al., 1991). From a stock of 1 mg/ml 4,6-diamidino-2-
phenylindole, 1 μl was added to the filtered supernatants. The nuclei were analyzed 
with the BRYTE HS or CyFlow flow cytometer with Win-Bryte (Bio-Rad, Hercules, 
CA) or FloMax (Partec, Münster, Germany) software, respectively. Analysis of leaf 
epidermal cell numbers and sizes of the transgenic lines was performed as 
described previously (Verkest et al., 2005a).  
For immunoprecipitations, 300 μg of total protein extract in homogenization buffer 
(25 mM Tris-Cl, pH 7.6, 75 mM NaCl, 15 mM MgCl2, 15 mM EGTA, 15 mM p-
nitrophenylphosphate, 60 mM β-glycerophosphate, 1 mM DTT, 0.1% Nonidet P-40, 
0.1 mM Na3VO4, 1 mM NaF, and protease inhibitor cocktail P9599 (Sigma-Aldrich)) 
were incubated with 30 μl of 50% (v/v) anti-HA Affinity Matrix (Roche Diagnostics) 
for 1 h at 4°C on a rotating wheel. Thereafter, beads were washed three times with 
RIPA buffer (20 mM Tris-Cl, pH 7.4, 5 mM EDTA, 2 mM EGTA, 100 mM NaCl, 
2 mM NaF, 0.2% Nonidet P-40, 300 μM phenylmethylsulfonyl fluoride, and 10 μg/ml 
aprotinin and pepstatin), and used for CDK activity reactions or protein gel blot 
analysis. Kinase assays were performed as described by De Veylder et al. (1997) 
and Verkest et al. (2005a). 
                        
157 
Chapter 5 
R  eferences  
 
Alt JR, Gladden AB, Diehl JA (2002) p21(Cip1) Promotes cyclin D1 nuclear 
accumulation via direct inhibition of nuclear export. J Biol Chem. 277: 
8517-23 
Beemster GTS, Vercruysse S, West G, Rombaut D, Van Hummelen P, 
Galichet A, Gruissem W, Inzé D, Vuylsteke M (2005) Genome-wide 
analysis of gene expression profiles associated with cell cycle 
transitions in growing organs of Arabidopsis. Plant Physiol 138: 734-
743 
Blain SW, Montalvo E, Massague J (1997) Differential interaction of the cyclin-
dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin 
D2-Cdk4. J Biol Chem. 272: 25863-25872 
Boudolf V, Vlieghe K, Beemster GTS, Magyar Z, Torres Acosta JA, Maes S, 
Van Der Schueren E, Inzé D, De Veylder L (2004) The plant-specific 
cyclin-dependent kinase CDKB1;1 and transcription factor E2Fa-DPa 
control the balance of mitotically dividing and endoreduplicating cells in 
Arabidopsis. Plant Cell 16: 2683-2692 
Chen J, Jackson PK, Kirschner MW, Dutta A (1995) Separate domains of p21 
involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388 
Chen J, Saha P, Kornbluth S, Dynlacht BD, Dutta A (1996) Cyclin-binding 
motifs are essential for the function of p21CIP1. Mol Cell Biol. 16: 4673-
4682 
Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ 
(1999) The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential 
activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 
18: 1571-1583 
Cho JW, Park SC, Shin EA, Kim CK, Han W, Sohn S-I, Song PS, Wang MH 
(2004) Cyclin D1 and p22ack1 play opposite roles in plant growth and 
development. Biochem. Biophys. Res. Commun. 324: 52-57 
Clough SJ, Bent AF (1998) Floral dip: a simplified method for Agrobacterium-
mediated transformation of Arabidopsis thaliana. Plant J. 16: 735-743 
158 
Mutational analysis of KRP2 
Coelho CM, Dande RA, Sabelli PA, Sun Y, Dilkes BP, Gordon-Kamm WJ, 
Larkins BA (2005) Cyclin-dependent kinase inhibitors in maize 
endosperm and their potential role in endoreduplication. Plant Physiol. 
138: 2323-2336 
De Veylder L, Beeckman T, Beemster GTS, Krols L, Terras F, Landrieu I, Van 
Der Schueren E, Maes S, Naudts M, Inzé D (2001) Functional 
analysis of cyclin-dependent kinase inhibitors of Arabidopsis. Plant Cell 
13: 1653-1667 
De Veylder L, Segers G, Glab N, Casteels P, Van Montagu M, Inzé D (1997) 
The Arabidopsis Cks1At protein binds to the cyclin-dependent kinases 
Cdc2aAt and Cdc2bAt. FEBS Lett. 412: 446-452 
Dewitte W, Riou-Khamlichi C, Scofield S, Healy JM, Jacqmard A, Kilby NJ, 
Murray JA (2003) Altered cell cycle distribution, hyperplasia, and 
inhibited differentiation in Arabidopsis caused by the D-type cyclin 
CYCD3. Plant Cell 15: 79-92  
Dunphy WG (1994) The decision to enter mitosis. Trends in Cell Biology 4: 202-
207 
Ewen ME, Faha B, Harlow E, Livingston DM (1992) Interaction of p107 with 
cyclin A independent of complex formation with viral oncoproteins. 
Science 255: 85-87 
Fusco C, Guidotti E, Zervos AS (1999) In vivo construction of cDNA libraries for 
use in the yeast two-hybrid system. Yeast 15: 715-720 
Galbraith DW, Harkins KR, Knapp S (1991) Systemic endopolyploidy in 
Arabidopsis thaliana. Plant Physiol. 96: 985-989 
Goubin F, Ducommun B (1995) Identification of binding domains on the 
p21Cip1 cyclin-dependent kinase inhibitor. Oncogene 10: 2281-2287 
Grafi G, Larkins BA (1995) Endoreduplication in maize endosperm: involvement 
of M phase-promoting factor inhibition and induction of S phase-related 
kinases. Science 269: 1262-1264 
Hall M, Bates S, Peters G (1995) Evidence for different modes of action of 
cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 
and p27 bind to cyclins. Oncogene 11: 1581-1588 
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, 
Dobrowolski S, Bai C, Connell-Crowley L, Swindell E (1995) 
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 6: 387-400 
159 
Chapter 5 
Hemerly A, de Almeida Engler J, Bergounioux C, Van Montagu M, Engler G, 
Inzé D, Ferreira P (1995) Dominant negative mutants of the Cdc2 
kinase uncouple cell division from iterative plant development. EMBO J. 
14: 3925-3936 
Jasinski S, Perennes C, Bergounioux C, Glab N (2002b) Comparative molecular 
and functional analyses of the tobacco cyclin-dependent kinase inhibitor 
NtKIS1a and its spliced variant NtKIS1b. Plant Physiol 130: 1871-1882 
Jasinski S, Riou-Khamlichi C, Roche O, Perennes C, Bergounioux C, Glab N 
(2002a) The CDK inhibitor NtKIS1a is involved in plant development, 
endoreduplication and restores normal development of cyclin 
D3;1-overexpressing plants. J Cell Sci 115: 973-982 
Koncz C, Schell J (1986) The promoter of TL-DNA gene 5 controls the tissue-
specific expression of chimaeric genes carried by a novel type of 
Agrobacterium binary vector. Mol. Gen. Genet. 204: 383-396 
Kono A, Umeda-Hara C, Lee J, Ito M, Ichimiya H, Umeda M (2003) Arabidopsis 
D-type cyclin CYCD4;1 is a novel cyclin partner of B2-type 
cyclin-dependent kinase. Plant Physiol 132: 1315-1321 
LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, 
Fattaey A, Harlow E (1997) New functional activities for the p21 family 
of CDK inhibitors. Genes Dev. 11: 847-862 
Lacy ER, Wang Y, Post J, Nourse A, Webb W, Mapelli M, Musacchio A, 
Siuzdak G, Kriwacki RW (2005) Molecular basis for the specificity of 
p27 toward cyclin-dependent kinases that regulate cell division. J Mol 
Biol. 349: 764-773 
Lacy ER, Filippov I, Lewis WS, Otieno S, Xiao L, Weiss S, Hengst L, 
Kriwacki RW (2004) p27 binds cyclin-CDK complexes through a 
sequential mechanism involving binding-induced protein folding. Nat. 
Struct. Mol. Biol. 11: 358-364 
Li Y, Graham C, Lacy S, Duncan AM, Whyte P (1993) The adenovirus E1A-
associated 130-kD protein is encoded by a member of the 
retinoblastoma gene family and physically interacts with cyclins A and 
E. Genes Dev. 7: 2366-2377 
Lin J, Reichner C, Wu X, Levine AJ (1996) Analysis of wild-type and mutant 
p21WAF-1 gene activities. Mol Cell Biol 16: 1786-1793 
Lui H, Wang H, DeLong C, Fowke LC, Crosby WL, Fobert PR (2000) The 
Arabidopsis Cdc2a-interacting protein ICK2 is structurally related to 
160 
Mutational analysis of KRP2 
ICK1 and is a potent inhibitor of cyclin-dependent kinase activity in vitro. 
Plant J. 21: 379-385 
Luo Y, Hurwitz J, Massague J. (1995) Cell-cycle inhibition by independent CDK 
and PCNA binding domains in p21Cip1. Nature 375: 159-161 
MacAuley A, Cross JC, Werb Z (1998) Reprogramming the cell cycle for 
endoreduplication in rodent trophoblast cells. Mol. Biol. Cell 9: 795-807 
Miyazaki K, Arnold FH (1999) Exploring nonnatural evolutionary pathways by 
saturation mutagenesis: rapid improvement of protein function. J Mol 
Evol. 49: 716-720 
Morgan DO (1995) Principles of CDK regulation. Nature 374: 131-134 
Nakanishi M, Robetorye RS, Adami GR, Pereira SO, Smith JR (1995) 
Identification of the active region of the DNA synthesis inhibitory gene 
p21SDI1/Cip1/WAF1. EMBO J. 1: 555-563 
Ormenese S, de Almeida Engler J, De Groodt R, De Veylder L, Inzé D, 
Jacqmard A (2004) Analysis of the spatial expression pattern of seven 
Kip related proteins (KRPs) in the shoot apex of Arabidopsis thaliana. 
Ann Bot 93: 575-580 
Peters JM. (1998) SCF and APC: the Yin and Yang of cell cycle regulated 
proteolysis. Curr Opin Cell Biol. 10: 759-768 
Pines J (1994) Protein kinases and cell cycle control. Sem. Cell. Biol. 5: 187-193 
Riou-Khamlichi C, Huntley R, Jacqmard A, Murray JA (1999) Cytokinin 
activation of Arabidopsis cell division through a D-type cyclin. Science 
283: 1541-1544 
Russo AA, Jeffrey PD, Patten AK, Massagué J, Pavletich NP (1996) Crystal 
structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the 
cyclin A—Cdk2 complex. Nature (London) 382: 325-331 
Schnittger A, Weinl C, Bouyer D, Schöbinger U, Hülskamp M (2003) 
Misexpression of the cyclin-dependent kinase inhibitor ICK1/KRP1 in 
single-celled Arabidopsis trichomes reduces endoreduplication and cell 
size and induces cell death. Plant Cell 15: 303-315 
Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent 
kinases. Genes Dev. 9: 1149-1163 
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of 
G1-phase progression. Genes Dev. 13: 1501-1512 
161 
Chapter 5 
Valvekens D, Van Montagu M, Van Lijsebettens M (1988) Agrobacterium 
tumefaciens-mediated transformation of Arabidopsis thaliana root 
explants by using kanamycin selection. Proc. Natl. Acad. Sci. USA 85: 
5536-5540 
van Engelen FA, Molthoff JW, Conner AJ, Nap J-P, Pereira A, Stiekema WJ 
(1995) pBINPLUS: an improved plant transformation vector based on 
pBIN19. Transgenic Res. 4: 288-290 
Vandepoele K, Raes J, De Veylder L, Rouzé P, Rombauts S, Inzé D (2002) 
Genome-wide analysis of core cell cycle genes in Arabidopsis. Plant 
Cell 14: 903-916 
Verkest A, de O Manes C-L, Vercruysse S, Maes S, Van Der Schueren E, 
Beeckman T, Genschik P, Inzé D, De Veylder L (2005a) The 
cyclin-dependent kinase inhibitor KRP2 controls the mitosis-to-endocycle 
transition during Arabidopsis leaf development through a specific 
inhibition of the mitotic CDKA;1 kinase complexes. Plant Cell 17: 
1723-1736 
Verkest A, Weinl C, Inzé D, De Veylder L, Schnittger A (2005b) Swithching the 
cell cycle: Kip-related proteins in plant cell cycle control. Plant Physiol. 
139: 1099-1103 
Vlach J, Hennecke S, Amati B (1997) Phosphorylation-dependent degradation 
of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J. 16: 5334-
5344 
Vlieghe K, Boudolf V, Beemster GTS, Maes S, Magyar Z, Atanassova A, de 
Almeida Engler J, Inzé D, De Veylder L (2005) The DP-E2F-like 
DEL1 gene controls the endocycle in Arabidopsis thaliana. Curr. Biol. 
15: 59-63 
Wang H, Fowke LC, Crosby WL (1997) A plant cyclin-dependent kinase inhibitor 
gene. Nature (London) 386: 451-452 
Wang H, Qi Q, Schorr P, Cutler AJ, Crosby WL, Fowke LC (1998) ICK1, a 
cyclin-dependent protein kinase inhibitor from Arabidopsis thaliana 
interacts with both Cdc2a and CycD3, and its expression is induced by 
abscisic acid. Plant J. 15: 501-510 
Wang H, Zhou Y, Gilmer S, Whitwill S, Fowke LC (2000) Expression of the 
plant cyclin-dependent kinase inhibitor ICK1 affects cell division, plant 
growth and morphology. Plant J. 24: 613-623 
Weinl C, Marquardt S, Kuijt SJH, Nowack MK, Jakoby MJ, Hülskamp M, 
Schnittger A (2005) Novel functions of plant cyclin-dependent kinase 
inhibitors, ICK1/KRP1, can act non-cell-autonomously and inhibit entry 
into mitosis. Plant Cell 17: 1704-1722 
162 
Mutational analysis of KRP2 
Welcker M, Lukas J, Strauss M, Bartek J (1998) p21WAF1/CIP1 mutants deficient 
in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of 
active cyclinD/CDK4 complexes in human tumor cells. Cancer Res. 59: 
5053-5056 
Wohlschlegel JA, Dwyer BT, Takeda DY, Dutta A (2001) Mutational analysis of 
the Cy motif from p21 reveals sequence degeneracy and specificity for 
different cyclin-dependent kinases. Mol Cell Biol. 21: 4868-4874 
Zhou Y, Li G, Brandizzi F, Fowke LC, Wang H (2003a) The plant 
cyclin-dependent kinase inhibitor ICK1 has distinct functional domains for 
in vivo kinase inhibition, protein instability and nuclear localization. Plant J 
35: 476-489 
Zhou Y, Wang H, Gilmer S, Whitwill S, Fowke LC (2003b) Effects of 
co-expressing the plant CDK inhibitor ICK1 and D-type cyclin genes on 
plant growth, cell size and ploidy in Arabidopsis thaliana. Planta 216: 
604-613 
Zhou Y, Fowke LC, Wang H (2002) Plant CDK inhibitors: studies of interactions 
with cell cycle regulators in the yeast two-hybrid system and functional 
comparisons in transgenic Arabidopsis plants. Plant Cell Rep. 20: 967-
975 
 
 
 
 
 
 
 
 
 
 
 
163 
Chapter 5 
 
164 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter page: Fluorescence microscopy image of nuclear, DAPI stained 
Arabidopsis cell suspension cultures. 
 
 
 
 
Table of contents  
  
 
Chapter 6: Molecular analysis of an Arabidopsis cyclin-dependent kinase 
inhibitor interacting KBR1 RING finger protein   
 Abstract  169 
 Introduction  170 
 Results  172 
 Isolation of the KBR1 gene from Arabidopsis   172 
 KBR1 interacts with KRPs and CDKA;1 173 
 KBR1 processes in vitro ubiquitin-ligase activity 174 
 Overexpression of KBR1 in Arabidopsis 176 
 KRP protein levels in transgenic lines 178 
 Identification of KBR1 interactors  179 
 Discussion 180 
 KBR1 possesses E3 ligase activity  181 
 KBR1 E3 activity regulates KRP abundance  182 
 KBR1 function links stress – cell cycle regulation?   184 
 Methods 186 
 Yeast two-hybrid system 186 
 Generation of wild type and mutant KBR1 proteins 187 
 In vitro ubiquitination experiments 187 
 Regeneration and molecular analysis of transgenic lines and growth 
  conditions 188  
 References 188 
 
 
  
  
KRP degradation by KBR1 
Molecular analysis of an Arabidopsis cyclin-
dependent kinase inhibitor interacting KBR1 RING 
finger protein  
  
 
Aurine Verkest, Kristiina Himanen, Mirande Naudts, Dirk Inzé, Lieven De Veylder 
 
Abstract  
   
 
The ubiquitin-proteasome pathway drives the cell division cycle by the timely 
destruction of numerous regulatory proteins. The two main activities that catalyze 
substrate ubiquitination in the cell cycle, the SCF complexes and the APC/C, 
define a superfamily of E3 ubiquitin-ligases, all based on related cullin and RING 
finger protein subunits. Furthermore, some RING finger proteins can act as single 
subunit E3s. The Arabidopsis genome contains more than 400 RING finger 
proteins and several studies have implicated single and multisubunit RING finger 
E3s in a number of processes in plants. However, at present, control of the plant 
cell cycle by ubiquitin-dependent proteolysis is poorly understood. A two-hybrid 
screen using the Arabidopsis thaliana CDK inhibitor KRP5 as a bait led to the 
identification of a 33.5 kDa protein containing a RING finger motif, named KBR1. 
KBR1 displays in vitro E3 ubiquitin ligase activity and is shown to interact with all 
different KRPs tested. In addition, KBR1 was found to associate with CDKA;1. 
Although overexpression of the wild-type KBR1 gene in Arabidopsis appears to 
be lethal, the analysis of transgenic plants overexpressing dominant negative 
KBR1 alleles suggests a function for KBR1 in the regulation of cell cycle and plant 
growth during stress. Moreover, a screening for putative KBR1 substrates led to 
the isolation of several stress regulated interactors. Finally, the protein level of the 
CDK inhibitor KRP2 was elevated in transgenic Arabidopsis plants with reduced 
KBR1 activity, illustrating that KBR1 is part of an E3 complex regulating the KRP 
proteolysis. 
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Selective protein degradation by the ubiquitin-proteasome pathway has emerged 
as a powerful regulatory mechanism in a wide variety of cellular processes 
including cell cycle progression, morphogenesis and signal transduction. Ubiquitin 
conjugation requires the sequential activity of three enzymes or protein 
complexes called the ubiquitin-activating enzyme (E1), the ubiquitin-conjugating 
enzyme (E2) and the ubiquitin-protein ligase (E3) (Hershko & Ciechanover, 
1998). Once a polyubiquitin chain is assembled on a substrate, the substrate is 
quickly captured and degraded by the 26S proteasome (Smalle & Vierstra 2004). 
The cardinal regulatory step of substrate recognition is performed by the E3 
ligases (Jackson et al., 2000). Recent findings reveal that all known E3s utilize 
one of two possible catalytic domains, a HECT domain or a RING finger domain. 
The zinc binding RING finger domain, constituting the largest class of E3s, are 
formed by either a single polypeptide containing both RING finger and substrate 
binding domains, or by a multi-component complex with separate polypeptides 
containing these domains (Ciechanover et al., 2000). Several types of 
multisubunit E3s are known in which a small RING finger protein is an essential 
component. All single-subunit RING E3s examined so far bind either directly or as 
a homodimer or heterocomplex with their E2 and their substrate, catalyzing 
substrate ubiquitination and sometimes their own (E2-dependent) ubiquitination. 
The proportion of the genome that is devoted to ubiquitination is larger in plants 
than in animals or fungi (Moon, 2004). Cross-species comparisons show a good 
conservation of genes encoding ubiquitin, E1 and E2. In contrast, plant proteins 
with a suspected E3 function are more diverged, and homologues can be 
identified only in a minority of cases. A database search indicates more than 400 
RING finger domains in the Arabidopsis genome (Kosarev et al., 2002, Vierstra 
2003, Stone et al., 2005). Although it is currently unclear whether all RING finger 
domains mediate interaction with an E2, it is possible that each RING finger 
protein is part of a distinct E3. Studies have implicated single and multisubunit 
RING finger E3s in a number of processes in plants. However, only for few RING 
proteins functional interactions with their substrates have been characterized 
(Matsuda et al., 2001, Hardtke et al., 2002, Holm et al., 2002, Xie et al., 2002, 
Stary et al., 2003).  
During cell division the unidirectional cell cycle progression is in part controlled by 
the ubiquitin-mediated proteolysis of several cell cycle regulatory proteins. In 
mammalia, two main types of multisubunit E3s are involved in cell cycle 
regulation. Skp1-Cdc53/cullin-Fbox protein (SCF) complexes are responsible for 
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transition from G1 to S phase by catalyzing the phosphorylation-dependent 
ubiquitination of G1 cyclins, CDK inhibitors, transcription factors and many other 
proteins (Patton et al., 1998). The anaphase-promoting complex/cyclosome 
(APC/C) is active from the beginning of anaphase untill the end of G1, a window 
during which it eliminates anaphase inhibitors, mitotic cyclins and components of 
the mitotic spindle (Zachariae et al., 1999). Both SCF and APC/C multisubunit 
RING enzymes are conserved in plants, but the identity of their substrates and 
their importance in cell cycle regulation is largely unknown (Capron et al., 2003a; 
Viestra et al., 2003). Several plant cell cycle proteins were shown to be regulated 
by proteasomal degradation (Criqui et al., 2000 and 2001; Castellano et al., 2001 
and 2004; del Pozo et al., 2002; Planchais et al., 2004; Verkest et al., 2005). The 
mechanisms that regulate the ubiquitination of these proteins constitute essential 
components of cell cycle control, but are poorly understood at present.  
CDK inhibitory proteins are important cell cycle regulators and have been proven to 
be regulated by ubiquitin-dependent degradation in several organisms (Henchoz et 
al., 1997; Feldman et al., 1997; Carrano et al., 1999; Bornstein et al., 2003; Kamura 
et al., 2003; Kamura et al., 2004). Proteins related to the class of mammalian 
Kip/Cip CDK inhibitors have been identified in plants and designated Kip-related 
proteins (KRPs) in Arabidopsis (De Veylder et al., 2001; Vandepoele et al., 2002). 
The Arabidopsis genome encodes seven KRP genes. Despite the limited sequence 
homology with their mammalian counterparts, KRPs have been shown to be true 
functional homologs of the Kip/Cip proteins in inhibiting CDK activity both in vitro 
and in vivo (Wang et al., 1997; Wang et al., 2000; De Veylder et al., 2001; Zhou et 
al., 2002). Currently, little is known about the regulation of the KRPs at the 
posttranslational level but preliminary evidence shows that at least some of them 
are regulated through proteolysis. Functional analysis of KRP1 deletion mutants 
indicated the presence of a regulatory motif for protein instability in its N-terminal 
domain (Zhou et al., 2003; Weinl et al., 2005). Recently, we have shown that KRP2 
protein stability is regulated by the proteasome, as KRP2 protein levels become 
stabilized in cells treated with the proteasome inhibitor MG132 (Verkest et al., 
2005). Moreover, in vitro analysis illustrated that KRP2 is a CDK/cyclin substrate 
and that its phosphorylation is at least in part responsible for KRP2 proteolysis. 
However, it is currently not known which ubiquitin-ligase is responsible for KRP 
degradation.  
Here, we report the isolation and partial characterization of a RING finger protein, 
designated Arath;KBR1, that interacts with KRPs and CDKA;1 and has in vitro E3 
ligase activity. The results presented indicate that the KBR1 ubiquitin-ligase possibly 
targets a broad range of substrates involved in the regulation of cell cycle and plant 
growth during stress.  
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Isolation of the KBR1 gene from Arabidopsis  
 
To identify putative KRP5 interacting proteins, a two-hybrid screen was performed 
based on GAL4 recognition sites to regulate the expression of both his3 and lacZ 
reporter genes (Chien et al., 1991; Fields and Sternglanz, 1994). The 
pGBT.KRP5 vector, encoding a fusion between the C-terminus of the GAL4 DNA-
binding domain and KRP5 was constructed by cloning the full-length coding 
region of KRP5 into the pGBT9 vector. The screening was performed with a 
GAL4 activation domain cDNA fusion library constructed from mRNA of 
Arabidopsis thaliana cell suspension cultures harvested at different growth 
stages, including the early exponential, exponential, early stationary and 
stationary phases. The HF7c yeast reporter strain was co-transformed with the 
pGBT.KRP5 vector and the library, and 106 independent transformants were 
screened for growth on histidine free medium and lacZ gene activation. 
 
At4g19700 
MAVQAHHMNIFSQFISPNRDCVKFQENMNHGEFEFTGGEVPLITGESFAVEPLAAKANFN
KAESGLSYNFTVPPLSTKRQRDFQFSDSNAPVKRRSVAFDSSSPSLINVELVSQIQNQQQ
SEIDRFVAQQTEKLRIEIEARQQTQTRMLASAVQNVIAKKLKEKDDEIVRIRNLNWVLQERV
KSLYVENQIWRDIAQTNEANANTLRTNLDQVLAQLETFPTASAVVEDDAESSCGSCCGDG
GGEAVTAVGGGCKRCGEREASVLVLPCRHLCLCTVCGGSALLRTCPVCDMVMNASVHV
NMSS 
 
Figure 1. Sequence of KBR1. The RING-HCa motif with its Cys and His Zinc-binding 
reisdues is indicated in black and red. 
 
One of the interacting clones (At4g19700) encoded a putative 33.5kDa protein 
with a C-terminal located Zinc-finger motif and was named KRP Binding RING 
finger protein 1 (Arath;KBR1). The RING domain is similar to the DNA binding 
zinc fingers with Cys and/or His residues coordinating the attachment of two zinc 
ions, but is rather involved in protein-protein interactions because the zinc ions 
are coordinated in a cross-brace structure (Barlow et al., 1994). The Cys-rich 
RING domain was initially identified in a protein encoded by the Really Interesting 
New Gene (Freemont et al., 1991). RING protein genes encode candidate 
ubiquitin E3 ligases functioning in E2-dependent protein degradation. The RING 
domains that are essential for E3 ligase activity of RING containing proteins have 
either a Cys or His residue at metal ligand position 5 as C3HC4 for RING–HC 
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type and C3H2C3 for RING–H2 type domains. Sequence analysis of KBR1 
detected a RING-HC motif belonging to the HCa-class (Figure 1; Stone et al., 
2005). 
 
 
KBR1 interacts with KRPs and CDKA;1 
 
To assess whether the binding of KBR1 with KRP5 is specific or accounts for all 
KRPs, additional yeast two-hybrid interaction assays were performed. The full-
length cDNA of the KBR1 gene was isolated and cloned into an appropriate yeast 
two-hybrid vector, resulting in a transcriptional fusion between KBR1 and the 
GAL4 transcriptional activation domain (pGAD.KBR1). In a yeast reporter strain, 
the pGAD.KBR1 plasmid was co-transformed with vectors encoding a fusion 
between different KRPs, CDKA;1 and CDKB1;1 cDNAs and the GAL4 DNA-
binding domain (pGBT). As a control empty pGBT and pGAD vectors were used. 
Transformed strains were plated on medium without His, which allows growth of 
yeast only when the two proteins interact. Although pGBT.KRP2 showed 
transactivation, all other KRP transformed yeasts only grew on His-lacking 
medium in the presence of KBR1, demonstrating that KBR1 interacts with all 
Arabidopsis KRPs tested (Table 1). Furthermore, KBR1 was found to interact as 
well with CDKA;1, but not with the G2/M-specific CDKB1;1, implying a specific 
role of KBR1 in cell cycle.  
 
Table 1. Two-hybrid interaction of KBR1 with different KRPs and CDKs 
 
 KRP2 KRP3 KRP4 KRP5 KRP6 KRP7 CDKA;1 CDKB1;1 
         
KBR1 TA + + + + + + - 
         
+ growth on medium -His; - no growth on medium –His; TA transactivation 
 
 
To confirm the observed interaction of KBR1 with KRPs and CDKA;1 in vitro pull 
down assays were performed. Although several attempts were undertaken, we 
were unsuccessful in confirming the yeast two-hybrid interaction in vitro (data not 
shown). E3 ligase substrate recognition is often dependent on phosphorylation 
modifications and E3 activity on homo- or heterodimerization of RING proteins. 
Possibly the lack of necessary posttranslational modifications and/or additional 
cofactors prevented the in vitro functional interaction observed in living yeast 
cells. In agreement with this, kinase assays performed with p10CKS1At affinity-
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purified CDK/cyclin complexes isolated from actively dividing cell suspensions 
demonstrated that KBR1 is phosphorylated by CDKs, suggesting interaction of 
KBR1 with CDKA;1 (Figure 2).  
 
 
Figure 2. In vitro phosphorylation of KBR1 by CDKs.  
A. Purified recombinant MBP and MBP.KBR1.  
B. y32P incorporation in MBP.KBR1 by active CDK complexes. 
 
 
KBR1 processes in vitro ubiquitin-ligase activity 
 
To investigate whether KBR1 has E3 ligase activity, in vitro ubiquitylation 
experiments were performed. These assays typically rely on the function of RING 
protein E3s to bring their substrate in close vicinity with the E2 ubiquitin-
conjugate. E3 activity can be reconstituted in vitro by providing to the putative E3 
enzyme ubiquitin, an ubiquitin-activating E1, a conjugating E2 enzyme, ATP, and 
the target protein. A successful reaction results in an increased molecular weight 
of the target protein, caused by poly-ubiquitylation. In the absence of a trans-
target, various E3s have been shown to self-ubiquitylate (Bays et al., 2001; Fang 
et al., 2000; Lorick et al., 1999; Nuber et al., 1998). In our particular experiment, 
wheat germ lysate was used as a source of E1 and E2, because it possesses a 
high ubiquitin-dependent proteolysis activity (Hatfield and Vierstra, 1989). 
Recombinant MBP-KBR1, being a fusion between the maltose-binding protein 
and KBR1, was incubated at 30°C with ATP, ubiquitin and the wheat germ lysate 
in the presence of the proteasome inhibitor carbobenzoxyl-leucinyl-leucinyl-leucinal 
(MG132), which was used to block proteolysis, allowing the detection of poly-
ubiquitylated protein. Immunoblotting using an anti-MBP antibody of fractions 
collected at the indicated times showed that prolonged incubation of MBP-KBR1 
led to the formation of slower-migrating ladders (Figure 3A), illustrating KBR1 E3 
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ligase activity. MBP alone or the omission of wheat germ lysate did not result in 
high molecular mass modifications.  
We next tried to reconstitute self-ubiquitination of MBP-KBR1 by purified 
components only using ubiquitin, MBP-KBR1 and HsUbcH5a (E2) and 
mammalian E1 in an in vitro assay mixture as described by Seo et al. (2003). 
Incubation of MBP-KBR1 did not result in high molecular mass ladders (data not 
shown). The reason for the inability of KBR1 to auto-ubiquitinate in the absence 
of applied plant extract is not known but suggests the necessity of 
cofactors/additional activating proteins.   
 
It has been shown that the RING finger motif is required for the ubiquitin-ligase 
activity of almost all RING protein containing E3 enzymes. To test whether this 
also holds true for KBR1 we analyzed the in vitro ubiquitylation of deletion and 
point mutants of MBP-KBR1. Abrogation of the intact RING domain by mutation, 
deletion or addition of Zinc chelators often impairs E2-dependent ubiquitylation. 
Figure 3B shows the RING-HC type domain of KBR1 and the KBR1 deletion and 
point mutants generated for subsequent characterizations. In the KBR1.M2 
mutant the complete C-terminal located RING-HC domain was deleted. Two 
different point mutation alleles were constructed, because KBR1 possesses two 
possible RING domain configurations. In KBR1.M1, the Cys2 residue of motif 1 
was mutated into a Ser residue, whereas in KBR1.M3 the mutation of Cys7 
should abrogate both possible RING motifs. Deletion of the RING motif of KBR1 
diminished the appearance of a smear when MBP-KBR1.M2 was incubated with 
ubiquitin, ATP, wheat germ lysate and MG132 (Figure 3C), indicating that the 
RING motif is necessary for E3 activity. Curiously, incubation of the point mutants 
MBP-KBR1.M1 and MBP-KBR1.M3 still resulted in the generation of high 
molecular mass ladders (Figure 3C).  
 
Figure 3. E3 ubiquitin-ligase activity of wild-type and mutant KBR1.  
A. MBP.KBR1 was assayed for E3 activity in the presence or absence of wheat germ 
lysate (WGL). MBP was used as negative control.  
B. Schematic overview of the generated wild-type and mutant KBR1 proteins.  
C. Assay of self-ubiquitination of MBP.KBR1.FL and mutants. 
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Overexpression of KBR1 in Arabidopsis 
 
To investigate the role of KBR1 in plant development, transgenic plants were 
generated harboring the wild-type and mutant KBR1 alleles under the control of 
the constitutive cauliflower mosaic virus 35S promoter. No transgenic lines were 
obtained for KBR1 and KBR1.M1, suggesting that KBR1 overexpression is lethal 
and that the KBR1.M1 is still functional. In contrast, multiple independent 
transgenic lines were obtained for the KBR1.M2 and KBR1.M3 constructs. Two 
independent lines overexpressing KBR1.M2 and KBR1.M3 were selected in 
which the mRNA levels exceeded those found in untransformed plants (Figure 
4D). KBR1.M2OE plants were smaller when compared to wild-type plants (Figure 
4A). By contrast, KBR1.M3 overexpressing plants did not reveal any obvious 
phenotypical changes (Figure 4A). Mutant seedlings and soil grown plants looked 
similar in size to untransformed control plants. Stems, cauline and rosette leaves, 
flowers, siliques appeared simultaneously in wild-type and KBR1.M3OE plants and 
their morphology was comparable. However, when grown in continuous light 
conditions these transgenic plants displayed altered phenotypes. When initially, in 
Petri dishes and normal light conditions, grown wild-type looking KBR1.M3 
seedlings were transferred to soil in pots and grown in continuous light the 
transgenic plants showed reduced growth phenotypes (Figure 6B). Furthermore, 
when KBR1.M3 seedlings were grown in continuous light young plants showed a 
senescence phenotype and displayed at a later stage a high lethality in 
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comparison with wild-type plants (Figure 6C). These data suggest that functional 
KBR1 is required for normal plant growth and has a role in light stress control.  
 
 
 
 
 
Figure 4. Phenotypic and molecular analysis of KBR1 overexpressing Arabidopsis plants.  
A. Phenotypes of 3-week-old wild-type (Col-0) plants and two independent KBR1.M2 and 
KBR1.M3 overexpressing plants.  
B. Reduced growth phenotypes of KBR1.M3 overexpressing plants when transferred to 
continuous light.  
C. Phenotypes of 7-day-old KBR1.M3 overexpressing seedlings grown in continuous light.  
D. RNA gel blot analysis of wild-type and KBR1.M overexpressing plants. Equal loading of the 
gel was confirmed by methylene blue staining of the membrane (bottom panel). 
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KRP protein levels in transgenic lines 
 
The measured lack or weakened in vitro E3 activity of KBR1.M2 and KBR1.M3 
combined with the phenotypes observed for plants overexpressing these KBR1 
mutants suggests that these mutant alleles might operate as dominant negatives. 
E3 ubiquitin-ligase proteins mediate substrate recognition and bring them in 
contact with E2 ubiquitin-conjugating enzymes. The RING domain is directly 
binding the E2 enzymes while the substrate recognition sites usually lie outside 
the RING domain. As such, abrogation of the intact RING domain impairs or 
reduces E3 activity. These dominant negative E3 ligases are still able to interact 
with their substrates but their degradation is reduced due to the titration effect 
caused by the binding with ectopically expressed dominant negative E3 ligases 
(Seo et al., 2003). In this case the phenotypes are expected to be milder than 
those of knockout of the E3 ligase. The observed KBR1 phenotypes are in 
accordance with this hypothesis since there are no KBR1 knockout lines  
available, suggesting gametophytic lethality, while KBR1.M2 and KBR1.M3 
overexpressing plants show lethality at a later stage in development. As such, 
KBR1 proteolytic substrates are expected to accumulate in KBR1.M2 and 
KBR1.M3 overexpressing plants. 
To investigate whether KRPs are KBR1 substrates we compared the KRP2 
protein levels in wild-type, KBR1.M2OE, and KBR1.M3OE plants. Protein blot 
analysis using a specific antibody against KRP2 (Verkest et al., 2005) showed 
accumulation of KRP2 in the transgenic lines when compared to wild-type plants 
(Figure 5). This suggests that KBR1 functions in the degradation of KRPs. 
 
 
 
Figure 5. Immunoblot analysis on protein extracts from three-week old wild-type (Col-0) and 
transgenic plants using an anti-KRP2 antibody. Rubisco protein levels visualized by Ponceau 
S staining act as loading control. 
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Identification of KBR1 interactors 
 
The suggested lethality of wild-type KBR1 overexpression in plants indicates an 
important role for this particular E3 ligase in Arabidopsis. Possibly KBR1 targets 
multiple substrates for degradation and/or functions in complex with several 
different ubiquitination involved proteins. In order to identify regulation partners 
and putative additional substrates of KBR1 a second two-hybrid screen was 
performed, using the KBR1 itself as a bait. The pGBT.KBR1 vector was co-
transformed with the library in the yeast HF7c reporter strain. A total of 107 
independent cotransformants were screened for their ability to grow on histidine 
free medium. A 4-day incubation at 30°C yielded 129 colonies that were tested 
for LacZ gene activation and used for plasmid DNA preparation for sequencing. 
Many different candidate interactors were isolated (Supplementary table). 
Confirmation of these interaction partners of KBR1 awaits retransformation 
experiments.  
Among the different KBR1 interacting proteins 26S proteasome subunits and an 
ubiquitin-activating domain containing protein were found, corresponding with the 
proposed function for KBR1 in ubiquitin-mediated protein degradation. In addition, 
KBR1 showed interaction with several other RING finger motif containing proteins 
(RFMs). Moreover, KBR1 was found to homodimerize. These data suggest that 
KBR1 may form homo- and/or heterocomplexes for activation and/or recognition 
of a broad range of substrates. To investigate the mechanism of KBR1 
dimerization in more detail, we analyzed the yeast two-hybrid interaction of KBR1 
with its mutated forms. Also we tested the necessity of the intact RING domain for 
KRP and CDKA;1 interaction. All KBR1 alleles were found to interact with full 
length KBR1, the KRPs, and CDKA;1 (Table 2), indicating that the RING motif is 
dispensable for KBR1 oligomerization and binding to target proteins. 
 
Table 2. Two-hybrid interaction of KBR1 mutants with KBR1, KRP5 and CDKs 
 
 KBR1.FL KBR1.M2 KBR1.M3 KRP5 CDKA;1 CDKB1;1 
       
KBR1.FL + + + + + - 
KBR1.M2 + + + + + - 
KBR1.M3 + + + + + - 
       
+ growth on medium –His (10 mM 3-AT); - no growth on medium –His (10 mM 3-AT) 
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Furthermore, several transcription factors (TF) were found to interact with KBR1 
in the yeast two-hybrid screen. These were often isolated more than once, 
indicating that they may represent biological significant interaction partners and 
as such putative substrates of KBR1 (Table  
3). All transcription factors were found to be induced by stress conditions 
according to the Digital Northerns provided by Genevestigator (Zimmermann et 
al., 2004), further implying a role for KBR1 in stress. 
 
Table 3. Digital Northern (Genevestigator) of KBR1 interactors 
 
KBR1 interacting Transcription Factors 
(TF) 
 
Conditions inducing TF expression 
according to Genevestigator 
MYB92 (At5g10280) Every stress( root specific + cells) 
Zn Finger (At1g34370) Every stress (root specific) 
TCP20 (HLH TF) (At3g27010) Dormancy (potato buds), CHX 
Nuclear protein (At3g09980) Heat stress (SAM, flower) 
TCP (At3g47620) Every stress (shoot specific), light signaling 
C2H2 Zn Finger (At2g02080) 
 
Dormancy, senescence, seeds, UV light 
CHX cycloheximide; SAM shoot apical meristem  
 
 
Discussion 
   
 
Ubiquitination plays a central role in regulating protein turnover and modification 
of proteins by the attachment of the polypeptide ubiquitin. The diversity and 
number of proteins regulated by ubiquitination predicts the existence of a high 
diversity of E3 ligases. Indeed, more than 5% of predicted Arabidopsis genes are 
proposed to encode ubiquitination and 26S proteasome activities related proteins, 
and numerous genes encoding RING Finger motif proteins (RFMs) have been 
isolated or predicted in higher plants (Kosarev et al., 2002, Vierstra 2003, Stone 
et al., 2005). RING domains are Zn2+-binding structures that were first recognized 
for their ability to mediate protein-protein interactions (Saurin et al., 1996). More 
recently, they have been shown to be integral parts of a second major class, in 
addition to HECT-domain proteins, of ubiquitin-ligases in which the RING is 
essential for function (Borden, 2000; Freemont, 2000; Lorick et al., 1999). Several 
Arabidopsis RFMs are proven to mediate ubiquitination (Stone et al., 2005), but 
only for few of these biological functions and/or substrates are identified.  
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KBR1 possesses E3 ligase activity 
 
Although future investigations are required to unravel the complex composition 
and activity mechanism of the KBR1 E3 ligase, our data suggest that KBR1 
meets the criteria of a genuine E3 enzyme. Crude in vitro ubiquitylation assays 
indicated that the 304 amino-acid and RING-HC motif containing Arabidopsis 
protein KBR1 indeed harbors ubiquitin-ligase activity. However, the inability to 
reconstitute self-ubiquitylation of MBP-KBR1 with purified recombinant E1 and E2 
enzymes indicates that an additional unknown factor, present in the wheat germ 
lysate, is necessary for its E3 function. KBR1 is a small protein and sequence 
analysis revealed no known protein-protein interaction domains, suggesting that 
KBR1 functions in complex with other proteins. Besides as single-polypeptide 
RING E3s, RING proteins exist as part of several types of multisubunit E3s and in 
complex with other RING proteins (Jackson et al., 2000). Although the performed 
yeast two-hybrid screen with KBR1 may not have revealed all interactions, no 
known subunits of multicomponent E3s were isolated, whereas many different 
associating RFMs were identified. Di- or polymerization of RING proteins often 
occurs as a general regulatory mechanism of RING E3 ligases. For example, the 
heterodimer mammalian BRCA1-BARD1 RING finger complex, involved in 
ubiquitination of RNA polymerase II, contains significant E3 activity, whereas 
individually BRCA1 and BARD1 display almost no ubiquitin-ligase activity in vitro 
(Hashizume et al., 2001; Starita et al., 2005). Similarly, KBR1 might require 
polymerization with other RFMs to be active. Alternatively, the KBR1 might need 
prior activation by posttranslational modifications. KBR1 was found to associate 
with CDKA;1 and was efficiently phopshorylated by CDKs. There are several 
examples where CDK phosphorylation plays regulatory roles in RFM E3 function 
(Elias et al., 2005; Hayami et al., 2005).  
It is believed that part of the RFM function is simply to bind and activate E2s. In 
vitro enzymatic systems showed that single-subunit or heterodimeric RING 
proteins are sufficient and necessary to catalyze formation of multi-ubiquitin 
chains (Lorick et al., 1999). The multicomponent SCF and APC/C RING E3s also 
require the RING components of ROC1/Rbx1 and APC11 for ubiquitin-ligase 
activity. E2 binding of RFMs was shown to occur through their RING motif. As 
such, deletion or mutation of this motif results in loss of catalytic activity of most 
RFMs. A complete deletion of the RING motif of KBR1 indeed resulted in loss of 
E3 activity, suggesting that this motif is possibly involved in E2 binding. However, 
mutation of Zinc-chelating Cys residues had no effect on KBR1 in vitro ubiquitin-
ligase activity. In the case of KBR1.M1 this can be explained by the fact that this 
mutation does not necessarily abrogate the RING domain, since KBR1 has two 
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possible RING motifs. Overexpression of this mutant allele of KBR1 did not result 
in any transgenics, just as observed for the wild-type KBR1 gene, indicating that 
KBR1.M1 encodes still an active protein and that the overexpression of active 
KBR1 interferes with the regeneration of transgenic lines. The observed in vitro 
activity of KBR1.M3 is more puzzling, as in this mutant allele both possible RING 
finger configurations should be abrogated. The viability of KBR1.M3OE plants, 
however, indicates that KBR1.M3 is less active than wild-type KBR1. Indeed, 
mutations of Cys residues in RING domains do not always result in a total 
inactivation of E3 activity. E.g. one mutation of ROC1/Rbx1 destroyed ubiquitin-
ligase activity, whereas another one only reduced it (Ohta et al., 1999). Evaluation 
of other KBR1 mutants could indicate a similar mechanism. Moreover, 
oligomerization of KBR1 could be required for the surface scaffold necessary for 
E2 binding. Although our data indicates that KBR1 dimerization occurs 
independent from the RING motif, other RFMs were reported to hetero-
oligomerize through their RING motif (Wu et al., 1996; Stad et al., 2000). Perhaps 
heterodimerization of KBR1 with another RFM through its RING motif is not 
completely impaired by the KBR1.M3 mutation. In such a scenario, the residual 
E3 activity observed when evaluating KBR1.M3 results from intermolecular trans-
ubiquitylation of KBR1 by E2-interaction of its complexing RFM.  
 
 
KBR1 E3 activity regulates KRP abundance 
 
In both fungi and animal cells, single- and multi-subunit RING E3s were shown to 
play critical roles during the cell cycle by promoting degradation of regulatory 
proteins (Tyers and Jorgensen, 2000; Vodermaier, 2004). In plants, the control of 
the cell cycle by RING E3 enzymes has not yet been established, but 
accumulating data points to their importance in this process. Down-regulation of 
Arath;Rbx1, the RFM component of the SCF complex, resulted in the 
accumulation of CYCD3;1 protein in Arabidopsis (Lechner et al., 2002).  
Consistent with a role for SCF E3s in cell cycle control Arabidopsis cullin Cul1 
loss-of-function mutants arrest in early embryogenesis at the zygote stage (Shen 
et al., 2002). Similarly, APC/C subunits apc2 and apc6/nomega Arabidopsis 
knock-out lines are impaired in female gametophyte development, after meiosis 
(Capron et al., 2003b; Kwee et al., 2003). Interestingly, these arrested mutant 
gametophytes failed to degrade mitotic cyclin reporter proteins. Another example 
of cell cycle control was found in alfalfa where the APC/C activator CCS52 was 
shown to control the switch from the mitotic cycle to endoreduplication, an 
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alternative cell cycle during which DNA replication is not followed by mitosis and 
cytokinesis (Cebolla et al., 1999).  
Because of their importance in cell cycle regulation and exit, CDK inhibitory 
proteins are strictly regulated. Yeast and mammalian inhibitors are mainly 
regulated through mechanisms that affect their abundance rather than their intrinsic 
activity. In mammalia the concentration of the CDK inhibitor p27Kip1 is thought to 
be regulated predominantly by ubiquitin-dependent degradation. The best studied 
degradation pathway acts in the nucleus and requires p27Kip1 phosphorylation at 
Thr187 by cyclinE/CDK2 complexes and subsequent recognition and degradation 
at the S-G2 phase by Skp2 (S-phase kinase associated protein2), a member of 
the F-box family of proteins that associates with Skp1, Cul1 and the RING finger 
protein ROC1/Rbx1 to form an SCF E3 complex (Montagnoli et al., 1999; Carrano 
et al., 1999; Tsvetkov et al., 1999). Moreover CKS1, which belongs to the highly 
conserved Suc1/Cks1 family of proteins that bind to some CDKs and 
phosphorylated proteins and are essential for cell cycle progression, is required 
for and enhances SCFSkp2 mediated ubiquitination of p27 (Ganoth et al., 2001; 
Spruck et al., 2001). More recently, the existence of a second ubiquitin-
proteasome dependent pathway of p27Kip1 degradation was identified (Malek et 
al., 2001; Hara et al., 2001). This Skp2- and Thr187 independent mechanism 
operates in the cytoplasm and degrades p27Kip1 at the G0-G1 transition (Hara et 
al., 2001). Purification of the SCFSKP2-independent E3 activity identified a RING 
protein containing E3 enzyme, designated KPC (Kip1 ubiquitylation-promoting 
complex) responsible for CDK phosphorylation independent ubiquitylation of p27Kip1 
(Kamura et al., 2004).  
In plants little is known about the posttranslational regulation of CDK inhibitors. 
Previously, we demonstrated that the Arabidopsis CDK inhibitor KRP2 is an 
unstable protein and that its degradation depends on the presence of an active 
proteasome (chapter 3; Verkest et al., 2005). In vitro analysis illustrated that several 
KRPs are CDK substrates and KRP2 phosphorylation by CDKs was shown to be at 
least in part responsible for Arath;KRP2 proteolysis. Moreover, Arath;CKS1 seems 
to negatively regulate KRP2 function and protein stability (chapter 4). These data 
suggest the possibility that the Arabidopsis KRPs are degraded by a plant SCFSkp2-
like ubiquitin-ligase. Two F-box proteins, similar to the metazoan Skp2, have been 
identified in Arabidopsis. The plant SCFSkp2 functions in regulating the cell cycle by 
controlling the abundance of the E2Fc transcription factor (del Pozo et al., 2002). 
However, the demonstration that any KRP protein is degraded by this ubiquitin-
ligase is still missing. The isolation and identification of the KRP interacting and 
ubiquitin-ligase activity containing RFM KBR1 indicated that it might control SKP-
independent ubiquitin-dependent degradation of the Arabidopsis CDK inhibitors. 
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Although we were unable to prove in vitro binding and ubiquitylation of KRPs by 
KBR1 (data not shown), overexpression of dominant negative forms of the KBR1 
allele resulted in the accumulation of KRP2 protein levels in Arabidopsis. Further 
investigations are however required to verify that this increase in KRP2 protein level 
is the direct consequence of its lowered ubiquitin-dependent proteolysis.  
 
 
KBR1 function links stress – cell cycle regulation? 
 
Because of their sessile lifestyle, plant survival largely depends on their ability to 
adjust to a plethora of environmental conditions. Response to the environment is 
mediated by a myriad of regulatory pathways which integrate both intra- and 
extracellular signals to the regulation of plant growth. Stress responses can be 
divided into early and late responses. Upon perception of stress, plant growth is 
arrested to allow acclimation to the new conditions. After the transient growth 
arrest follows a recovery phase and growth is resumed. During these responses, 
the plant cell cycle is regulated through the levels and activities of key cell cycle 
regulators (Logemann et al., 1995; Schuppler et al., 1998; Burssens et al., 2000; 
Granier et al., 2000; West et al., 2004). For the moment it is, however, not known 
which mechanisms link the perception of stress directly to the cell cycle. 
Hormones do play roles in regulating cell cycle gene expression, but negative 
regulators also need to be removed before positive responses can re-occur. In 
mammalia, recent studies identified RFMs as candidates in mediating external 
signals to the cell cycle (Casanovas et al., 2000; Chou, 2004). Arath;KBR1 may 
have a similar function. 
In plants, it is suggested that D-type cyclins operate as primary sensors of 
external conditions (De Veylder et al., 2003; Dewitte and Murray, 2003). In such a 
model, CDK/CycD complexes might be important complexes to be inhibited upon 
the perception of stress signals. Interestingly, KRPs were demonstrated to inhibit 
CycD/CDK complexes (Jasinski et al., 2002, Schnittger et al., 2003; Zhou et al., 
2003b; Cho et al., 2004; Coelho et al., 2005). The Arabidopsis KRPs moreover 
share the potential of the Kip/Cip inhibitors to respond to intrinsic and extracellular 
antimitogenic signals to arrest the cell cycle. KRP1 transcripts are induced by cold 
treatment, which correlates with a decrease in CDK activity (Wang et al., 1998). 
Furthermore, KRP1 expression was found to be induced by the phytohormone 
abscisic acid (ABA) (Wang et al., 1998), suggesting that this particular KRP might 
be in part responsible for the growth inhibitory effect triggered upon ABA treatment. 
By contrast, the mitogenic hormone auxin repressed KRP2 transcript levels, both in 
cell cultures and in planta (Richard et al., 2001; Himanen et al., 2002). This means 
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that the conditional phenotypes of reduced growth and early senescence observed 
in plants overexpressing dominant negative forms of KBR1 could result in part from 
the accumulation of KRPs. Although, misexpression of KRP1 in Arabidopsis 
trichomes induces cell death (Schnittger et al., 2003), and high overexpression of 
KRPs results in a yet to be analyzed senescence-like phenotype, no straightforward 
similarities are observed between KBR1.M and KRP overexpressing plants. 
However, in addition to KRPs, KBR1 may target other substrates. A yeast-two 
hybrid screen using KBR1 as bait identified a number of stress-induced 
transcription factors as KBR1 interacting proteins, suggesting that these TFs 
might represent potential substrates for ubiquitin-dependent proteolysis. Since 
stress and cell division are mutually exclusive, KBR1 might ensure cell cycle 
activity by mediating degradation of these stress-induced TFs. As such, the 
hypersensitivity of KBR1.M3OE plants to light stress might be due to the inability to 
resume cell division after stress adaptation as a consequence of the inability to 
degrade the TFs (Figure 6). Confirmation of this hypothesis, however, awaits 
extra experimentation. Also, the precise role of the stress-induced KBR1 
interacting proteins in cell cycle regulation remains to be determined. Their tissue 
specificity indicates that they may mediate growth arrest in the meristem upon a 
broad range of stresses with some organ specificity (Table 3). A role in cell cycle 
regulation for other Myb TFs was proven (Ito et al., 2001). TCP20 is a 
transcription factor regulating CYCB1;1 gene expression. Moreover, one of the 
KBR1 interactors, a nuclear protein with unknown function was independently 
identified as a yeast two-hybrid KRP interactor (Cropdesign), suggesting a 
possible interconnection between KRP and TF accumulation.  
In conclusion, these data support a function of KBR1 in stress responses and 
imply a role for KBR1 as a positive regulator of the cell cycle by mediating 
degradation of negative cell cycle regulators (Figure 6). Even though further 
stress assessments are required to refine the conditions where KBR1 could be 
active we suggest a role for KBR1 in signaling with the environment.  
  
stress CDK KBR1
KRP
TF
cell division? ?
 
Figure 6. Hypothetical model of the role of KBR1 as positive regulator of the cell cycle  
  through degradation of stress induced negative cell cycle regulators. For details, see text. 
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Yeast two-hybrid system 
 
Vectors and strains used were provided with the Matchmaker Two-Hybrid System 
(Clontech, Palo Alto, CA). Baits were constructed by inserting PCR fragments into 
the pGBT9 vector. The pGAD424 and pGBT9 vectors containing KRP2, KRP4, 
KRP5, KRP6, KRP7, CDKA;1 and CDKB1;1 were constructed as described 
previously (De Veylder et al., 2001). The KBR1 cDNA was isolated using RNA 
prepared from Arabidopsis thaliana seedlings (ecotype Columbia (Col-0)) and the 
Superscript RT II kit (Gibco BRL, Gaithersburg, MD) according to the 
manufacturer’s protocol. Primer sequences used can be given upon request. The 
KBR1 PCR fragment was cut with EcoRI and BamHI and cloned into the EcoRI 
and BamHI sites of pGBT9 and pGAD424.  
The GAL 4 activation domain cDNA fusion library was obtained from Clontech 
from mRNA of Arabidopsis thaliana cell suspensions harvested at various growth 
stages (De Veylder et al., 1999).  
For the screenings a 500mL culture of the Saccharomyces cerevisiae strain HF7c 
(MATa ura3-52 his3-200 ade2-101 lys2-801 trp1-901 leu2-3,112 gal4-542 gal80-
538 LYS2::GAL1UAS-GAL1TATA-HIS3 URA3::GAL417mers(3x)-CyC1TATA-LacZ) was 
cotransformed with 250 μg pGBTKRP5 or pGBTKBR1, 500 μg DNA of the library, 
and 20 µg salmon sperm carrier DNA using the lithium acetate method (Gietz et 
al., 1992). To estimate the number of independent cotransformants, 1/1000 of the 
transformation mix was plated on Leu− and Trp− medium. The rest of the 
transformation mix was plated on medium to select for histidine prototrophy (Trp−, 
Leu−, His−). After 4 days of growth at 30°C, the colonies larger than 2 mm were 
streaked on histidine-lacking medium supplemented with 10 mM 3-amino-1,2,4-
triazole (Sigma, St. Louis, MO).  
Of the His+ colonies the activation domain plasmids were isolated as described 
(Hoffman and Winston, 1987). The pGAD10 inserts were PCR amplified using the 
primers 5′-ATACCACTACAATGGATG-3′ and 5′-AGTTGAAGTGAACTTGCGGG-
3′. Plasmid DNA was electroporated into Escherichia coli XL1-Blue, and the DNA 
sequence of the inserts was determined.  
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Generation of wild-type and mutant KBR1 proteins 
 
The KBR1 coding region was PCR amplified with primers 5’- 
AAAAAGCAGGCTTCACAATGGCTGTTCAAGCTCAT -3’ and 5’- 
AGAAAGCTGGGTCAAGAAGACATGTTAACATGC -3’, and cloned into the 
GATEWAY pDONR207 vector (Invitrogen). Site-directed KBR1 mutants were 
generated by PCR of the KBR1 sequence in pDONR207 using the following pre-
phosphorylated primers: 5’- CGATATGGTCATGAACGCTAGTGTGC -3’ and 5’- 
GAAACCGGACAAGTCCGTAACAAAGC -3’ for KBR1.M3 and 5’- 
CGGTGAGAGAGAAGCGAGTGTGTGGG -3’ and 5’- 
GACCGTTTACAACCACCACCAACC -3’ for KBR1.M1. The linear PCR products 
were circularized by ligation and the resulting plasmids were sequenced to 
confirm if the correct residue substitution took place. The wild-type and point 
mutated KBR1 sequences were amplified with primers 5’- 
GGGAATTCATGGCTGTTCAAGCTCATCACATGAAC –3’ and 5’- 
GGGGATCCTCAAGAAGACATGTTAACATGCACACTAGC –3’ and the truncated 
KBR1.M2 with primers 5’- GGGAATTCATGGCTGTTCAAGCTCATCACATGAAC 
–3’ and 5’- 
AGAAAGCTGGGTCGGATCCTCAACTCGATTCCGCATCGTCTTCTACAACGG 
–3’. All PCR fragments were subsequently cloned in the EcoR1 and BamH1 sites 
of the pMal-2c vector (New England Biolabs). 
The pMALKBR1.FL, pMALKBR1.M1, pMALKBR1.M2 and pMALKBR1.M3 
plasmids were transformed in the Escherichia coli BL21-CodonPlusTM(DE3)-RIL 
strain (Novagen, Madison, WI) to produce the recombinant proteins and were 
purified by amylose affinity chromatography according to the manufacturer’s 
instructions (New England BioLabs). 
 
 
In vitro ubiquitination experiments 
 
Using the wheat germ lysate (Promega) as a source of E1 and E2, the 
ubiquitination assay of MBPKBR1 and its derivates was performed as followed. 150 
ng purified recombinant MBP, MBPKBR1, MRPKBR1.M1, MBPKBR1.M2 or 
MBPKBR1.M3 was brought to 150 µl containing 300 ng/µl ubiquitin (Sigma, St 
Louis, Missouri, USA), 100 µM MG132 (Affiniti Research, Exeter, UK) and 10 µl 
wheat germ lysate in a ubiquitination buffer (40 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 
2 mM ATP, 2 mM DTT). The reaction mixture was incubated at the 30°C and 50 µl 
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aliquots were taken at the appropriate times for analysis by immunoblotting with an 
anti-MBP antibody (New England BioLabs). 
For reconstitution of auto-ubiquitylation with E1 and E2, purified recombinant mouse 
E1 and HsUbcH5a were obtained from Biotrend. Ubiquitination assays were carried 
out in 30 µl reaction mixtures containing 20 ng each of E1 and UbcH5a, 500 ng 
MBP-KBR1.WT, and 10 µg ubiquitin in a 50 mM Tris pH 7.4, 2 mM ATP, 5 mM 
MgCl2 and 2 mM DTT buffer.    
 
 
Regeneration and molecular analysis of transgenic lines and growth 
conditions 
 
The KBR1, KBR1.M1, KBR1.M2 and KBR1.M3 coding regions were PCR amplified 
and cloned into the GATEWAY pDONR207 vector (Invitrogen).  Information about 
the primer sequences used can be given. After recombination with pH7WG2D, the 
obtained plasmids were mobilized by the helper plasmid pRK2013 into the 
Agrobacterium tumefaciens C58C1RifR harboring the plasmid pMP90 (Koncz and 
Schell, 1986). Arabidopsis thaliana (L.) Heynh. ecotype Columbia-0 (Col-0) was 
transformed by the floral dip method (Clough and Bent, 1998). 
Transgenic plants were selected on hygromycin-containing medium. Plants were 
grown under a 16-h light/8-h dark photoperiod at 22°C on germination medium, 
unless otherwise stated (Valvekens et al., 1988). Molecular analysis of the obtained 
transformants was performed by RNA gel blot analysis and protein blotting as 
described before (Verkest et al., 2005).  
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Supplementary table. 
 
Binding clone Function Isolated (×) 
 
At1g45976 Putative S-ribonucl. bind. prot. 
SBP1,RFM 
17 
At4g19700  KBR1 10 
At5g47050  Unknown, RFM 6 
At1g43700 VirE2-interacting protein VIP1 6 
At4g24690 Putative protein (Ub-associating 
domain) 
4 
At1g60610  Unknown, RFM 4 
At1g34370 Zn finger protein 4 
At3g27010 Unknown protein, TCP (HLH TF) 4 
At5g45100 Unknown, RFM 3 
At3g09980 Unknown, nuclear protein 2 
At5g10280 MYB TF 2 
At2g02080 Putative C2H2-type Zn finger 
protein 
2 
At5g13920 Putative protein, TCP 2 
At5g42980 Thioredoxin 1 
At1g13440 Glyceraldehyd-3-P dehydrogenase 1 
At3g03460 Hypothetical 1 
At3g27360 HistonH3 1 
At3g27960 Hypothetical 1 
At5g58290 26S proteasome AAA-ATPase 
subunit RPT3 
1 
At2g37290  Hypothetical 1 
At3g12920 Expressed protein, RFM 1 
At4g25530 Homeobox protein FWA 1 
At1g52410 Myosin-like protein 1 
At5g49160 DNA-methyltransferase 1 
O04905 Uridylate kinase 1 
O64903 Nucleoside diphosphate kinase 1 
At1g31780 Unknown 1 
At3g13670 Casein kinase, putative 1 
At3g47620 Putative protein 1 
At1g20640 Nodule inception protein, putative 1 
At1g28210 Putative mitochondrial protein AtJ1 1 
At5g51110 Putative protein 1 
At1g28290 Prolin-rich protein, putative 1 
AC009322_7 Putative splicing factor Prp8 1 
At2g05650 En/Spm-like transposon protein   1 
At5g16720 Putative protein 1 
At1g51950 Aux. regul. protein IAA18 putat. 1 
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Summary 
  
 
In eukaryotic cells, progression through the cell cycle is governed by a suite of 
kinase complexes, which in their minimal configuration consist of a Ser/Thr kinase 
(the cyclin-dependent kinase; CDK) and a regulating cyclin subunit. CDKs 
phosphorylate a plethora of substrates, as such triggering the transition from one 
cell cycle phase into the next one. The sequential and transient activation of 
different CDK/cyclin complexes dictates the unidirectional progression through 
the cell cycle (chapter 1). Because of its importance in growth and development, 
CDK/cyclin activity must be strictly controlled. Negative control of cell cycle 
progression has always received extensive attention, especially in animal 
systems where the inability to correctly exit the cell cycle can eventually result in 
the formation of tumours. CDK activity can be inhibited by several mechanisms. 
Indirectly, kinase activity is inhibited by the controlled degradation of cyclin 
subunits. Direct inhibition of the catalytic activity occurs through the 
phosphorylation of specific residues located in the ATP-binding region of the CDK 
protein. Another active method of CDK inhibition involves the docking of mainly 
small proteins, known as CDK inhibitors (CKIs), which induce a cell cycle arrest 
or delay cell cycle progression in response to intracellular or extracellular signals.  
The Arabidopsis thaliana genome contains seven CKI genes called KRPs (Kip 
related proteins), because of their homology with the mammalian CKIs of the 
Kip/Cip family (chapter 2). Overall, the KRPs display only low sequence identity to 
each other and the Kip/Cip inhibitors. Nevertheless, the plant KRP genes encode 
functional CDK inhibitors. Interaction analysis demonstrated that the KRPs bind 
D-type cyclins and A-type, but not B-type, CDKs. In addition, the KRPs were 
shown to be true biochemical homologues of the Kip/Cip proteins since 
recombinant KRPs are able to inhibit CDK activity in vitro, whereas their 
overexpression in plants results in a decrease in kinase activity in vivo. Also, they 
share the potential of the Kip/Cips to integrate developmental signals with the 
core cell cycle machinery as illustrated by their transcriptional regulation by plant 
hormones. Further transcriptional regulation of the plant inhibitors occurs during 
development and the cell cycle. However, despite accumulating information, little 
is known about the regulation of the plant CDK inhibitors at the post-
transcriptional and post-translational level. Moreover, even though the ability of 
KRPs to act as CDK inhibitors is becoming well established, information is lacking 
regarding their mechanism of CDK binding and inhibition and possible other KRP 
functions.  
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Here, we identified a new role for KRP2 as activator of the mitosis-to-endocycle 
transition (chapter 3). Arabidopsis KRP2 gain-of–function plants display a positive 
or negative effect on the DNA ploidy level, depending on the level of KRP2 
overexpression. The inhibition of the endocycle in strong KRP2OE plants is in 
agreement with previous reported KRPOE studies, but is apparently in 
contradiction with the observed stimulation of the endocycle in weak KRP2OE 
plants. We showed that constitutive expression of KRP2 slightly above its 
endogenous level only inhibited the mitotic cell cycle-specific CDKA;1 kinase 
complexes, whereas the endocycle-specific CDKA;1 complexes were unaffected, 
resulting in an increase in the DNA ploidy level. An identical effect on the 
endocycle could be observed by overexpressing KRP2 exclusively in mitotically 
dividing cells. In agreement with a role for KRP2 as activator of the mitosis-to-
endocycle transition, KRP2 protein levels were more abundant in 
endoreduplicating than in mitotically dividing tissues. We illustrated that KRP2 
protein abundance is regulated posttranscriptionally through CDK 
phosphorylation and proteasomal degradation. KRP2 phosphorylation by the 
mitotic cell cycle-specific CDKB1;1 kinase suggests a mechanism in which 
CDKB1;1 controls the level of CDKA;1 activity through regulating KRP2 protein 
abundance. In accordance to this model, KRP2 protein levels increased in plants 
with reduced CDKB1;1 activity. Moreover, the proposed model allowed a 
dynamical simulation of the in vivo observations, validating the sufficiency of the 
regulatory interactions between CDKA;1, KRP2, and CDKB1;1 in fine-tuning the 
mitosis-to-endocycle transition.  
More detailed analysis of the effect of CDK phosphorylation on KRP2 function and 
stability illustrated that KRP2 phosphorylation by CDKs enhances its degradation 
and results in loss of its binding and inhibitory specificity towards CDKA;1 kinases 
(chapter 4). Interestingly, mitotic CDKB1;1/cyclin complexes do not merely 
phosphorylate KRP2, marking it for destruction, but also only bind phosphorylated 
KRP2. This suggests a mechanism where multisite phosphorylation by CDK 
complexes followed by B-type CDKs enforces KRP2 proteolysis. We have shown 
as well that Arabidopsis CKS1 regulates KRP2 inhibitory activity. Overexpression 
of CKS1 resulted in plants with reduced KRP protein levels due to 
posttranslational regulation. In agreement with a role for CKS1 in KRP2 
proteolysis, CKS1 enhanced the CDKB1;1-dependent phosphorylation of KRP2, 
marking it for destruction. In addition, by competing for CDKA;1 binding, CKS1 
counteracts KRP2-mediated CDKA;1 inhibition, suggesting that KRP2 bound 
CDKA;1/cyclin complexes do not contain CKS1 and vice versa. In contrast, 
phosphorylated KRP2 is able to bind trimeric B-type, but not A-type, 
CDK/cyclin/CKS1 complexes. Although the structural basis for these different 
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complexes still needs to be examined, we suggest that KRP2 associates 
CDK/cyclin complexes differentially as inhibitor than as substrate, and 
hypothesize that CKS1-containing CDK/cyclin complexes only bind KRP2 as a 
substrate. As such, CKS1 helps in phosphorylating KRP2 by CDKs and triggers 
KRP2 degradation by a yet to be identified ubiquitin-ligase.   
To identify the active region(s) of KRP2, a deletion and mutational analysis was 
performed (chapter 5). Deletion of the N-terminal domain enhanced the effects of 
KRP2 in transgenic plants and illustrated a role for the N-terminal sequence in 
regulating KRP protein stability and CDKA;1 affinity. In contrast, deletion of the C-
terminal domain completely abolished the CDK binding activity of KRP2, 
demonstrating its necessity for kinase inhibition. The identification of the plant-
specific cyclin binding domain showed that, even though it efficiently complexes 
CDKA;1/cyclin complexes, it is insufficient for kinase inhibition. Likewise, point 
mutations made in the CDK binding domain of KRP2 confirmed the importance of 
this domain in CDK inhibition. Combined these data demonstrate that CDK 
inhibition by KRP2 requires the presence of both the CDK and cyclin binding 
domains of KRP2 and suggests that CDK/cyclin binding by KRPs, similarly to the 
mammalian Kip/Cip CKIs, mainly occurs through a sequential mechanism 
initiated by cyclin interaction.  Analysis of KRP2 mutants with impaired CDK 
inhibitory activity indicated a possible dual role for KRP2 as both negative and 
positive CDK regulator. Overexpression of KRP2.M3 resulted in Arabidopsis 
plants with a prolonged endocycle program due to an activation of endocycle 
CDKA;1 complexes, illustrating a role of KRP2 in the endocycle. The mechanism 
of CDK activation still needs to be investigated but KRP2 possibly acts as 
targeting and/or assembly factor of “insensitive” endocycle-specific CDK 
complexes. 
Although KRP2, among other plant cell cycle proteins, was shown to be regulated 
by proteolysis it is currently not known which ubiquitin-ligase is responsible for 
KRP degradation. A two-hybrid screen using the Arabidopsis KRP5 led to the 
identification of a RING finger motif containing protein, designated KBR1 (chapter 
6). RING protein genes encode candidate ubiquitin-ligases functioning in protein 
degradation. We show that KBR1 displays in vitro ubiquitin-ligase activity and 
interacts with different KRPs. Moreover, KBR1 was found to associate CDKA;1 
and to be an in vitro CDK substrate, further empathizing that KBR1 functions in 
cell cycle regulation. Analysis of the KRP protein level in Arabidopsis plants 
overexpressing truncated and mutated negative forms of the KBR1 allele 
demonstrated accumulation of KRP2, illustrating that KBR1 regulates KRP 
proteolysis. The identity of the KBR1 containing ubiquitin-ligase awaits further 
examination. Interestingly, dominant negative KBR1 transgenic plants point to a 
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role of KBR1 in the regulation of plant growth during stress. Accordingly, a 
screening for putative KBR1 substrates led to the isolation of several stress-
induced interactors. Based on our data we propose a role for KBR1 as positive 
regulator of the cell cycle by mediating degradation of negative cell cycle 
regulators. Also we suggest that KBR1 might provide a possible interconnection 
between signalling with the environment and the cell cycle.  
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Samenvatting 
  
 
In eukaryote cellen is de progressie doorheen de celcyclus gereguleerd door een 
groep kinase complexen bestaande uit een Ser/Thr kinase (het cycline-
afhankelijke kinase; CDK) en een regulerende cycline sub-unit. De transitie van 
de ene naar de andere celcyclus fase wordt veroorzaakt door de fosforylatie van 
verschillende CDK substraten. Aldus wordt de unidirectionele doorgang doorheen 
de celcyclus gedicteerd door de sequentiële en transiente activatie van 
verschillende CDK/cycline complexen (hoofdstuk 1). CDK/cycline activiteit is strikt 
gereguleerd. Negatieve controle van celcyclus progressie is sterk onderzocht, 
vooral in dierlijke systemen waar incorrecte celcyclus exit kan resulteren in 
tumorgenesis. De activiteit van CDKs wordt negatief gereguleerd door 
verschillende mechanismen. De celcyclus-afhankelijke degradatie van cyclines 
inhibeert CDK activiteit op een indirecte wijze, terwijl directe inhibitie van de 
katalytische activiteit geschiedt door fosforylatie van specifieke aminozuur 
residuen in het ATP-bindend domein van de CDKs. Een andere actieve methode 
van CDK inhibitie  wordt veroorzaakt door binding van laag moleculair gewicht 
eiwitten, gekend als CDK inhibitoren (CKIs), die in respons op intra- of 
extracellulaire signalen een celcyclus arrest of vertraging veroorzaken. 
Het Arabidopsis thaliana genoom bevat zeven CKI genen, die wegens hun 
homologie met de zoogdier CKIs van de Kip/Cip familie KRPs genoemd worden 
(Kip related proteins) (hoofdstuk 2). De KRPs vertonen slechts een lage 
sequentie identiteit onderling en tot de Kip/Cip inhibitoren. Niettemin, coderen ze 
functionele CDK inhibitoren. Interactie analyse toonde aan dat de KRPs D-type 
cyclines en A-type, maar niet B-type, CDKs binden. Bovendien werd aangetoond 
dat ze biochemische homologen zijn van de Kip/Cip eiwitten, daar recombinante 
KRPs in vitro CDK activiteit inhiberen, terwijl hun overexpressie in planten 
resulteert in een daling van de in vivo kinase activiteit. Eveneens delen de KRPs 
het potentieel van Kip/Cips om ontwikkelingssignalen te integreren in de celcyclus 
progressie, daar ze transcriptioneel gereguleerd worden door planthormonen. 
Verdere transcriptionele regulatie van de KRP inhibitors geschiedt tijdens plant 
ontwikkeling en gedurende de celcyclus. Ondanks deze kennis is er echter weinig 
geweten over de regulatie van de plant CDK inhibitoren op het 
posttranscriptioneel en posttranslationeel niveau. Voorts ontbreekt er informatie 
betreffende hun mechanisme van CDK binding en inhibitie en, alhoewel hun rol 
als CDK inhibitors reeds gevestigd is, over mogelijk andere functies van de 
KRPs. 
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Hoofdstuk 3 beschrijft de identificatie van een nieuwe rol voor KRP2 als activator 
van de transitie van de mitotische celcyclus naar de endocyclus. Arabidopsis 
KRP2 overexpressie planten vertonen een positief of negatief effect op het DNA 
ploidy niveau, afhankelijk van het niveau van KRP2 overexpressie. De inhibitie 
van de endocyclus in sterke KRP2OE planten is in overeenstemming met andere 
gepubliceerde KRP overexpressie studies, maar is blijkbaar in tegenspraak met 
de waargenomen stimulatie van endocyclus in zwakke KRP2OE planten. We 
toonden aan dat zwakke ectopische expressie van KRP2 boven het endogeen 
niveau slechts de mitotische celcyclus-specifieke CDKA;1 kinase complexen 
inhibeert en de endocyclus-specifieke CDKA;1 kinase activiteit niet beinvloedt, 
wat resulteert in een toename van het DNA ploidy niveau. Een identiek effect op 
endocyclus werd waargenomen in planten die KRP2 specifiek overexpresseren in 
mitotisch delende weefsels. In overeenstemming met een rol voor KRP2 als 
activator van de mitose-endocyclus overgang zijn KRP2 eiwit niveaus hoger in 
endoreduplicerende dan in mitotische weefsels. We illustreerden dat het KRP2 
proteine posttranslationeel gereguleerd wordt door CDK fosforylatie en 
proteasomale degradatie. Fosforylatie van KRP2 door mitotische celcyclus-
specifieke CDKB1;1 kinasen suggereert bovendien een mechanisme waarin 
CDKB1;1 het niveau van CDKA;1 activiteit controleert via regulatie van het 
proteine niveau van KRP2. In overeenstemming met dit model, accumuleert 
KRP2 in planten met verminderde CDKB1;1 activiteit. Eveneens liet het 
voorgestelde model een dynamische simulatie van de in vivo observaties toe, wat 
de rol van de regulerende interacties tussen CDKA;1, KRP2 en CDKB1;1 in de 
mitose-endocyclus transitie verder confirmeert. 
Een meer gedetailleerde analyse van het effect van CDK fosforylatie op de KRP2 
functie en stabiliteit illustreerde dat KRP2 fosforylatie door CDKs diens stabiliteit 
verlaagt en resulteert in verlies van diens bindings- en inhibitorische specificiteit 
voor CDKA;1 kinasen (hoofdstuk 4). Bovendien blijken mitotische 
CDKB1;1/cycline complexen niet enkel KRP2 te fosforyleren, maar binden ze 
eveneens gefosforyleerd KRP2. Dit suggereert een mechanisme waar multi-site 
fosforylatie door CDKA;1 complexen gevolgd door B-type CDK kinasen resulteert 
in KRP2 proteolyse. Eveneens toonden we aan dat Arabidopsis CKS1 de KRP2 
activiteit reguleert. Overexpressie van CKS1 resulteerde in planten met lagere 
KRP eiwitniveaus ten gevolge van posttranslationele regulatie. In 
overeenstemming met een rol voor CKS1 in KRP2 proteolyse, verhoogde CKS1 
de CDKB1;1-afhankelijke fosforylatie van KRP2, wat resulteert in KRP2 
degradatie. Bovendien competeteert CKS1 met KRP2 voor CDKA;1 interactie wat 
de inhibitie van CDKA;1 complexen door KRP2 vermindert en suggereerd dat 
KRP2 gebonden CDKA;1/cycline complexen geen CKS1 binden en vice versa. 
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Gefosforyleerd KRP2 kan daarentegen wel trimere B-type, en niet A-type, 
CDK/cycline/CKS1 complexen binden. Hoewel de structurele basis voor deze 
verschillende complexen nog moet worden onderzocht, suggereren we dat KRP2 
CDK/cycline kinasen verschillend bindt als inhibitor dan als substraat en stellen 
we dat CKS1 gecomplexeerde CDK/cycline complexen KRP2 enkel als substraat 
binden. Zodoende helpt CKS1 in de fosforylatie van KRP2 door CDKs en 
veroorzaakt het de degradatie van KRP2 door een nog niet geidentificeerd 
ubiquitine-ligase.  
Teneinde de actieve regios van KRP2 te identificeren werd een deletie en 
mutationele analyse van KRP2 uitgevoerd (hoofdstuk 5). De deletie van het N-
terminaal KRP2 domein versterkte het effekt van KRP2 in transgene lijnen en 
suggereert een rol voor de N-terminale sequentie in de regulatie van KRP 
proteine stabiliteit en CDKA; 1 affiniteit. In tegenstelling, veroorzaakte de deletie 
van het C-terminaal domein het volledig verlies van de CDK bindende en 
inhiberende functie van KRP2. De identificatie van het plant-specifieke KRP2 
cycline bindende domein toonde aan dat het, alhoewel het efficient 
CDKA;1/cyclines bindt, onvoldoende is voor kinase ihibitie. Eveneens 
bevestigden gerichte mutaties van residuen in de CDK bindende sequentie van 
KRP2 het belang van dit domein voor CDK inhibitie. Deze resultaten tonen aan 
dat CDK inhibitie de aanwezigheid van zowel het CDK als cycline bindende 
domein van KRP2 vereist. Dit suggereert dat CDK/cycline binding door KRPs, 
zoals de dierlijke Kip/Cip CKIs, voornamelijk geschiedt via een sequenteel 
mechanisme dat door cycline interactie geinitieerd wordt. De analyse van KRP2 
mutanten met gewijzigde CDK inhiberende functies wijst bovendien op een 
mogelijke duale rol voor KRP2 als zowel negatieve als positieve regulator van 
CDKs. Overexpressie van KRP2.M3 resulteerde in Arabidopsis planten met een 
verlengd endocyclus programma ten gevolge van de activatie van endocyclus-
specifieke CDKA;1 complexen. Dit illustreert een regulerende functie van KRP2 in 
de endocyclus. Alhoewel het mechanisme van CDK activatie nog moet worden 
onderzocht functioneert KRP2 eventueel als targeting- en/of assemblagefactor 
van niet inhibeerbare endocyclus-specifieke CDK complexen. 
Hoewel KRP2, net als andere plant celcyclus proteinen, gereguleerd wordt door 
proteolyse is het momenteel niet geweten welk ubiquitine-ligase de degradatie 
van KRPs veroorzaakt. Een gist two-hybrid   screening met Arabidopsis KRP5 
leidde tot de identificatie van een RING finger motief bevattend eiwit genaamd 
KBR1 (hoofdstuk 6). RING finger proteinen zijn kandidaat ubiquitine-ligasen die in 
eiwitdegradatie functioneren. We toonden aan dat KBR1 in vitro ubiquitine-ligase 
activiteit bezit en interageert met verschillende KRPs. Voorts bindt KBR1 CDKA;1 
en is het een in vitro CDK substraat, wat verder suggereert dat KBR1 een rol in 
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de celcyclus heeft. Analyse van het KRP eiwitniveau in Arabidopsis planten die 
negatieve vormen van het KBR1 alleel overexpresseren toonden accumulatie van 
KRP2 aan en illustreren dat KBR1 KRP proteolyse regelt. Bovendien, suggereren 
deze transgene planten dat KBR1 een functie heeft in de regulatie van 
plantengroei tijdens stress. Dusdanig, resulteerde een screening naar vermeende 
KBR1 substraten tot de isolatie van verscheidene stress geinduceerde 
interactors. Gebaseerd op onze gegevens stellen we een functie van  KBR1 als 
positieve regulator van de celcyclus voor, door degradatie van de negatieve 
regulators van de celcyclus te bemiddelen. Ook suggereren we dat KBR1 een 
mogelijke interconnectie vormt tussen het signaleren met de omgeving en de 
celcyclus. 
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Abstract 
   
 
In plant cells, overexpression of critical genes can be hampered by deleterious 
effects on development that results in a counterselection of transgenic cells 
harboring the gene of interest. Inducible expression systems have been reported, 
but many of them show unwanted leaky expression. To circumvent this potential 
problem, a novel inducible system was developed based on two previously 
characterized systems: the CRE-loxP site-specific recombination system of 
bacteriophage P1 and the subcellular targeting of proteins by a mammalian 
glucocorticoid receptor (GR). By fusing the receptor domain of the rat GR to the 
carboxyl terminus of the CRE recombinase, a double-lock conditional 
transcriptional induction system was created that is highly useful to overexpress 
genes whose expression may block transgenic regeneration. Furthermore, 
because the designed vector utilizes the GATEWAY  recombination 
technology, cloning was restriction- and ligation-free, thus rendering the vector 
suitable for high-throughput research. The system was tested in Nicotiana 
tabacum bright yellow-2 (BY-2) cells and its efficiency was demonstrated for the 
controlled overexpression of the gus reporter gene and a mutant allele of the A-
type cyclin-dependent kinase (CDKA), which is known to be a potent inhibitor of 
the cell cycle. 
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Abstract  
   
 
Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle. In yeast, only 
one CDK is sufficient to drive cells through the cell cycle, whereas higher 
eukaryotes developed a family of related CDKs. Curiously, plants contain a unique 
class of CDKs (B-type CDKs), whose function is still unclear. We show that the 
CDKB1;1 gene of Arabidopsis (Arabidopsis thaliana) is highly expressed in guard 
cells and stomatal precursor cells of cotyledons, suggesting a prominent role for B-
type CDKs in stomatal development. In accordance, transgenic Arabidopsis plants 
with reduced B-type CDK activity had a decreased stomatal index because of an 
early block of meristemoid division and inhibition of satellite meristemoid formation. 
Many aberrant stomatal cells were observed, all of them blocked in the G2 phase of 
the cell cycle. Although division of stomatal precursors was inhibited, cells still 
acquired stomatal identity, illustrating that stomatal cell differentiation is independent 
of cellular and nuclear division. 
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